POPULARITY
5 episodes with medrxiv
2 episodes with medrxiv
3 episodes with medrxiv
2 episodes with medrxiv
2 episodes with medrxiv
2 episodes with medrxiv
2 episodes with medrxiv
2 episodes with medrxiv
7 episodes with medrxiv
En este episodio entrevistamos a Bernat de las Heras, investigador en neurorehabilitación y experto en neuroplasticidad post-ictus. Desde su formación inicial en Ciencias del Deporte hasta su doctorado en la Universidad McGill, Bernat ha explorado cómo el ejercicio cardiovascular —en especial el aeróbico y HIIT— puede modular la neuroplasticidad cerebral tras un ictus. Bernat nos explica los beneficios y limitaciones del entrenamiento interválico de alta intensidad, su percepción por parte de los pacientes, y cómo combinarlo de forma efectiva con otras estrategias terapéuticas. Hablamos también de aprendizaje y localización de la lesión. Una conversación profunda y práctica para entender los límites actuales de la evidencia, y al mismo tiempo, abrir nuevas vías para la rehabilitación neurológica individualizada. Referencias del episodio: 1) Ploughman, M., Attwood, Z., White, N., Doré, J. J., & Corbett, D. (2007). Endurance exercise facilitates relearning of forelimb motor skill after focal ischemia. The European journal of neuroscience, 25(11), 3453–3460. https://doi.org/10.1111/j.1460-9568.2007.05591.x (https://pubmed.ncbi.nlm.nih.gov/17553014/). 2) Jeffers, M. S., & Corbett, D. (2018). Synergistic Effects of Enriched Environment and Task-Specific Reach Training on Poststroke Recovery of Motor Function. Stroke, 49(6), 1496–1503. https://doi.org/10.1161/STROKEAHA.118.020814 (https://pubmed.ncbi.nlm.nih.gov/29752347/). 3) De Las Heras, B., Rodrigues, L., Cristini, J., Moncion, K., Ploughman, M., Tang, A., Fung, J., & Roig, M. (2024). Measuring Neuroplasticity in Response to Cardiovascular Exercise in People With Stroke: A Critical Perspective. Neurorehabilitation and neural repair, 38(4), 303–321. https://doi.org/10.1177/15459683231223513 (https://pubmed.ncbi.nlm.nih.gov/38291890/). 4) Roig, M., & de Las Heras, B. (2018). Acute cardiovascular exercise does not enhance locomotor learning in people with stroke. The Journal of physiology, 596(10), 1785–1786. https://doi.org/10.1113/JP276172 (https://pubmed.ncbi.nlm.nih.gov/29603752/). 5) Rodrigues, L., Moncion, K., Eng, J. J., Noguchi, K. S., Wiley, E., de Las Heras, B., Sweet, S. N., Fung, J., MacKay-Lyons, M., Nelson, A. J., Medeiros, D., Crozier, J., Thiel, A., Tang, A., & Roig, M. (2022). Intensity matters: protocol for a randomized controlled trial exercise intervention for individuals with chronic stroke. Trials, 23(1), 442. https://doi.org/10.1186/s13063-022-06359-w (https://pubmed.ncbi.nlm.nih.gov/35610659/). 6) Cristini, J., Kraft, V. S., De Las Heras, B., Rodrigues, L., Parwanta, Z., Hermsdörfer, J., Steib, S., & Roig, M. (2023). Differential effects of acute cardiovascular exercise on explicit and implicit motor memory: The moderating effects of fitness level. Neurobiology of learning and memory, 205, 107846. https://doi.org/10.1016/j.nlm.2023.107846 (https://pubmed.ncbi.nlm.nih.gov/37865261/). 7) Moncion, K., Rodrigues, L., De Las Heras, B., Noguchi, K. S., Wiley, E., Eng, J. J., MacKay-Lyons, M., Sweet, S. N., Thiel, A., Fung, J., Stratford, P., Richardson, J. A., MacDonald, M. J., Roig, M., & Tang, A. (2024). Cardiorespiratory Fitness Benefits of High-Intensity Interval Training After Stroke: A Randomized Controlled Trial. Stroke, 55(9), 2202–2211. https://doi.org/10.1161/STROKEAHA.124.046564 (https://pubmed.ncbi.nlm.nih.gov/39113181/). 8) De las Heras, B., Rodrigues, L., Cristini, J., Moncion, K., Dancause, N., Thiel, A., Edwards, J. D., Eng, J. J., Tang, A., & Roig, M. (2024). Lesion location changes the association between brain excitability and motor skill acquisition post-stroke. medRxiv. https://doi.org/10.1101/2024.07.30.24311146 (https://www.medrxiv.org/content/10.1101/2024.07.30.24311146v1.article-info). 9) Rodrigues, L., Moncion, K., Angelopoulos, S. A., Heras, B. L., Sweet, S., Eng, J. J., Fung, J., MacKay-Lyons, M., Tang, A., & Roig, M. (2025). Psychosocial Responses to a Cardiovascular Exercise Randomized Controlled Trial: Does Intensity Matter for Individuals Post-stroke?. Archives of physical medicine and rehabilitation, S0003-9993(25)00498-8. Advance online publication. https://doi.org/10.1016/j.apmr.2025.01.468 (https://pubmed.ncbi.nlm.nih.gov/39894292/). 10) de Las Heras, B., Rodrigues, L., Cristini, J., Weiss, M., Prats-Puig, A., & Roig, M. (2022). Does the Brain-Derived Neurotrophic Factor Val66Met Polymorphism Modulate the Effects of Physical Activity and Exercise on Cognition?. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 28(1), 69–86. https://doi.org/10.1177/1073858420975712 (https://pubmed.ncbi.nlm.nih.gov/33300425/). 11) MacKay-Lyons, M., Billinger, S. A., Eng, J. J., Dromerick, A., Giacomantonio, N., Hafer-Macko, C., Macko, R., Nguyen, E., Prior, P., Suskin, N., Tang, A., Thornton, M., & Unsworth, K. (2020). Aerobic Exercise Recommendations to Optimize Best Practices in Care After Stroke: AEROBICS 2019 Update. Physical therapy, 100(1), 149–156. https://doi.org/10.1093/ptj/pzz153 (https://pubmed.ncbi.nlm.nih.gov/31596465/).
Liberty Dispatch - Episode 316 ~ March 07, 2025In this episode of Liberty Dispatch, host Andrew DeBartolo talks about Canada's next PM, government corruption and some COVID fallout. Mark Carney might be in his honeymoon phase, and he might be our first-ever totally unelected PM, but his corruption, elitism, and lies are being exposed day by day. Subscribe or follow our new Substack page: https://ldcanada.substack.com/; Segment 1 - Get Ready for High Chancellor Carney:Matthew Lau: Carney’s spending plan would put even Trudeau to shame | National Post: https://nationalpost.com/opinion/matthew-lau-carneys-spending-plan-would-put-even-trudeau-to-shame;Carney’s budgeting proposal a disaster for Alberta | National Post: https://nationalpost.com/news/canada/carneys-budgeting-proposal-disaster-alberta;Tories question Carney on whether he divested from conflict-of-interest companies | Western Standard: https://www.westernstandard.news/news/tories-question-carney-on-whether-he-divested-from-conflict-of-interest-companies/62408;Rebel News: Video on Carney’s potential conflicts | X: https://x.com/RebelNewsOnline/status/1892980839102796106;Carney, Trudeau found to be heavily linked to Beijing, WEF in new exposé | Western Standard: https://www.westernstandard.news/news/carney-trudeau-found-to-be-heavily-linked-to-beijing-wef-in-new-expose/62552;Mark Carney leads Pierre Poilievre by 14 points as the best candidate to negotiate with Trump | Cult MTL: https://cultmtl.com/2025/02/mark-carney-leads-pierre-poilievre-by-14-points-as-the-best-candidate-to-negotiate-with-trump;Will Trump’s tariffs rob victory from Poilievre? | The Free Press: https://www.thefp.com/p/will-trumps-tariffs-rob-victory-from;Betting markets still roundly predicting a Poilievre win | National Post: https://nationalpost.com/opinion/betting-markets-still-roundly-predicting-a-poilievre-win?s=09 Segment 2 -Canada's UNBELIEVABLY Corrupt Politicians:Ford unveils PC election platform in Ontario campaign | CBC News: https://www.cbc.ca/news/canada/toronto/ford-pc-election-platform-ontario-campaign-1.7466800;Ford to end MPP pay freeze | Juno News: https://www.junonews.com/p/ford-to-end-mpp-pay-freeze;Trudeau commits military aid to Ukraine during peace talks | Rebel News: https://www.rebelnews.com/trudeau_commits_military_aid_to_ukraine_during_peace_talks;Poilievre vows to ‘always stand with Ukraine’ as third year of Russian war begins | CTV News: https://www.ctvnews.ca/politics/article/poilievre-vows-to-always-stand-with-ukraine-as-third-year-of-russian-war-begins;Canada getting high-speed internet expansion | Prime Minister of Canada: https://www.pm.gc.ca/en/news/news-releases/2025/02/19/canada-getting-high-speed;Concerned citizen comments on policy decisions | X: https://x.com/Concern70732755/status/1892287255722492209; Segment 3 - COVID Clean-Up:Research paper on COVID-19 study | medRxiv: https://www.medrxiv.org/content/10.1101/2025.02.18.25322379v1.full.pdf;Wuhan lab conducts ominous experiments as new COVID strain emerges | Rebel News: https://www.rebelnews.com/wuhan_lab_conducts_ominous_experiments_new_covid_emerges;COVID vaccines linked to new syndrome and biological changes, Yale study finds | Daily Mail: https://www.dailymail.co.uk/health/article-14414367/covid-vaccines-new-syndrome-biological-changes-yale.html;FDA admits COVID-vaccinated individuals may be at risk for blood clots for up to 15 years | Slay News: https://slaynews.com/news/fda-admits-covid-vaccinated-risk-blood-clots-15-years;Medical study on COVID-19 implications | International Journal of Innovative Research in Medical Sciences (IJIRMS): https://ijirms.in/index.php/ijirms/article/view/2035;Scientists discover new bat coronavirus in China, raising pandemic fears | UNILAD Tech: https://www.uniladtech.com/science/news/scientists-discover-bat-coronavirus-china-pandemic-fears-764544-20250224;Experts predicted COVID, now warn of a new virus that could threaten all mankind | UNILAD Tech: https://www.uniladtech.com/science/news/experts-predicted-covid-new-virus-threaten-all-mankind-760947-20250207.SHOW SPONSORS:Invest with Rocklinc: info@rocklinc.com or call them at 905-631-546; Diversify Your Money with Bull Bitcoin: https://mission.bullbitcoin.com/dispatch;BarterPay: https://barterpay.ca/; Barter It: https://www.barterit.ca/;Get freedom from Censorious CRMs by signing up for SalesNexus: https://www.salesnexus.com/;PLEXUS Worldwide: Reboot your health today! email them @ healthandliberty@proton.me or go to http://plexusworldwide.ca/healthandliberty; SUBSCRIBE TO OUR SHOWS/CHANNELS:LIBERTY DISPATCH PODCAST: https://libertydispatch.podbean.com; https://rumble.com/LDshow; CONTACT US: libertydispatch@pm.me STAY UP-TO-DATE ON ALL THINGS LD:Instagram: https://www.instagram.com/liberty_dispatch/; Facebook: https://www.facebook.com/LibertyDispatchCanada; X: @LDCanada - https://x.com/_LDCanada; Rumble: https://rumble.com/LDshow; YouTube: https://www.youtube.com/@libertydispatch Please LIKE, SUBSCRIBE, RATE, & REVIEW, and SHARE it with others!
Liberty Dispatch - Episode 316 ~ March 07, 2025 In this episode of Liberty Dispatch, host Andrew DeBartolo talks about Canada's next PM, government corruption and some COVID fallout. Mark Carney might be in his honeymoon phase, and he might be our first-ever totally unelected PM, but his corruption, elitism, and lies are being exposed day by day. Subscribe or follow our new Substack page: https://ldcanada.substack.com/; Segment 1 - Get Ready for High Chancellor Carney: Matthew Lau: Carney's spending plan would put even Trudeau to shame | National Post: https://nationalpost.com/opinion/matthew-lau-carneys-spending-plan-would-put-even-trudeau-to-shame; Carney's budgeting proposal a disaster for Alberta | National Post: https://nationalpost.com/news/canada/carneys-budgeting-proposal-disaster-alberta; Tories question Carney on whether he divested from conflict-of-interest companies | Western Standard: https://www.westernstandard.news/news/tories-question-carney-on-whether-he-divested-from-conflict-of-interest-companies/62408; Rebel News: Video on Carney's potential conflicts | X: https://x.com/RebelNewsOnline/status/1892980839102796106; Carney, Trudeau found to be heavily linked to Beijing, WEF in new exposé | Western Standard: https://www.westernstandard.news/news/carney-trudeau-found-to-be-heavily-linked-to-beijing-wef-in-new-expose/62552; Mark Carney leads Pierre Poilievre by 14 points as the best candidate to negotiate with Trump | Cult MTL: https://cultmtl.com/2025/02/mark-carney-leads-pierre-poilievre-by-14-points-as-the-best-candidate-to-negotiate-with-trump; Will Trump's tariffs rob victory from Poilievre? | The Free Press: https://www.thefp.com/p/will-trumps-tariffs-rob-victory-from; Betting markets still roundly predicting a Poilievre win | National Post: https://nationalpost.com/opinion/betting-markets-still-roundly-predicting-a-poilievre-win?s=09 Segment 2 -Canada's UNBELIEVABLY Corrupt Politicians: Ford unveils PC election platform in Ontario campaign | CBC News: https://www.cbc.ca/news/canada/toronto/ford-pc-election-platform-ontario-campaign-1.7466800; Ford to end MPP pay freeze | Juno News: https://www.junonews.com/p/ford-to-end-mpp-pay-freeze; Trudeau commits military aid to Ukraine during peace talks | Rebel News: https://www.rebelnews.com/trudeau_commits_military_aid_to_ukraine_during_peace_talks; Poilievre vows to ‘always stand with Ukraine' as third year of Russian war begins | CTV News: https://www.ctvnews.ca/politics/article/poilievre-vows-to-always-stand-with-ukraine-as-third-year-of-russian-war-begins; Canada getting high-speed internet expansion | Prime Minister of Canada: https://www.pm.gc.ca/en/news/news-releases/2025/02/19/canada-getting-high-speed; Concerned citizen comments on policy decisions | X: https://x.com/Concern70732755/status/1892287255722492209; Segment 3 - COVID Clean-Up: Research paper on COVID-19 study | medRxiv: https://www.medrxiv.org/content/10.1101/2025.02.18.25322379v1.full.pdf; Wuhan lab conducts ominous experiments as new COVID strain emerges | Rebel News: https://www.rebelnews.com/wuhan_lab_conducts_ominous_experiments_new_covid_emerges; COVID vaccines linked to new syndrome and biological changes, Yale study finds | Daily Mail: https://www.dailymail.co.uk/health/article-14414367/covid-vaccines-new-syndrome-biological-changes-yale.html; FDA admits COVID-vaccinated individuals may be at risk for blood clots for up to 15 years | Slay News: https://slaynews.com/news/fda-admits-covid-vaccinated-risk-blood-clots-15-years; Medical study on COVID-19 implications | International Journal of Innovative Research in Medical Sciences (IJIRMS): https://ijirms.in/index.php/ijirms/article/view/2035; Scientists discover new bat coronavirus in China, raising pandemic fears | UNILAD Tech: https://www.uniladtech.com/science/news/scientists-discover-bat-coronavirus-china-pandemic-fears-764544-20250224; Experts predicted COVID, now warn of a new virus that could threaten all mankind | UNILAD Tech: https://www.uniladtech.com/science/news/experts-predicted-covid-new-virus-threaten-all-mankind-760947-20250207. SHOW SPONSORS: Invest with Rocklinc: info@rocklinc.com or call them at 905-631-546; Diversify Your Money with Bull Bitcoin: https://mission.bullbitcoin.com/dispatch; BarterPay: https://barterpay.ca/; Barter It: https://www.barterit.ca/; Get freedom from Censorious CRMs by signing up for SalesNexus: https://www.salesnexus.com/; PLEXUS Worldwide: Reboot your health today! email them @ healthandliberty@proton.me or go to http://plexusworldwide.ca/healthandliberty; SUBSCRIBE TO OUR SHOWS/CHANNELS: LIBERTY DISPATCH PODCAST: https://libertydispatch.podbean.com; https://rumble.com/LDshow; CONTACT US: libertydispatch@pm.me STAY UP-TO-DATE ON ALL THINGS LD: Instagram: https://www.instagram.com/liberty_dispatch/; Facebook: https://www.facebook.com/LibertyDispatchCanada; X: @LDCanada - https://x.com/_LDCanada; Rumble: https://rumble.com/LDshow; YouTube: https://www.youtube.com/@libertydispatch Please LIKE, SUBSCRIBE, RATE, & REVIEW, and SHARE it with others!
Liberty Dispatch - Episode 316 ~ March 07, 2025In this episode of Liberty Dispatch, host Andrew DeBartolo talks about Canada's next PM, government corruption and some COVID fallout. Mark Carney might be in his honeymoon phase, and he might be our first-ever totally unelected PM, but his corruption, elitism, and lies are being exposed day by day. Subscribe or follow our new Substack page: https://ldcanada.substack.com/; Segment 1 - Get Ready for High Chancellor Carney:Matthew Lau: Carney’s spending plan would put even Trudeau to shame | National Post: https://nationalpost.com/opinion/matthew-lau-carneys-spending-plan-would-put-even-trudeau-to-shame;Carney’s budgeting proposal a disaster for Alberta | National Post: https://nationalpost.com/news/canada/carneys-budgeting-proposal-disaster-alberta;Tories question Carney on whether he divested from conflict-of-interest companies | Western Standard: https://www.westernstandard.news/news/tories-question-carney-on-whether-he-divested-from-conflict-of-interest-companies/62408;Rebel News: Video on Carney’s potential conflicts | X: https://x.com/RebelNewsOnline/status/1892980839102796106;Carney, Trudeau found to be heavily linked to Beijing, WEF in new exposé | Western Standard: https://www.westernstandard.news/news/carney-trudeau-found-to-be-heavily-linked-to-beijing-wef-in-new-expose/62552;Mark Carney leads Pierre Poilievre by 14 points as the best candidate to negotiate with Trump | Cult MTL: https://cultmtl.com/2025/02/mark-carney-leads-pierre-poilievre-by-14-points-as-the-best-candidate-to-negotiate-with-trump;Will Trump’s tariffs rob victory from Poilievre? | The Free Press: https://www.thefp.com/p/will-trumps-tariffs-rob-victory-from;Betting markets still roundly predicting a Poilievre win | National Post: https://nationalpost.com/opinion/betting-markets-still-roundly-predicting-a-poilievre-win?s=09 Segment 2 -Canada's UNBELIEVABLY Corrupt Politicians:Ford unveils PC election platform in Ontario campaign | CBC News: https://www.cbc.ca/news/canada/toronto/ford-pc-election-platform-ontario-campaign-1.7466800;Ford to end MPP pay freeze | Juno News: https://www.junonews.com/p/ford-to-end-mpp-pay-freeze;Trudeau commits military aid to Ukraine during peace talks | Rebel News: https://www.rebelnews.com/trudeau_commits_military_aid_to_ukraine_during_peace_talks;Poilievre vows to ‘always stand with Ukraine’ as third year of Russian war begins | CTV News: https://www.ctvnews.ca/politics/article/poilievre-vows-to-always-stand-with-ukraine-as-third-year-of-russian-war-begins;Canada getting high-speed internet expansion | Prime Minister of Canada: https://www.pm.gc.ca/en/news/news-releases/2025/02/19/canada-getting-high-speed;Concerned citizen comments on policy decisions | X: https://x.com/Concern70732755/status/1892287255722492209; Segment 3 - COVID Clean-Up:Research paper on COVID-19 study | medRxiv: https://www.medrxiv.org/content/10.1101/2025.02.18.25322379v1.full.pdf;Wuhan lab conducts ominous experiments as new COVID strain emerges | Rebel News: https://www.rebelnews.com/wuhan_lab_conducts_ominous_experiments_new_covid_emerges;COVID vaccines linked to new syndrome and biological changes, Yale study finds | Daily Mail: https://www.dailymail.co.uk/health/article-14414367/covid-vaccines-new-syndrome-biological-changes-yale.html;FDA admits COVID-vaccinated individuals may be at risk for blood clots for up to 15 years | Slay News: https://slaynews.com/news/fda-admits-covid-vaccinated-risk-blood-clots-15-years;Medical study on COVID-19 implications | International Journal of Innovative Research in Medical Sciences (IJIRMS): https://ijirms.in/index.php/ijirms/article/view/2035;Scientists discover new bat coronavirus in China, raising pandemic fears | UNILAD Tech: https://www.uniladtech.com/science/news/scientists-discover-bat-coronavirus-china-pandemic-fears-764544-20250224;Experts predicted COVID, now warn of a new virus that could threaten all mankind | UNILAD Tech: https://www.uniladtech.com/science/news/experts-predicted-covid-new-virus-threaten-all-mankind-760947-20250207.SHOW SPONSORS:Invest with Rocklinc: info@rocklinc.com or call them at 905-631-546; Diversify Your Money with Bull Bitcoin: https://mission.bullbitcoin.com/dispatch;BarterPay: https://barterpay.ca/; Barter It: https://www.barterit.ca/;Get freedom from Censorious CRMs by signing up for SalesNexus: https://www.salesnexus.com/;PLEXUS Worldwide: Reboot your health today! email them @ healthandliberty@proton.me or go to http://plexusworldwide.ca/healthandliberty; SUBSCRIBE TO OUR SHOWS/CHANNELS:LIBERTY DISPATCH PODCAST: https://libertydispatch.podbean.com; https://rumble.com/LDshow; CONTACT US: libertydispatch@pm.me STAY UP-TO-DATE ON ALL THINGS LD:Instagram: https://www.instagram.com/liberty_dispatch/; Facebook: https://www.facebook.com/LibertyDispatchCanada; X: @LDCanada - https://x.com/_LDCanada; Rumble: https://rumble.com/LDshow; YouTube: https://www.youtube.com/@libertydispatch Please LIKE, SUBSCRIBE, RATE, & REVIEW, and SHARE it with others!
Do you feel like your attention is fractured? Maybe you move through the day scattered, only to realize that you missed some good stuff along the way. In this episode, we'll talk about the practice of savoring, a simple skill that can help us regain control of our attention amidst the constant distractions of modern life. If you enjoyed this episode, please rate and review us wherever you listen to your favorite podcasts! Sources and Notes: Joy Lab Program: Take the next leap in your wellbeing journey with step-by-step practices to help you build and maintain the elements of joy in your life. Intentional Systemic Mindfulness Finan, P. H., et al. (2023). Effects of Savoring Meditation on Positive Emotions and Pain-Related Brain Function: A Mechanistic Randomized Controlled Trial in People With Rheumatoid Arthritis. medRxiv. Access here. Full transcript available here. Please remember that this content is for informational and educational purposes only. It is not intended to provide medical advice and is not a replacement for advice and treatment from a medical professional. Please consult your doctor or other qualified health professional before beginning any diet change, supplement, or lifestyle program. Please see our terms for more information. If you or someone you know is struggling or in crisis, help is available. Call the NAMI HelpLine: 1-800-950-6264 available Monday through Friday, 10 a.m. – 10 p.m., ET. OR text "HelpLine" to 62640 or email NAMI at helpline@nami.org. Visit NAMI for more. You can also call or text SAMHSA at 988 or chat 988lifeline.org.
Don't miss this new editorial from Harlan M Krumholz, MD, SM, FACC, FAHA, and Joshua D. Wallach, PhD, MS, which discusses the transformative role of preprints in scientific publishing, particularly in cardiovascular research, highlighting their potential to accelerate discoveries, foster collaboration, and increase transparency. It outlines the updated policy of the JACC that encourages authors to post preprints before submission, emphasizes transparency and version control, and integrates with medRxiv for seamless submission processes. The piece also addresses concerns about preprints, emphasizing their rigorous screening process and the benefits for authors in terms of visibility, feedback, and research quality.
Cristina guest hosts her first episode with special guest Dr. Marina Watowich: an Evolutionary Biologist and current NIH F32 Postdoctoral Research Fellow in the Department of Biological Sciences at Vanderbilt University. Dr. Watowich earned her Ph.D. in Biology in 2022 from the University of Washington, where she specialized in Data Science. Her research focuses on how environmental perturbations impact long-term health-related phenotypes and why some individuals are more resilient/susceptible to adverse conditions. To do this, she uses a combination of genomic approaches, computational techniques, and long-term observational data to understand how the environment 'gets under the skin' to result in phenotypic variation. Marina was recently awarded an F32 grant from the National Institutes of Aging to explore the consequences of differential immune investment on molecular aging phenotypes in subsistence-level populations. ------------------------------ Find the papers discussed in this episode: Watowich, Marina M., et al. "Natural disaster and immunological aging in a nonhuman primate." Proceedings of the National Academy of Sciences 119.8 (2022): e2121663119. Watowich, M. M., Arner, A. M., Wang, S., John, E., Kahumbu, J. C., Kinyua, P., ... & Lea, A. J. (2024). The built environment is more predictive of cardiometabolic health than other aspects of lifestyle in two rapidly transitioning Indigenous populations. medRxiv. ------------------------------ Contact Marina: website: https://mwatowich.github.io/; email: marina.watowich@vanderbilt.edu ------------------------------ Contact the Sausage of Science Podcast and Human Biology Association: Facebook: facebook.com/groups/humanbiologyassociation/, Website: humbio.org, Twitter: @HumBioAssoc Cristina Gildee, Host, SoS Co-Producer, HBA Junior Fellow Website: cristinagildee.org, E-mail: cgildee@uw.edu
Professor David Putrino is a physiotherapist with a PhD in Neuroscience. He is currently the Director of Rehabilitation Innovation for the Mount Sinai Health System, and a Professor in the Department of Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai. Professor Putrino recently opened the Mount Sinai Cohen Center for Recovery from Complex Chronic Illness in New York also known as (CoRE) and serves as CoRE's Family Director and is also a member of PolyBio's Long COVID Research Consortium.Today we talk about the pathophysiology of Long COVID in the context of describing research into targeted treatments for the disease.REFERENCES1 Proal AD, VanElzakkerMB, Aleman S, Bach K, Boribong BP, Buggert M, Cherry S, Chertow DS, Davies HE, Dupont CL, Deeks SG. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19(PASC). Nature Immunology. 2023 Oct;24(10):1616-27.2 Klein J, Wood J,Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, Tabachnikova A, Greene K, Tabacof L, Malik AA, Silva Monteiro V. Distinguishing features of Long COVID identified through immune profiling. Nature. 2023 Nov 2;623(7985):139-48.3 Long COVID low-dose Rapamycin clinical trial4 Lumbrokinase LongCOVID & ME/CFS clinical trial5 Silva J, Takahashi T, Wood J, Lu P, Tabachnikova A, Gehlhausen JR, Greene K,Bhattacharjee B, Monteiro VS, Lucas C, Dhodapkar RM. Sex differences insymptomatology and immune profiles of Long COVID. medRxiv. 2024 Mar 2:2024-02.6 VanElzakker MB, Bues HF, Brusaferri L, Kim M, Saadi D, Ratai EM, Dougherty DD, Loggia ML. Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C] PBR28 PET correlates with vascular disease measures. Brain, Behavior, and Immunity.7 Fernández-CastañedaA, Lu P, Geraghty AC, Song E, Lee MH, Wood J, O'Dea MR, Dutton S, Shamardani K, Nwangwu K, Mancusi R. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022 Jul 7;185(14):2452-68.
Evolution Radio Show - Alles was du über Keto, Low Carb und Paleo wissen musst
Folge ansehen oder anhören auf YouTube I Apple Podcasts I SpotifyDanke an die WerbepartnerProdotti Amano - Gesichtspflege aus 9 hochwertigen Bio-Ölen - ohne jegliche Zusatzstoffe. Das geniale Bio-Gesichtsöl findest du auf prodottiamano.com.Mit dem Code JULIA10 bekommst du 10% Rabatt auf die Bestellung deines Bio-Gesichtsöls.http://www.prodottiamano.com Kapitel00:00 Das erwartet dich in der Folge02:19 Prododtti Amano - Bio Gesichtsöl aus Oliven04:27 Begrüßung und Ally erzählt über seine Herausforderungen mit Angsttörungen, Depressionen und ADHS08:16 Über seinen Professor findet er zur ketogenen Ernährung10:59 Das Problem der modernen Medizin - wir denken in Silos19:06 Allys erste Schritte in die ketogene Diät - Fehler und was er gelernt hat24:11 Milch und Milchprodukte36:25 Ketone messen, Fasten und ausreichende Versorgung mit Mikronährstoffen40:49 KetoFeel Studie - was wird gemacht und wie läuft sie abWir sprechen überWir sprechen über Allys' persönliche Reise und seine wichtigen Erkenntnisse.Die Geburtsstunde einer komplett neuen Fachrichtung: Metabolic Psychiatriy und den Aktuellen Wissensstand und die Zukunft der ketogenic metabolic therapy für psychiatrische Erkrankungen.Individualisierung ist zentral: Es ist wichtig, die individuellen Bedürfnisse und Reaktionen des Körpers bei der Anpassung der ketogenen Diät zu berücksichtigen. Nahrungsmittelunverträglichkeiten und -allergien können eine Rolle bei mentalen Gesundheitsproblemen spielen.Milchprodukte - ja oder nein? Die KetoFeel Studie - Ally erklärt worum es in der Studie gehen wird und wie sie aufgebaut sein wird. https://www.gofundme.com/f/ketofeel-oxford-studyAlles über Ally Houstonhttps://metpsy.com/Ally war in seinem “früheren” Leben Physiker. Nachdem er unter ADHS, saisonaler Depression, chronischer Angst und einer Reihe anderer metabolischer Probleme gelitten hatte, führte eine paläo-ketogene Diät und Lebensstiländerungen zu einem Quantensprung in seiner Gesundheit. Der Effekt war so tiefgreifend, dass er den Beruf wechselte. Er ist jetzt metabolic mental health Coach, ausgebildet von PreKure und Dr. Georgia Ede. Im Jahr 2025 wird er an der Universität Oxford eine Studie leiten, die die ketogene Diät plus MetPsy für ADHS mit Depression testet.https://baszuckigroup.com/https://www.metabolicmind.org/Relevante ArtikelDr. Georgia Ede https://www.diagnosisdiet.com/Calabrese, Lori, Rachel Frase, and Mariam Ghaloo. "Complete remission of depression and anxiety using a ketogenic diet: case series." Frontiers in Nutrition 11 (2024): 1396685. https://www.frontiersin.org/articles/10.3389/fnut.2024.1396685/fullCampbell, Iain H., et al. "A Pilot Study of a Ketogenic Diet in Bipolar Disorder: Clinical, Metabolomic and Magnetic Resonance Spectroscopy Outcomes." medRxiv (2023): 2023-10. https://www.medrxiv.org/content/10.1101/2023.05.28.23290595v1Dietch, D.M. et al. (2023) ‘Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: systematic review and implications for clinical practice', BJPsych Open, 9(3), p. e70. Available at: https://doi.org/10.1192/bjo.2023.36.Danan, A. et al. (2022) ‘The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients', Frontiers in Psychiatry, 13, p. 951376. Available at: https://doi.org/10.3389/fpsyt.2022.951376.Omori, N.E. et al. (2023) ‘Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders', Frontiers in Psychiatry, 14, p. 1142682. Available at: https://doi.org/10.3389/fpsyt.2023.1142682.Sethi S, Ford JM. The Role of Ketogenic Metabolic Therapy on the Brain in Serious Mental Illness: A Review. Journal of Psychiatry and Brain Science. 2022;7(5). doi:10.20900/jpbs.20220009Mentzelou, M. et al. (2023) ‘The Relationship of Ketogenic Diet with Neurodegenerative and Psychiatric Diseases: A Scoping Review from Basic Research to Clinical Practice', Nutrients, 15(10), p. 2270. Available at: https://doi.org/10.3390/nu15102270.Tillery EE, Ellis KD, Threatt TB, Reyes HA, Plummer CS, Barney LR. The use of the ketogenic diet in the treatment of psychiatric disorders. Mental Health Clinician. 2021;11(3):211-219. doi:10.9740/mhc.2021.05.211BuchtippsChange Your Diet, Change Your Mind: A powerful plan to improve mood, overcome anxiety and protect memory for a lifetime of optimal mental health by Dr. Georgia Edehttps://amzn.to/4bZIpRNBrain Energy: A Revolutionary Breakthrough in Understanding Mental Health--and Improving Treatment for Anxiety, Depression, OCD, PTSD, and More by Chris Palmer, MDhttps://amzn.to/45ukJlKDanke an die Werbepartner, ohne deren Unterstützung dieser Podcast nicht möglich wäre.Prodotti Amano - Gesichtspflege aus 9 hochwertigen Bio-Ölen - ohne jegliche Zusatzstoffe. Prodotti Amano ist ein kleines, feines Startup, das nicht nur Labor-zertifiziertes TOP Extra Vergine Bio-Olivenöl produziert, nein – sie haben jetzt auch ein wirklich einzigartiges Bio-Gesichtsöl entwickelt.Neben Olivenöl aus eigenem regenerativem Anbau, sind unter anderem kostbare Öle wie BIO-Kaktusfeigenkernöl, BIO-Granatapfelkernöl, BIO-Traubenkernöl und BIO- Sanddornfruchtfleischöl enthalten.Das geniale Bio-Gesichtsöl findest du auf prodottiamano.com.Mit dem Code JULIA10 bekommst du 10% Rabatt auf die Bestellung deines Bio-Gesichtsöls.http://www.prodottiamano.com Zeige deinen SupportDir gefällt die Show und die Inhalte? Der beste Weg, uns zu unterstützen, kostet dich nur ein paar Sekunden. Hinterlasse eine Bewertung und/ oder einen Kommentar auf YouTube, iTunes oder Spotify. Bevor wir beginnen, möchte ich mich bei meinen Sponsoren bedanken, deren Unterstützung es mir ermöglicht, regelmäßig spannende Inhalte für dich zu erarbeiten. Bitte beachten Sie auch immer den aktuellen "Haftungsausschluss (Disclaimer) und allgemeiner Hinweis zu medizinischen Themen" auf https://juliatulipan.com/haftungsausschluss/
Welcome to The Daily Wrap Up, a concise show dedicated to bringing you the most relevant independent news, as we see it, from the last 24 hours (6/2/24). As always, take the information discussed in the video below and research it for yourself, and come to your own conclusions. Anyone telling you what the truth is, or claiming they have the answer, is likely leading you astray, for one reason or another. Stay Vigilant. !function(r,u,m,b,l,e){r._Rumble=b,r[b]||(r[b]=function(){(r[b]._=r[b]._||[]).push(arguments);if(r[b]._.length==1){l=u.createElement(m),e=u.getElementsByTagName(m)[0],l.async=1,l.src="https://rumble.com/embedJS/u2q643"+(arguments[1].video?'.'+arguments[1].video:'')+"/?url="+encodeURIComponent(location.href)+"&args="+encodeURIComponent(JSON.stringify([].slice.apply(arguments))),e.parentNode.insertBefore(l,e)}})}(window, document, "script", "Rumble"); Rumble("play", {"video":"v4wtmcf","div":"rumble_v4wtmcf"}); Video Source Links (In Chronological Order): (45) Tim Richardson MP on X: "I want to share with you some pretty big news. Premier @JacintaAllanMP has asked me to serve as the Parliamentary Secretary for Men's Behaviour Change, a national first. https://t.co/QJBzJO3UGE" / X Parliamentary Secretary for Men's Behaviour Change - Brave Search (13) The Perpetual Shadow Band
What surprises lurk in our sewage? How did racist city planners end up saving Black lives? Why does Arizona grow hay for cows in Saudi Arabia? Three strange stories about the most fundamental substance we all take for granted. SOURCES:Brian Beach, professor of economics at Vanderbilt University.Marc Johnson, professor of molecular microbiology and immunology at the University of Missouri School of Medicine.Amy Kirby, program lead for the National Wastewater Surveillance System at the Centers for Disease Control and Prevention.Natalie Koch, professor of geography at Syracuse University. RESOURCES:Arid Empire: The Entangled Fates of Arizona and Arabia, by Natalie Koch (2023)."How a Saudi Firm Tapped a Gusher of Water in Drought-Stricken Arizona," by Isaac Stanley-Becker, Joshua Partlow, and Yvonne Wingett Sanchez (The Washington Post, 2023)."Arizona Is in a Race to the Bottom of Its Water Wells, With Saudi Arabia's Help," by Natalie Koch (The New York Times, 2022)."Tracing the Origin of SARS-CoV-2 Omicron-Like Spike Sequences Detected in Wastewater," by Martin Shafer, Devon Gregory, Marc Johnson, et al. (medRxiv, 2022)."Water and Waste: A History of Reluctant Policymaking in U.S. Cities," by Brian Beach (Working Paper, 2022).Water, Race, and Disease, by Werner Troesken (2004).COVID Data Tracker: Wastewater Surveillance, by the Centers for Disease Control and Prevention. EXTRAS:"What Is Sportswashing (and Does It Work)?" by Freakonomics Radio (2022)."Covid-19," series by Freakonomics Radio (2020-2021).
Welcome to the Olink® Proteomics in Proximity podcast! Below are some useful resources mentioned in this episode: Olink tools and software• Olink® Explore 3072, the platform utilized by the UK Biobank to measure ~3000 proteins in plasma: https://olink.com/products-services/explore/• Olink® Explore HT, Olink's most advanced solution for high-throughput biomarker discovery, measuring 5400+ proteins simultaneously with a streamlined workflow and industry-leading specificity: https://olink.com/products-services/exploreht/ UK Biobank Pharma Proteomics Project (UKB-PPP), one of the world's largest scientific studies of blood protein biomarkers conducted to date, https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/news/uk-biobank-launches-one-of-the-largest-scientific-studies Research articles• Dhindsa, R.S., Burren, O.S., Sun, B.B. et al. Rare variant associations with plasma protein levels in the UK Biobank. 2023 Nature, DOI: 10.1038/s41586-023-06547-xhttps://www.nature.com/articles/s41586-023-06547-x• Sun, B.B., Chiou, J., Traylor, M. et al. Plasma proteomic associations with genetics and health in the UK Biobank. 2023 Nature, DOI: 10.1038/s41586-023-06592-6 https://www.nature.com/articles/s41586-023-06592-6• Ticau S, Sridharan G, Tsour S, et al. Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis 2021 Neurology, DOI: 10.1212/WNL.0000000000011090https://n.neurology.org/content/96/3/e412.long• Zannad F, Ferreira JP, Butler J, et al. Effect of Empagliflozin on Circulating Proteomics in Heart Failure: Mechanistic Insights from the EMPEROR Program. 2022 European Heart Journal, DOI: 10.1093/eurheartj/ehac495 https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehac495/6676779• Eldjarn GH, et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature. 2023 Oct;622(7982):348-358. doi: 10.1038/s41586-023-06563-xhttps://www.nature.com/articles/s41586-023-06563-x#Sec44• [PREPRINT] Carrasco-Zanini et al 2023 Proteomic prediction of common and rare diseases MedRxiv https://www.medrxiv.org/content/10.1101/2023.07.18.23292811v1• Michaëlsson E, Lund LH, Hage C, et al. Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF. 2023 JACC. Heart Failure, DOI: 10.1016/j.jchf.2023.03.002https://www.sciencedirect.com/science/article/pii/S2213177923001257• Girerd N, Levy D, Duarte K, et al. Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. 2023 Circulation Heart Failure, DOI: 10.1161/CIRCHEARTFAILURE.122.009694https://www.ahajournals.org/doi/abs/10.1161/CIRCHEARTFAILURE.122.009694Subscribe to the podcast on your favorite player or app:Apple Podcasts: https://apple.co/3T0YbSm Spotify Podcasts: https://open.spotify.com/show/2sZ2wxO... Google Podcasts: https://podcasts.google.com/feed/aHR0... Amazon Music: https://music.amazon.com/podcasts/d97... Podcast Addict: https://podcastaddict.com/podcast/409... Deezer: https://www.deezer.com/show/5178787 Player FM: https://player.fm/series/series-3396598 In case you were wondering, Proteomics in Proximity refers to the principle underlying Olink technology called the Proximity Extension Assay (PEA). More information about the assay and how it works can be found here: https://bit.ly/3Rt7YiY For any questions regarding information about Olink Proteomics, please email us at info@olink.com or visit our website: https://www.olink.com/Interested in a specific podcast topic or guest? Reach out to us at PIP@olink.comWHAT IS PROTEOMICS IN PROXIMITY?Proteomics in Proximity discusses the intersection of proteomics with genomics for drug target discovery, the application of proteomics to reveal disease biomarkers, and current trends in using proteomics to unlock biological mechanisms. Co-hosted by Olink's Cindy Lawley and Sarantis Chlamydas.
In this episode, we interview Dr. John Inglis and Dr. Richard Sever, the executive director and assistant director respectively of the Cold Spring Harbor Laboratory Press. John and Richard also co-founded both bioRxiv and medRxiv, the primary preprint servers for biological and medical research. We discuss what makes the Cold Spring Harbor Laboratory Press unique, how they founded bioRxiv and medRxiv, how preprinting allows us to do experiments on the publication system itself, and much more!In the episode, John recommends a book on career options for biomedical scientists.Note from the editor: Unfortunately, there were some minor issues with Richard's source audio which resulted in some occasional skipping. Our apologies for this!For more information about EBRC, visit our website at ebrc.org. If you are interested in getting involved with the EBRC Student and Postdoc Association, fill out a membership application for graduate students and postdocs or for undergraduates and join today!Episode transcripts are the unedited output from Whisper and likely contain errors.
Wat mag je wel trauma noemen en wat niet? Heeft iedereen dan ook echt een trauma in zijn of haar leven? En helpt het ons als we zeggen dat iedereen trauma heeft? Abonneer je op de podcast, dan help je de podcast meer mensen te bereiken. Vinden we leuk. En check ook onze insta pagina voor snippets en de mogelijkheid om vragen te stellen. Adverteren in deze podcast? Mail naar podcasts@astrolads.com Bronnen en ander lees- en luister- en kijkvoer: - Boek van Bessel van der Kolk: The body keeps the score, wordt door Thijs en Lennard veel besproken - Ook het werk van Gabor Maté over trauma, waar hij het heeft over kleine t en grote T trauma. Dit kun je lezen in Myth of Normal. - Bessel is ook te vinden in Zomergasten uit 2022: https://www.youtube.com/watch?v=gVk50bM25zE - Gabor over 7 dingen die er met je gebeuren bij trauma: https://www.youtube.com/watch?v=O5jmsJAClpw - En wat van de cijfers rondom trauma: https://www.vzinfo.nl/posttraumatische-stressstoornis/leeftijd-en-geslacht - Kijk naar Succession, een toffe serie over hoe trauma door generaties heen speelt - Check het boek van onze vriend Ferry Zandvliet: Souvenirs: beter na Bataclan. Over hoe Ferry juist Post traumatische groei heeft doorgemaakt. - En vergeet de docu Trip of Compassion niet over hoe XTC/MDMA hielp bij mensen met PTSS in Israël. Nerd-literatuur: - Smelser, N. J. (2004). Psychological trauma and cultural trauma. Cultural trauma and collective identity, 4, 31-59. - Jones, E., & Wessely, S. (2006). Psychological trauma: A historical perspective. Psychiatry, 5(7), 217-220. - Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D., Charney, D. S., & Keane, T. M. (1995). The development of a clinician-administered PTSD scale. Journal of traumatic stress, 8, 75-90. - Wampold, B. E., Imel, Z. E., Laska, K. M., Benish, S., Miller, S. D., Flűckiger, C., ... & Budge, S. (2010). Determining what works in the treatment of PTSD. Clinical psychology review, 30(8), 923-933. - Brady, K. T. (1997). Posttraumatic stress disorder and comorbidity: recognizing the many faces of PTSD. Journal of Clinical Psychiatry, 58(9), 12-15. - Bradley, R., Greene, J., Russ, E., Dutra, L., & Westen, D. (2005). A multidimensional meta-analysis of psychotherapy for PTSD. American journal of Psychiatry, 162(2), 214-227. - Verstrael, S., van der Wurff, P., & Vermetten, E. (2013). Eye movement desensitization and reprocessing (EMDR) as treatment for combat-related PTSD: a meta-analysis. Military Behavioral Health, 1(2), 68-73. - Valiente-Gómez, A., Moreno-Alcázar, A., Treen, D., Cedrón, C., Colom, F., Perez, V., & Amann, B. L. (2017). EMDR beyond PTSD: A systematic literature review. Frontiers in psychology, 8, 1668. - Chen, L., Zhang, G., Hu, M., & Liang, X. (2015). Eye movement desensitization and reprocessing versus cognitive-behavioral therapy for adult posttraumatic stress disorder: systematic review and meta-analysis. The Journal of nervous and mental disease, 203(6), 443-451. - de Jongh, A., Amann, B. L., Hofmann, A., Farrell, D., & Lee, C. W. (2019). The status of EMDR therapy in the treatment of posttraumatic stress disorder 30 years after its introduction. Journal of EMDR Practice and Research, 13(4), 261-269. - Sarparast, A., Thomas, K., Malcolm, B., & Stauffer, C. S. (2022). Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology, 239(6), 1945-1976. - Shore, R. J., Ioudovski, P., McKeown, S., Dumont, E., & Goldie, C. (2019). Mapping Psilocybin-Assisted Therapies: A Scoping Review. medRxiv, 2019-12
For the first time ever, parents going through IVF can use whole genome sequencing to screen their embryos for hundreds of conditions. Harness the power of genetics to keep your family safe, with Orchid. Check them out at orchidhealth.com. On this episode of Unsupervised Learning Razib talks to Penn State astrophysicist, Steinn Sigurdsson. Sigurdsson was a one-time colleague at the ScienceBlogs website in the twenty-aughts with Razib, where he ran the astrophysics-themed Dynamic of the Cats blog. At its peak, ScienceBlogs had nearly 100 writers who commented on topics as diverse as agriculture, Creationism and cosmology. Originally from Iceland, Sigurdsson's professional accomplishments have been wide-ranging, from serving as scientific director of arXiv to directing an institute focused on exobiology. Razib first asks him about the history of arXiv, which goes back over 30 years. It was the preprint server that blazed the bath for bioRxiv in biology, medRxiv in medicine and PsyArXiv in psychology. Razib asked Sigurdsson if preprint servers lead to open science, and if they will do away with peer preview. Do they affect the winner-take-all dynamics that apply to scientific publications? Razib and Sigurdsson also discuss the threat and promise of papers generated with AI methods like “large language models” pioneered by Google and popularized by OpenAI, and that have finally caught up to human-level fluency within the last 9 months with ChatGPT. Then Razib queries Sigurdsson on numerous astrophysical topics. Is the universe going to expand forever? (Probably, and that expansion is speeding up.) Do we understand most of the matter and energy in the universe? (No.) Sigurdsson also discusses in detail the fact that now in 2023 we have confirmed black holes empirically in a manner that couldn't have been imagined a generation ago. Additionally, Razib has to confront the possibility that physics might abandon causality, and even open the door to magic, within the twisted maze of their equations in order to make sense of the universe. Finally, they discuss the probability of other life in the universe if our solar system is representative, the probability of intelligent life, how many planets there are in the universe and the possibility of Dyson (or Musk?) spheres in our solar system in the future.
Welcome to the Olink® Proteomics in Proximity podcast! Below are some useful resources from this episode: Published study of primary focusÁlvez MB, Edfors F, von Feilitzen K, Zwahlen M, Mardinoglu A, Edqvist PH, Sjöblom T, Lundin E, Rameika N, Enblad G, Lindman H, Höglund M, Hesselager G, Stålberg K, Enblad M, Simonson OE, Häggman M, Axelsson T, Åberg M, Nordlund J, Zhong W, Karlsson M, Gyllensten U, Ponten F, Fagerberg L, Uhlén M. Next generation pan-cancer blood proteome profiling using proximity extension assay. Nat Commun. 2023 Jul 18;14(1):4308. doi: 10.1038/s41467-023-39765-y. PMID: 37463882; PMCID: PMC10354027. https://pubmed.ncbi.nlm.nih.gov/37463882/ Laboratory, first author, and corresponding author of the study· SciLifeLab, a collaborative resource for life scientists located in Sweden: https://www.scilifelab.se/· María Bueno Álvez (first author), PhD student, Science for Life Laboratory (SciLifeLab): https://www.linkedin.com/in/mar%C3%ADa-bueno-%C3%A1lvez-33395b192/ · Dr. Mathias Uhlén (corresponding author), Professor of Microbiology, Royal Institute of Technology (KTH), Leader of the Human Protein Atlas, Founding director of the Science for Life Laboratory (SciLifeLab): https://www.kth.se/pro/sysbio/uhlen-group/researchers/mathias-uhlen-1.67763 Olink tools and software· Olink® Explore 1536, the platform that measured proteins in this study with a next-generation sequencing (NGS) readout: https://olink.com/products-services/explore/· Olink® Explore HT, Olink's newest solution for high-throughput biomarker discovery that measures 5300+ proteins simultaneously with minimal sample consumption: https://olink.com/products-services/exploreht/ · Olink® Insight, an open-access resource to accelerate protein biomarker discovery: https://insight.olink.com/ UK Biobank Pharma Proteomics Project (UKB-PPP), one of the world's largest scientific studies of blood protein biomarkers conducted to date· Published article: Styrkarsdottir U, Lund SH, Thorleifsson G, Saevarsdottir S, Gudbjartsson DF, Thorsteinsdottir U, Stefansson K. Cartilage Acidic Protein 1 in Plasma Associates With Prevalent Osteoarthritis and Predicts Future Risk as Well as Progression to Joint Replacements: Results From the UK Biobank Resource. Arthritis Rheumatol. 2023 Apr;75(4):544-552. doi: 10.1002/art.42376. Epub 2022 Dec 28. PMID: 36239377. https://pubmed.ncbi.nlm.nih.gov/36239377/ · UKB-PPP website: https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/news/uk-biobank-launches-one-of-the-largest-scientific-studies Analysis of UK Biobank proteomics data from cancer patients, with co-authors including Ruth C. Travis, Karl Smith-Byrne, and Joshua R. AtkinsPreprint article: Papier K, Atkins JR, Tong TYN, Gaitskell K, Desai T, Ogamba CF, Parsaeian M, Reeves GK, Mills IG, Key TJ, Smith-Byrne K, Travis RC. Identifying proteomic risk factors for cancer using prospective and exome analyses: 1,463 circulating proteins and risk of 19 cancers in the UK Biobank. medRxiv 2023.07.28.23293330; doi: https://doi.org/10.1101/2023.07.28.23293330. https://www.medrxiv.org/content/10.1101/2023.07.28.23293330v1 U-CAN Biobank, a prospective biobank of cancer patient biomaterial in SwedenGlimelius B, Melin B, Enblad G, Alafuzoff I, Beskow A, Ahlström H, Bill-Axelson A, Birgisson H, Björ O, Edqvist PH, Hansson T, Helleday T, Hellman P, Henriksson K, Hesselager G, Hultdin M, Häggman M, Höglund M, Jonsson H, Larsson C, Lindman H, Ljuslinder I, Mindus S, Nygren P, Pontén F, Riklund K, Rosenquist R, Sandin F, Schwenk JM, Stenling R, Stålberg K, Stålberg P, Sundström C, Thellenberg Karlsson C, Westermark B, Bergh A, Claesson-Welsh L, Palmqvist R, Sjöblom T. U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden. Acta Oncol. 2018 Feb;57(2):187-194. doi: 10.1080/0284186X.2017.1337926. Epub 2017 Jun 20. PMID: 28631533. https://pubmed.ncbi.nlm.nih.gov/28631533/ Galleri GRAIL test, a blood-based test that detects a biosignature shared by over 50 cancer types: https://grail.com/galleri-test/ Genotype-Tissue Expression (GTEx) project, a biobank and open-access database to study tissue-specific gene expression and regulation: https://www.gtexportal.org/home/ Human Protein Atlas (HPA), a Swedish-based program with the aim to map all human proteins using an integration of various omics technologies and provide these data freely available to the scientific community: https://www.proteinatlas.org/ Would you like to subscribe to the podcast on your favorite player or app? You can do so here: Apple Podcasts: https://apple.co/3T0YbSm Spotify Podcasts: https://open.spotify.com/show/2sZ2wxO... Google Podcasts: https://podcasts.google.com/feed/aHR0... Amazon Music: https://music.amazon.com/podcasts/d97... Podcast Addict: https://podcastaddict.com/podcast/409... Deezer: https://www.deezer.com/show/5178787 Player FM: https://player.fm/series/series-3396598 In case you were wondering, Proteomics in Proximity refers to the principle underlying Olink Proteomics assay technology called the Proximity Extension Assay (PEA), and more information about the assay and how it works can be found here: https://bit.ly/3Rt7YiY For any questions regarding information Olink Proteomics, please email us at info@olink.com or visit our website: https://www.olink.com/ WHAT IS PROTEOMICS IN PROXIMITY?Proteomics in Proximity discusses the intersection of proteomics with genomics for drug target discovery, the application of proteomics to reveal disease biomarkers, and current trends in using proteomics to unlock biological mechanisms. Co-hosted by Olink's Dale Yuzuki, Cindy Lawley and Sarantis Chlamydas.
In "Perspective and Humility," Dr. Osterholm and Chris Dall discuss the state of the pandemic in the U.S. and internationally, a recent study on recombinant flu vaccines, and respiratory protection in healthcare settings.UN Report: Global hunger numbers rose to as many as 828 million in 2021 (WHO)From Asymptomatic COVID to Long COVID: Major Advances in Genetic Underpinnings (Eric Topol, Ground Truths)A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection (Augusto et al., Nature)Genome-wide Association Study of Long COVID (Lammi et al., MedRxiv)Genetic Risk Factors for Severe and Fatigue Dominant Long COVID and Commonalities with ME/CFS Identified by Combinatorial Analysis (Taylor et al., MedRxiv)Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design (Zimmerman et al., Vaccine)
Today I had the privilege of speak with Professor Christoph Lange, Secretary General of the Union, founding chairman of TBNet and is the clinical lead for the Unite4TB Consortium. Professor Lange spoke to us about where we're up to with our EndTB Goals. Professor Lange spoke about the significant barriers that remain, where our shortfalls have come, where our successes have arisen, and what exciting opportunities lay in the years ahead for tuberculosis.REFERENCESLange, Christoph, et al. "Perspective for precision medicine for tuberculosis." Frontiers in Immunology 11 (2020): 566608Lange, Christoph, et al. "Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement." (2014): 23-63.Günther, Gunar, et al. "Relative cost of multidrug-resistant TB medicines in Europe." The international journal of tuberculosis and lung disease 27.5 (2023): 341-344.Koehler, Niklas, et al. "Pretomanid-resistant tuberculosis." Journal of Infection 86.5 (2023): 520-524.Domínguez, José, et al. "Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement." The Lancet Infectious Diseases 23.4 (2023): e122-e137.Heyckendorf, Jan, et al. "Method for diagnosis and treatment monitoring and individual therapy end decision in tuberculosis infection." U.S. Patent Application No. 17/904,544Villar-Hernández, Raquel, et al. "Tuberculosis: current challenges and beyond." Breathe 19.1 (2023)Günther, Gunar, et al. "Availability and costs of medicines for the treatment of tuberculosis in Europe." Clinical microbiology and infection 29.1 (2023): 77-84DiNardo, Andrew R., et al. "Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes." European Respiratory Journal 60.3 (2022).Günther, Gunar, et al. "Cost and availability of drugs and treatment regimens and availability of drug resistance testing for tuberculosis in Europe." medRxiv (2022): 2022-02Boeree, M. J., et al. "UNITE4TB: a new consortium for clinical drug and regimen development for TB." The International Journal of Tuberculosis and Lung Disease 25.11 (2021): 886Lönnroth, Knut, N. Sarita Shah, and Christoph Lange. "State-of-the-art series on tuberculosis and migration." The international journal of tuberculosis and lung disease 20.10 (2016): 1280-1281.DiNardo, Andrew R., et al. "Tuberculosis endotypes to guide stratified host-directed therapy." Med 2.3 (2021): 217-232.
In this episode recorded at the 2023 SHEA Spring Meeting in Seattle, Martin talks to Associate Professor Alex Sundermann about his work on sequencing all isolates from local healthcare settings and the discoveries that this enables. Healthcare infections due to previous admissions, endoscopes, even pseudo-outbreaks are all laid bare by this approach. Some recent papers from the group are listed below: 1. Sundermann AJ, et al. Two artificial tears outbreak-associated cases of XDR Pseudomonas aeruginosa detected through whole genome sequencing-based surveillance. medRxiv. 2023. https://doi:10.1101/2023.04.11.23288417 2. Sundermann AJ, et al. Sensitivity of National Healthcare Safety Network definitions to capture healthcare-associated transmission identified by whole-genome sequencing surveillance. Infect Control Hosp Epidemiol. 2023:1-3. https://doi:10.1017/ice.2023.52 3. Branch-Elliman W, et al. The future of automated infection detection: Innovation to transform practice (Part III/III). Antimicrob Steward Healthc Epidemiol. 2023;3(1):e26. https://doi:10.1017/ash.2022.333 4. Sundermann AJ, et al. Whole-genome sequencing surveillance and machine learning for healthcare outbreak detection and investigation: A systematic review and summary. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e91. https://doi:10.1017/ash.2021.241 5. Sundermann AJ, et al. Whole-Genome Sequencing Surveillance and Machine Learning of the Electronic Health Record for Enhanced Healthcare Outbreak Detection. Clin Infect Dis. 2022;75(3):476-482. https://doi:10.1093/cid/ciab946 6. Sundermann AJ, et al. Outbreak of Pseudomonas aeruginosa Infections from a Contaminated Gastroscope Detected by Whole Genome Sequencing Surveillance. Clin Infect Dis. 2021;73(3):e638-e642. https://doi:10.1093/cid/ciaa1887 7. Kumar P, et al. Method for Economic Evaluation of Bacterial Whole Genome Sequencing Surveillance Compared to Standard of Care in Detecting Hospital Outbreaks. Clin Infect Dis. 2021;73(1):e9-e18. https://doi:10.1093/cid/ciaa512 8. Sundermann AJ, et al. Automated data mining of the electronic health record for investigation of healthcare-associated outbreaks. Infect Control Hosp Epidemiol. 2019:1-6. https://doi:10.1017/ice.2018.343
In this episode recorded at the 2023 SHEA Spring Meeting in Seattle, Martin talks to Associate Professor Alex Sundermann about his work on sequencing all isolates from local healthcare settings and the discoveries that this enables. Healthcare infections due to previous admissions, endoscopes, even pseudo-outbreaks are all laid bare by this approach. Some recent papers from the group are listed below: 1. Sundermann AJ, et al. Two artificial tears outbreak-associated cases of XDR Pseudomonas aeruginosa detected through whole genome sequencing-based surveillance. medRxiv. 2023. https://doi:10.1101/2023.04.11.23288417 2. Sundermann AJ, et al. Sensitivity of National Healthcare Safety Network definitions to capture healthcare-associated transmission identified by whole-genome sequencing surveillance. Infect Control Hosp Epidemiol. 2023:1-3. https://doi:10.1017/ice.2023.52 3. Branch-Elliman W, et al. The future of automated infection detection: Innovation to transform practice (Part III/III). Antimicrob Steward Healthc Epidemiol. 2023;3(1):e26. https://doi:10.1017/ash.2022.333 4. Sundermann AJ, et al. Whole-genome sequencing surveillance and machine learning for healthcare outbreak detection and investigation: A systematic review and summary. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e91. https://doi:10.1017/ash.2021.241 5. Sundermann AJ, et al. Whole-Genome Sequencing Surveillance and Machine Learning of the Electronic Health Record for Enhanced Healthcare Outbreak Detection. Clin Infect Dis. 2022;75(3):476-482. https://doi:10.1093/cid/ciab946 6. Sundermann AJ, et al. Outbreak of Pseudomonas aeruginosa Infections from a Contaminated Gastroscope Detected by Whole Genome Sequencing Surveillance. Clin Infect Dis. 2021;73(3):e638-e642. https://doi:10.1093/cid/ciaa1887 7. Kumar P, et al. Method for Economic Evaluation of Bacterial Whole Genome Sequencing Surveillance Compared to Standard of Care in Detecting Hospital Outbreaks. Clin Infect Dis. 2021;73(1):e9-e18. https://doi:10.1093/cid/ciaa512 8. Sundermann AJ, et al. Automated data mining of the electronic health record for investigation of healthcare-associated outbreaks. Infect Control Hosp Epidemiol. 2019:1-6. https://doi:10.1017/ice.2018.343
In his weekly clinical update Dr. Griffin discusses confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era, the effectiveness of maternal Influenza vaccination in Peru, characteristics and predictors of persistent symptoms post-COVID-19 in children and young people, parental nonadherence to health policy recommendations for prevention of COVID-19 transmission among children, community-onset bacterial coinfection in children critically ill with SARS-CoV-2 infection, bivalent booster effectiveness against severe COVID-19 outcomes in Finland, viral kinetics of sequential SARS-CoV-2 infections, risk of COVID-19 associated pulmonary aspergillosis based on corticosteroid duration in intensive care patients, immunomodulators for severe COVID19 in transplant patients: do they increase the risk of secondary infection, long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population, cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection, one-year adverse outcomes among us adults with Post–COVID-19 condition vs those without COVID-19 in a large commercial insurance database, and long-term gastrointestinal outcomes of COVID-19. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Confronting the evolution and expansion of anti-vaccine activism (The Lancet) Effectiveness of maternal influenza vaccination in Peru (OFID) Characteristics and predictors of persistent symptoms post-COVID-19 (BMJ) Parental nonadherence to health policy recommendations for prevention of COVID-19 (JAMA) Community-onset bacterial coinfection in children ill with SARS-CoV-2 infection (OFID) Bivalent booster effectiveness against severe COVID-19 outcomes (medRxiv) Viral kinetics of sequential SARS-CoV-2 infections (medRxiv) Risk of COVID-19 associated pulmonary aspergillosis based on corticosteroid duration in ICU patients (OFID) Immunomodulators for severe COVID-19 in transplant patients (TID) Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population (eClinicalMedicine) Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection (BMJ) One year adverse outcomes among US adults with post COVID-19 condition vs those without COVID-19 (JAMA) Long-term gastrointestinal outcomes of COVID-19 (Nature) Contribute to our ASTMH fundraiser at PWB Dr. Griffin's treatment guide (pdf) Letters read on TWiV 990 Don't crush Paxlovid (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
A discussion of vaccine information, hesitancy and uptake among multiple populations and how we can improve uptake in our daily practices Show References McElfish PA, Willis DE, Shah SK, Bryant-Moore K, Rojo MO, Selig JP. Sociodemographic Determinants of COVID-19 Vaccine Hesitancy, Fear of Infection, and Protection Self-Efficacy. J Prim Care Community Health. Jan-Dec 2021;12:21501327211040746. doi:10.1177/21501327211040746 MacDonald NE, Hesitancy SWGoV. Vaccine hesitancy: Definition, scope and determinants. Vaccine. Aug 14 2015;33(34):4161-4. doi:10.1016/j.vaccine.2015.04.036 Nguyen LH, Joshi AD, Drew DA, et al. Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake. medRxiv. Feb 28 2021;doi:10.1101/2021.02.25.21252402 Wong LP, Alias H, Danaee M, et al. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries. Infect Dis Poverty. Oct 7 2021;10(1):122. doi:10.1186/s40249-021-00900-w Jacobson RM, St Sauver JL, Finney Rutten LJ. Vaccine Hesitancy. Mayo Clin Proc. Nov 2015;90(11):1562-8. doi:10.1016/j.mayocp.2015.09.006 S. B. Omer, D. A. Salmon, W. A. Orenstein, M. P. deHart and N. Halsey. Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases. NEJM 2009 Vol. 360 Issue 19 Pages 1981-1988 Lila J. Finney Rutten, Xuan Zhu, Aaron L. Leppin, Jennifer L. Ridgeway, Melanie D. Swift, Joan M. Griffin, Jennifer L. St Sauver, Abinash Virk, Robert M. Jacobson. Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy. Mayo Clinic Proceedings. Volume 96, Issue 3. 2021. Pages 699-707. Raymond John D Vergara, Philip Joseph D Sarmiento, James Darwin N Lagman, Building public trust: a response to COVID-19 vaccine hesitancy predicament, Journal of Public Health, Volume 43, Issue 2, June 2021, Pages e291–e292, https://doi.org/10.1093/pubmed/fdaa282 Corbie-Smith G. Vaccine Hesitancy Is a Scapegoat for Structural Racism. JAMA Health Forum. 2021;2(3):e210434. doi:10.1001/jamahealthforum.2021.0434 The 'successful failures' of Apollo 13 and Covid-19 vaccination - STAT (statnews.com)
Interview with Joshua D. Wallach, PhD, MS, and Guneet Janda, BS, authors of Comparison of Clinical Study Results Reported in medRxiv Preprints vs Peer-reviewed Journal Articles. Hosted by Angel N. Desai, MD, MPH. Related Content: Comparison of Clinical Study Results Reported in medRxiv Preprints vs Peer-reviewed Journal Articles
View on Odysee: https://odysee.com/@BretWeinstein:f/EvoLens135:4 View on Spotify (With video): ***** In this 135th in a series of live discussions with Bret Weinstein and Heather Heying (both PhDs in Biology), we discuss the state of the world through an evolutionary lens. This week, we discuss how, with regard to Covid, natural immunity compares to vaccine-induced immunity. Is the omicron variant unique in this regard? What science has been done to address the question? When is it acceptable to cite a preprint, and when must you absolutely, positively rely solely on peer-reviewed literature? What did the world do to deserve wrestling with this virus into an unspecified future? Are the Attorneys General of Missouri and Louisiana on to something? Political violence in this country is being pursued by the January 6 committee—but how much of it is being included? And: is peer review value added, or value subtracted? Also: how alarmist are glaciers? ***** Support the sponsors of the show: Thesis: personalized nootropics for motivation, creativity, confidence and more. To get a customized Thesis starter kit, take the quiz at takethesis.com/DARKHORSE, and use code DARKHORSE at checkout for 10% off your first box. LMNT: Electrolyte drink mix with all the good salts, and none of the bad stuff. Free sample pack of all 8 flavors with any purchase at DrinkLMNT.com/DARKHORSE. MDHearingAid: Use promo code DARKHORSE to receive a significant discount off your order of already inexpensive, high-quality hearing aids, plus receive a free extra charging case. https://www.mdhearingaid.com ***** Our book, A Hunter-Gatherer's Guide to the 21st Century, is available everywhere books are sold, and signed copies are available here: https://darvillsbookstore.indielite.org Check out our store! Epic tabby, digital book burning, saddle up the dire wolves, and more: https://darkhorsestore.org Heather's newsletter, Natural Selections (subscribe to get free weekly essays in your inbox): https://naturalselections.substack.com ***** Mentioned in this episode: Nature News article on prior Omicron infection: https://www.nature.com/articles/d41586-022-01950-2 CDC on SARS-CoV2 variants: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html?msclkid=29647209ac7011ec95de22acaee31a78 Altarawneh et al 2022. Protection of SARS-CoV-2 natural infection against reinfection with the BA. 4 or BA. 5 Omicron subvariants. medRxiv: https://www.medrxiv.org/content/10.1101/2022.07.11.22277448v1 Chemaitelly et al 2022. Duration of immune protection of SARS-CoV-2 natural infection against reinfection in Qatar. medRxiv: https://www.medrxiv.org/content/10.1101/2022.07.06.22277306v1.full.pdf Missouri & Louisiana Attorneys General File Suit Against President Biden, Top Admin Officials for Allegedly Colluding with Social Media Giants to Censor and Suppress Free Speech: https://ago.mo.gov/home/news/2022/05/05/missouri-louisiana-ags-file-suit-against-president-biden-top-admin-officials-for-allegedly-colluding-with-social-media-giants-to-censor-and-suppress-free-speech Jeremy Lee Quinn article in Newsweek on January 6 hearings: https://www.newsweek.com/jan-6-followed-years-political-violence-committee-should-investigate-leftist-violence-too-1727190 Support the show
In this episode of the Epigenetics Podcast, we caught up with Morgan Levine from Altos lab to talk about her work on Epigenetic Clocks and Biomarkers of Ageing. The Levine Lab focuses on deciphering mechanisms that lead to epigenetic ageing, which can be measured by epigenetic clocks. Epigenetic clocks were first described in 2011 by Bocklandt et al.. Later-on, the Horvath and the Hannum clock were described by using a combination of CpGs to calculate biological/epigenetic age in contrast to chronological age. The Levine Lab themselves worked on generating an advanced version of an Epigenetic clock, called "DNAm PhenoAge" that will now be used, and not only in human samples. The team now moves to mouse models and to cells in a dish and using those models to investigate the mechanisms behind epigenetic aging. References Liu, Z., Leung, D., Thrush, K., Zhao, W., Ratliff, S., Tanaka, T., Schmitz, L. L., Smith, J. A., Ferrucci, L., & Levine, M. E. (2020). Underlying features of epigenetic aging clocks in vivo and in vitro. Aging cell, 19(10), e13229. https://doi.org/10.1111/acel.13229 Levine, M. E., Lu, A. T., Quach, A., Chen, B. H., Assimes, T. L., Bandinelli, S., Hou, L., Baccarelli, A. A., Stewart, J. D., Li, Y., Whitsel, E. A., Wilson, J. G., Reiner, A. P., Aviv, A., Lohman, K., Liu, Y., Ferrucci, L., & Horvath, S. (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging, 10(4), 573–591. https://doi.org/10.18632/aging.101414 Levine, M., McDevitt, R. A., Meer, M., Perdue, K., Di Francesco, A., Meade, T., Farrell, C., Thrush, K., Wang, M., Dunn, C., Pellegrini, M., de Cabo, R., & Ferrucci, L. (2020). A rat epigenetic clock recapitulates phenotypic aging and co-localizes with heterochromatin. eLife, 9, e59201. https://doi.org/10.7554/eLife.59201 Kuo, C. L., Pilling, L. C., Atkins, J. C., Masoli, J., Delgado, J., Tignanelli, C., Kuchel, G., Melzer, D., Beckman, K. B., & Levine, M. (2020). COVID-19 severity is predicted by earlier evidence of accelerated aging. medRxiv : the preprint server for health sciences, 2020.07.10.20147777. https://doi.org/10.1101/2020.07.10.20147777 Related Episodes Aging and Epigenetics (Peter Tessarz) Epigenetic Mechanisms of Aging and Longevity (Shelley Berger) Contact Active Motif on Twitter Epigenetics Podcast on Twitter Active Motif on LinkedIn Active Motif on Facebook Email: podcast@activemotif.com
As we enter year three of the COVID-19 pandemic, we would like to review the latest updates about HIV and COVID-19. In the first segment we will speak with Dr. Robert Fullilove, EdD, about the social and historical factors which have led to racial health disparities for HIV and COVID-19. In the second segment we will speak with Dr. Keith Sigel, MD, PhD, MPH, who will unpack the latest research and data about COVID-19 outcomes for Persons Living with HIV (PLWH). The goal of this episode will be to provide information for providers about how to understand and meet their patients' needs in relation to HIV and COVID-19. Part 1: Robert Fullilove, EdD, Robert Fullilove Columbia University Mailman School of Public Health https://www.publichealth.columbia.edu/people/our-faculty/ref5 Burns, D Learning for Our Common Health Association of American Colleges and Universities Washington, DC 109-119 1999 Golembeski C, Fullilove R Criminal (in)justice in the City and Its Associated Health Consequences. American Journal of Public Health 95 1701-6 2005 Green LL, Fullilove MT, Fullilove, RE. Remembering the Lizard: Reconstructing Sexuality in the Rooms of Narcotics Anonymous. Journal of Sex Research 42 28-34 2005 Fullilove RE HIV Prevention in the African American Community: Why Isn't Anybody Talking about the Elephant in the Room? AIDScience 1 1-7 2001 Fullilove MT and Fullilove RE What's housing got to do with it? American Journal of Public Health 90 183-4 2000 Fullilove RE, Green LL, Fullilove MT The Family to Family Program: A Structural Intervention with Implications for the Prevention of HIV/AIDS and Other Community Epidemics. AIDS. Vol 14 (1S) 2000.63-67 14(1S) 63-67 2000 Levine RS, Foster JE, Fullilove RE et al. Black-White Inequalities in Mortality and Life Expectancy, 1993-1999 :Implications for Healthy People 2010. Public Health Reports 116 474-83 2001 Malebranch DJ, Peterson JL, Fullilove RE, Stackhouse RW. Race and Sexual Identity: Perceptions about Medical Culture and Healthcare among Black Men Who Have Sex with Men. Journal of the National Medical Association 96 97-107 2004 Part 2: Keith Sigel, MD, PhD, MPH Braunstein, S. L., Lazar, R., Wahnich, A., Daskalakis, D. C., & Blackstock, O. J. (2021). Coronavirus disease 2019 (COVID-19) infection among people with human immunodeficiency virus in new york city: a population-level analysis of linked surveillance data. Clinical Infectious Diseases, 72(12), e1021-e1029. Centers of Disease Control and Prevention. (2021) COVID-19 and HIV. https://www.cdc.gov/hiv/covid-19/index.html Cooper, T. J., Woodward, B. L., Alom, S., & Harky, A. (2020). Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic review. HIV medicine, 21(9), 567-577. Garret, N., Tapley, A., Andriesen, J., Seocharan, I., Fisher, L. H., Bunts, L., ... & Corey, L. (2021). High rate of asymptomatic carriage associated with variant strain Omicron. MedRxiv. Sigel, K., Swartz, T., Golden, E., Paranjpe, I., Somani, S., Richter, F., ... & Glicksberg, B. S. (2020). Covid-19 and people with HIV infection: outcomes for hospitalized patients in New York City. Clinical Infectious Diseases. Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., ... & Ferguson, N. M. (2020). Estimates of the severity of coronavirus disease 2019: a model-based analysis. The Lancet infectious diseases, 20(6), 669-677.
A really exciting special episode this week, as we talk to co-founders of BioRxiv (@biorxivpreprint) and MedRxiv (@medrxivpreprint) Richard Sever (@cshperspectives) & John Inglis (@JohnRInglis). We discuss how they met and started with BioRxiv along with the challenges they faced. We then chat about the considerations when accepting or rejecting preprints, or why certain papers are rejected from BioRxiv (they don't just accept everything). We also touch on the impact COVID 19 and the pandemic had on preprints as well as discuss the fraudulent papers and how they don't tend to be pre-printed. If you've ever been concerned about preprints this is a great episode to learn more about how preprint servers work and what the future may hold for BioRxiv from the key people in the field. Other links BioRxiv - https://www.biorxiv.org/ MedRxiv - https://www.medrxiv.org/ Company Biologist - https://www.biologists.com/ preLights - https://prelights.biologists.com/ Cold Spring Harbour Lab Press - https://www.cshlpress.com/ Vixra - https://vixra.org/ This episode was produced by Jonny Coates and Emma Wilson and edited by John D Howard . If you enjoyed this show then hit that subscribe button and leave a review. If you love what we are trying to do then support us on Patreon https://www.patreon.com/preprintsinmotion where tiers start at as little as £1 a month! For the latest podcast news and updates follow us on Twitter @MotionPod or visit our website; www.preprintsinmotion.com. Produced by JEmJ Productions (find us on Twitter: Jonny @JACoates, Emma @ELWilson92, John @JohnDHoward8) and generously supported by ASAPbio (https://asapbio.org | @asapbio_).
Après avoir parlé du Paxlovid, on s'intéresse aux thérapies alternatives contre la COVID. Quelles sont les données d'efficacité concernant le remdésivir, la fluvoxamine et le budésonide inhalé? Quelles clientèles peuvent bénéficier de ces traitements? On en discute avec Jean-François Tessier, pharmacien à l'hôpital Maisonneuve-Rosemont du CIUSSS de l'Est-de-l'Ile de Montréal et président du RPE d'infectiologie de l'A.P.E.S. RÉFÉRENCES : Anil Gupta A, Gonzalez-Rojas Y, Juarez E et al. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab. N Engl J Med 2021; 385:1941-1950. DOI: 10.1056/NEJMoa2107934. Hammond J, Leister-Tebbe H, Gardner A et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. N Engl J Med 2022 (February). DOI: 10.1056/NEJMoa2118542. Lee T C, Morris M, Grover A S et al. Outpatient therapies for COVID-19: How do we choose? medRxiv 2021.12.17.21268007. DOI: 10.1101/2021.12.17.21268007 Canadian Treatments for COVID-19 for the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network and the Canadian Critical Care Trials Group. Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial. CMAJ February 22, 2022 194 (7) E242-E251; DOI: 10.1503/cmaj.211698 Sanjay Ramakrishnan S, Nicolau Jr D V, Langford B et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. The Lancet Respiratory Medicine, volume 9, issue 7, p763-772, july 01, 2021. DOI: 10.1016/S2213-2600(21)00160-0 Robert L. Gottlieb, R, Vaca C E, Paredes R et al. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients. N Engl J Med 2022; 386:305-315. DOI: 10.1056/NEJMoa2116846. COVID-19 advisory for Ontario. Science table. https://covid19-sciencetable.ca
STUDIES REFERENCED IN THIS EPISODE TELOGEN EFFLUVIUM - HAIR LOSS FOLLOWING COVID 19 STUDY 1 (starts at 3:09 ): Lopez-Leon S et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021 Jan 30;2021.01.27.21250617. STUDY 2 (starts at 4:47): Muller-Ramos P et al. Post-COVID-19 hair loss: prevalence and associated factors among 5,891 patients. Int J Dermatol 2022 Jan 26. STUDY 3 (starts at 10:32 ): Fernandez-de-Las-Penas et al. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J Clin Med. 2022 Jan 14;11(2):413. TELOGEN EFFLUVIUM IN CHILDREN STUDY 4 (starts at 12:45 ): Thomas et al. Single Centre Retrospective Review ofNutritional Deficiencies Associated With Telogen Effluvium in the Paediatric Population in Canada. J Cut Med Surg Jan 2022 (online) TRICHOTILLOMANIA STUDY 5 (starts at 18:44) : Moattari et al. Adverse psychocutaneous effects of prescription stimulant use and abuse: A systematic review. J Dtsch Dermatol Ges. 2022 Jan;20(1):7-15. STUDY 6: (starts at 23:12); Vaccaro et al. Erosive pustular dermatosis of the scalp as local complication of trichotillomania. J Cosmet Dermatol. 2022 Jan 8. 2022 Jan 8 TINEA CAPITIS STUDY 7 (starts at 27:51): Friedland et al. Epidemiologic features and risk of scarring in pediatric patients with kerion celsi. Pediatr Dermatol. 2022 Jan 13. doi: 10.1111/pde.14916. Online ahead of print.
Publications, presentations, citations - these are trophies that you can flash proudly on your CV. However, what medical students may underestimate, is the long hours required reading papers, processing data and revising manuscripts. While academic medicine can be rewarding and intellectually stimulating, it is not the only way to become a successful clinician, and it definitely isn't the be-all and end-all. Topics: •What do editors look for in manuscripts? •The importance of having a mentor in academia •Navigating author guidelines •Pre-print platforms •How does one get into publishing? •How do I get better at writing? •What do researchers look for when medical students reach out to them? •Predatory journals Expert guest: Dr Joseph Ross (@jsross119 on Twitter) is a Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management) at the Yale School of Medicine. He is also the co-founder of the preprint service for medicine and health sciences - medRxiv. Check out Edward Christopher's piece on predatory journals: https://blogs.bmj.com/bmj/2019/10/08/edward-christopher-how-can-medical-students-avoid-predatory-journals/ Check us out on social media: Twitter: https://twitter.com/BMJStudent Instagram: https://www.instagram.com/bmj_student/ Facebook: https://www.facebook.com/BMJStudent/ This podcast is produced and edited by Dom Byrne and Duncan Jarvies.
I predicted a plaque, a virus originally on my Facebook group "Ocala Conspiracy Forum" back in 2015. Go and join it on Facebook. So, while the world is freaking out with the Omicron, strain of Covid, scientists in France have identified a new variant, which has 46 mutations. Named IHU, the new B.1.640.2 variant has so far infected 12 people living in France. The first case was a person with a travel history to Cameroon, that's western Africa, and he was fully vaccinated said researchers in a paper published on medRxiv. Wait, a fully vaccinated person got the virus? But, I thought President Joe Biden said this is a pandemic of the unvaccinated? Just more misinformation from "Sleepy" Joe. --- Support this podcast: https://anchor.fm/lee-leffingwell/support
On today's show I'm going out on a limb to give you information about the pandemic that is not making headlines. This will help you with your business planning for 2022. I want to be clear that I'm not a doctor and I'm not providing medical advice. I'm merely reporting the results of scientific studies that have been released for publication and are currently undergoing peer review. Once complete the peer review process, this information would be officially published whereas today it's available as a pre print paper. You can draw your own conclusions about what this might mean for the course of this pandemic. There are numerous public health and governmental bodies sounding the alarm over 0Micron. This pandemic has taught us that anything is possible. First of all, the 0Micron variant is vastly more transmissible than its predecessors. You have been hearing that in the news for weeks. But the good news is that it is producing much less severe disease than it's predecessors. We also know that if you have antibodies to one of the previous variants, you are not protected from catching 0Micron. The big question is whether antibodies from 0Micron will protect you from Delta, and that is what this study looks at. It was conducted by the Africa Health Research Institute in Durban South Africa. A number of institutions participated in the study. I've included the link to the paper in the show notes. https://www.ahri.org/wp-content/uploads/2021/12/MEDRXIV-2021-268439v1-Sigal_corr.pdf We have already seen that the existing vaccines do not provide any antibody immunity against the 0Micron variant which is why many people who have been fully vaccinated are getting 0Micron. What they did is that they took samples from newly infected people at the onset of symptoms when the number of antibodies to protect against the virus is low because they have not yet been developed by the body's immune system. We are not talking about Tcell immunity, but antibody immunity. The researchers measured the immunity from the initial sample against 0Micron and against Delta and then compared with a second sample taken 14 days after the onset of symptoms when presumably the body would have generated enough antibodies to fight off the disease. The question is whether the antibodies produced by 0Micron protect against Delta? That is what they looked at in this study.
Dr Peter A. McCullough, MD, MPH, is a board-certified cardiologist, internist, epidemiologist who has testified before committees of the US and multiple State Senates regarding the treatment of COVID-19 and management of the ongoing pandemic. He has been in practice for over 40 years as an active treating physician combined with a decorative academic career that has placed him the most published cardiologist of all time. Join us as we explore:If it is safe to vaccinate your children The very real risk of myocarditis If you can get C-19 twice, why vaccinating post-COVID infection is dangerous, a huge amount of false + cases, C-19's mass psychosis The overwhelming evidence natural immunity is “complete, robust and durable” and “infinitely” superior to vaccinationMENTIONS:Avolio, E., et al. (2021). The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease. Clinical science (London, England : 1979), 135(24), 2667–2689. https://doi.org/10.1042/CS20210735 SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis. Tracy Beth Høeg, et al.medRxiv 2021.08.30.21262866; doi: https://doi.org/10.1101/2021.08.30.21... Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in cardiovascular medicine, 8, 758996. https://doi.org/10.3389/fcvm.2021.758996 Choi, S., Lee, et al. (2021). Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings. Journal of Korean medical science, 36(40), e286. https://doi.org/10.3346/jkms.2021.36....Professor Mattias Desmet https://www.ugent.be/psync/en/who/des...Shedding of Infectious SARS-CoV-2 Despite VaccinationKasen et al. medRxiv 2021.07.31.21261387; doi: https://doi.org/10.1101/2021.07.31.21... 141 Studies Showing Natural Immunity (up from 128)https://brownstone.org/articles/79-re... https://www.thegatewaypundit.com/2021... “Risks of Vaccines for Those Recovered from COVID-19 – Krammer, Raw & Mathioudakis”https://www.americaoutloud.com/risks-... Cohn, B. A., et al (2021). SARS-CoV-2 vaccine protection and deaths among US veterans during 2021. Science (New York, N.Y.), eabm0620. Advance online publication. https://doi.org/10.1126/science.abm0620Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study. Peter Nordström, et al. The Lancet Regional Health – Europe. December 2021. https://www.thelancet.com/journals/la... “Failure of Vaccines and Truth Revealed”. https://www.americaoutloud.com/failur... COVID-19-associated hospitalizations among vaccinated and unvaccinated adults ≥18 years – COVID-NET, 13 states, January 1 – July 24, 2021. Fiona P. Havers, et al. medRxiv 2021.08.27.21262356; doi:https://doi.org/10.1101/2021.08.27.21...Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections. A.J. Venkatakrishnan, et al. medRxiv 2021.05.23.21257668; doi:https://doi.org/10.1101/2021.05.23.21...Kostoff, R. N., et al. (2021). Why are we vaccinating children against COVID-19?. Toxicology reports, 8, 1665–1684. https://doi.org/10.1016/j.toxrep.2021...Disclaimer policy for all of our videos. https://madetothrive.co.za/terms-and-...
COVID 19 research is important, and green open access research sites which allow researchers to self-publish their studies online on sites such as MedRXiv have led to many important findings which have saved lives, but have also led to disinformation and fueled anti-vaccine as well as anti-mask movements. We discuss the history of these sites and go over the pros and cons of the research and studies that are now very accessible to the public prior to peer review. ★ Support this podcast on Patreon ★
南非和瑞典的研究團隊各自發表了很初步的針對Omicron變種病毒的初步中和抗體研究。寫在前面，這人數都不多，且都是初步的資料，解讀要很小心。 1.南非研究僅有12個人，都是打完第二劑BNT疫苗者一個月內的血清，其中有6個人之前有自然感染過。在實驗室測試是否血清可以中和活病毒。 2.相比於原始株，中和抗體平均有41倍的下降。 3.之前打過兩劑疫苗+自然感染者中和抗體則明顯較高，6個有5個還是可中和Omicron。 4.瑞典的研究則是用假病毒，取17個捐血者(BD)還有17個之前感染過的醫護人員(HW)，他們血清中都對原本武漢株有高的中和抗體，來看Omicron的中和抗體下降程度。 5.結果發現個別差異很大，中和抗體從1~23倍的下降都有。但幾乎所有血清都還是可以中和Omicron。 6.平均是下降7倍，好像比想像中好。 04b解讀： 1.南非當地用真病毒來做，瑞典還沒拿到所以是用假病毒做。但一路以來用真假病毒做其實結果都還算吻合。 2.為何兩個研究差異這麼大，可能有許多原因，瑞典研究沒有清楚交代抽血的時間點，之前打過什麼疫苗，還有之前有沒有過自然感染。另外這些試驗人數都不多，個別差異可能很大，還是要累積更多數據才能下確切結論。 3.南非研究顯示暴露過三次抗原者（一次自然感染，兩次BNT）對Omicron中和抗體較高。因此可能可以推論，加強針打下去應該也是對Omicron有幫助。我相信輝瑞很快也會有打完加強針的血清來測試的結果，因為他們才剛做完萬人的加強針臨床試驗。 4.雖然這兩個研究一個降41倍一個降7倍，但多半血清都還是可以中和Omicron，並沒有達到完全失效。我想初步來說這還算是個好消息。 5.之前各種變種病毒：Delta中和抗體大概是降7倍左右，Beta大概是10倍左右。這個倍數給大家參考。41倍看上去真的是滿嚇人的，如果這是真的，應該會嚴重影響到疫苗或自然感染對於有症狀感染的保護力。但是否可以防重症，我想有很大的機會還是會有用的。 接下來的一兩週，類似這樣的中和抗體研究應該會如雨後春筍一樣出來，讓我們繼續看下去吧。 更新：錄音時輝瑞剛剛發新聞稿，這裡我來說清楚些： 1.輝瑞以打完兩劑BNT後21天的血清，還有打完三劑加強針後一個月的血清來看是否可中和Omicron的假病毒。各自還有用武漢原始株，Beta還有Delta來對照。每組大概20人。 2.打完兩劑者，對武漢株中和抗體為155，對Beta是36約下降了4~5倍，對Omicron則是6！下降了25倍之多。 3.打完三劑者，對武漢株中和抗體為398，但對其他變種病毒也有顯著的拉升！相對下降的倍數就沒這麼多了。對Delta是339，對Beta是191，對Omicron可以到154，僅下降了2.5倍。 4.針對Omicron的中和抗體，會在打第三針後從6到154，增加到25倍。其所到達的濃度，跟之前第二針打完針對原始株的中和抗體的濃度155是相當的。所以預期應該能有不錯的保護力。 5.此外還針對了防重症的T細胞免疫做出研究。針對細胞毒殺T細胞會辨認的31個位點(CD8+ epitopes)，之前的變種病毒大概僅有1~2個受影響，Omicorn則是6個。但有25個（78%）還是不受影響的。因此對重症應該還是可以有一定的保護力。 6.結論指出：因為打完疫苗皆有B細胞和T細胞的免疫力，兩劑疫苗可能對防Omicron重症仍有效。 7.要強調這還是初步研究，輝瑞會持續做更多實驗室研究還有蒐集疫苗在真實世界的有效性，來評估接下來該怎麼做。 8.輝瑞會研發針對Omicorn的次世代疫苗，看是否可以有更好的保護力，還有延長保護的時間。 04b解讀： 1.輝瑞也是用假病毒做，而不像昨天第一篇南非當地用真病毒來做。但一路以來用真假病毒做其實結果都還算吻合。 2.兩劑BNT後中和抗體降25倍，而昨天南非，德國的研究分別是差41倍和24~37倍不等。解讀這些研究要小心看他抽血的時間點，之前打過什麼疫苗，還有之前有沒有過自然感染等等。另外這些試驗人數都不多，個別差異可能很大，還是要累積更多數據才能下確切結論。 3.我比較疑惑的是德國研究有抓打三劑BNT後半個月，三個月來看。結果半個月相比於Delta中和抗體下降37倍只有58%的人可以中和，三個月則下降32.8倍只有25%的人可以中和。和輝瑞自己做的結果差距有點大。且我的確擔心持久性的問題，就算輝瑞你現在做到打完加強針一個月後中和抗體好棒棒，但這次可以維持多久？如果如同德國做出來，三個月後只剩25%可以中和這病毒，難道以後三個月打一針嗎？ 4.大家也別太擔心，我想接下來研究會越來越多，更多研究出來我們應該會比較接近真相。不要因為單一研究就直接下定論，多看一下。我當然會持續幫大家追蹤。 南非：https://www.ahri.org/wp-content/uploads/2021/12/MEDRXIV-2021-267417v1-Sigal.pdf 瑞典：https://twitter.com/benjmurrell/status/1468341478363746310?s=21 德國：https://www.medrxiv.org/content/10.1101/2021.12.07.21267432v2 輝瑞新聞稿：https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-omicron-variant Pfizer-BioNTech Covid-19 shot loses power against Omicron variant, but booster restores protection https://www.statnews.com/2021/12/08/pfizer-biontech-covid-19-shot-loses-power-against-omicron-variant-but-booster-restores-protection/ Omicron變種病毒懶人包 傳染力 重症 疫苗有效性 要打加強針嗎？ https://linshibi.com/?p=39815 小額贊助支持本節目： https://pay.firstory.me/user/linshibi Powered by Firstory Hosting
Canary Cry News Talk #399 - 10.08.2021 RESET, RUMORS OF WARS: Battle of Sci, Tech, Social, Pol, Econ, Militia, Edu, Spiritual - CCNT 399 WEBSITE/SHOW NOTES: CanaryCryNewsTalk.com EVERYTHING ELSE: CanaryCry.Party SUPPORT: CanaryCryRadio.com/Support MEET UPS: CanaryCryMeetUps.com ravel: Ravel Podcast Facelikethesun Resurrection YouTube channel Truther Dating experiment INTRO 1:15 Episode 400 prep Candace Owens says we are in WW3 [New Arms Race] Clip: Another Biden speech went really well FLIPPY 9:34 Robot arm that finds lost items, fuses data from cameras and antennae (MIT Edu) CHINA 19:30 11 injured, US Nuke Submarine collides with “unknown object” South China Sea (DailyMail) SPACE POPE REPTILIAN 25:37 Quotes: The world needs more waccine, less war (American Mag) [New Arms Race] MONEY 35:01 NatWest, a bank in Britain, pleads guilty for money laundering (Reuters) Leak reveals Twitch Streamer earnings, millions (Fortune) Amazon secured $670 million in tax breaks, says watchdog (CBS NEWS) Note: Official, George Soros is trading Bitcoin (Yahoo) Note: Senator Cynthia Lummis reveals $100K purchase of Bitcoin (NBC) Moderna founders debut on Forbes' top 400 richest Americans (NY Post) Clip: Implications of “Little Guy” who front ran Institutions, Alex Machinsky Celsius Network CEO I AM WACCINE 55:08 WHO backs first malaria waccine for children (CNN) Not mention on CNN: Gavi, leading the way (Global Fund) Sanofi says positive results from first high dose flu + C19 booster shot (Sanofi Press) BREAK 1: Executive Producers, Paypal, Patrons 1:06:28 Clip: How surveillance advertising is tracking you COVID 19/PANDEMIC SPECIAL 1:43:52 Clip: Dr. Leanna Wen, US should be more like Canada Clip: Trudeau introduces mandate, no more testing? Clip: Newfoundland presser for mandate…squirt squirt Clips: Alex Jones exposes video from 2019, Fauci planning pandemic marketing (New Rescue) Clip: Fauci, 1 and 2 Clip: LA passes mandate, people push back BREAK 2: Art, Reviews, Jingles, Meet Ups 2:22:24 POLITICS 2:54:05 Abortion law on hold, Basil was right (CNN) Biden to sign bill to raise debt ceiling (The Hill) Kamala Harris to “Stop the Steal” (The Atlantic) ADDITIONAL STORIES San Fransisco to list mask mandates on Oct. 15 (SF Chron) Elon Musk to move Tesla HQ to Texas (AP) 18 former NBA players arrested for defrauding health care system (NBC) Chimeric injections in CRISPR reduces tumors (BioRxiv) Facebook renews ambitions to connect world (Wired) What Biden needs to say about Surveillance Tech and Foreign Policy (Just Security) Clip: Ethics professor pushes back on mandates, get's fired Note: Study finds waccinated people more susceptible to variant than unwaxxed (MedRxiv) Clip: Klaus says Henry Kissinger influence, Rockefeller admits recruiting Kissinger Priest absolved abuse, hours after addressing French Church abuse cases (DailyMail) Quotes: The world needs more waccine, less war (American Mag) [New Arms Race] Priest absolved abuse, hours after addressing French Church abuse cases (DailyMail) Fact Check: Sweden “bans”…halts all Moderna SpikeVax (Newsweek) Man who killed pharmacist brother was enraged about waccine (USA Today) European Parliament opposes AI mass surveillance (PC Mag) PRODUCERS ep. 399: Derek R**, Rachelle, Aaron J, Arnold W, Liz D, Veronica D, Juan A, Ethan N, Sean D, HeatheRuss, Morv, Sir Casey the Shield Knight, Mark D, Dominick R, JC, Child of God, Sir Sammons the Knight of the Fishes, Malik, Scott K, Gail M, DrWhoDunDat, Brandt W, Runksmash, Ciara, Douglas P TIMESTAMPS: Rachel C JINGLES: LearBag3000 ART: Dame Allie of the Skillet Nation Sir Dove, Knight of Rustbeltia Ryan N LivingTeaBill
Theme: COVID-19. Participants: Dr Matthew O'Sullivan (infectious diseases specialist), Prof. Sanjay Swaminathan (immunologist), Dr George Zhou (intensivist), Ali Sayeed (ICU registrar), Dr James Tadros (ED consultant), Dr Pramod Chandru (ED consultant), Harry Hong, Samoda Wilegoda Mudalige, Shreyas Iyer, Kit Rowe, and Caroline Tyers.Discussion:Ansems, K., Grundeis, F., Dahms, K., Mikolajewska, A., Thieme, V., & Piechotta, V. et al. (2021). Remdesivir for the treatment of COVID-19. Cochrane Database Of Systematic Reviews, 2021(8). https://doi.org/10.1002/14651858.cd014962.Presenter - Ali Sayeed, ICU Registrar at Westmead Hospital.Summary: Remdesivir is a small molecule pro-drug that inhibits viral replication via its inhibition of RNA polymerase - In Australia, it has been provisionally approved by the TGA for its use in COVID-19. The theory behind using Remdesivir is really in the early stages of COVID-19 pneumonitis (by reducing the viral load and thereby preventing the augmentation of the inflammatory response). This was a systematic review with included meta-analyses looking at the use of Remdesivir in COVID-19 compared with placebo or standard care. It included only randomised control trials, with the primary outcomes being all-cause mortality, changes in clinical status (such as time to liberation from mechanical intervention) and adverse events. The 5 studies analysed for this review were: the Beigel study (ACTT-1 trial) which enrolled 1,000 patients, the Spinner trial which had 600 patients, the Wang trial with 230 patients, the Mahajan trial with 82 patients, and the WHO Solidarity trial with over 5,000 patients. Remdesivir was found to have little to no impact on all-cause mortality at 28 days. The duration to liberation from non-invasive and invasive mechanical ventilation was found to be 17 days in the Remdesivir group compared with 20 days in the control group in the Beigel study, and 7 days in the Remdesivir group compared with 15 days in the control group in the Wang study, although neither of these results were statistically significant. The Beigel study demonstrated a difference in time to recovery in the Remdesivir group compared with the placebo group, with a median difference of 5 days (however it is unclear whether this result was statistically significant). The significant heterogeneity in study protocols, methodology, subgroups and settings made it very difficult to compare these studies statistically. Take-Home Points: Remdesivir likely has very limited or no effect on hard outcomes in COVID-19 (in particular on mortality). The benefit of Remdesivir is not constant across disease severities; if there is a benefit it is likely to be a subset of patients (which appears to be those on low-flow oxygen). It does not appear to affect hospital length of stay (there is not sufficient evidence to suggest it does). All outcomes were based on low certainty evidence, and it is unlikely that there will be further evidence on Remdesivir alone to come, as most patients will be receiving combination therapy in ongoing studies. Of all the treatment modalities that we have for COVID-19, Remdesivir appears to be the one that has the least impact, but it was the one that was available first, and has very few side effects. At present in NSW, COVID-19 patients requiring oxygen are being treated with a combination of Dexamethasone, Remdesivir and Baracitinib (or Tocilizumab). References: Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of COVID-19 – final report. New England Journal of Medicine 2020;383:1813-26.[DOI: 10.1056/NEJMoa2007764]. Spinner CD, Gottlieb RL, Criner GJ, Arribas Lopez JR, Cattelan AM, Soriano Viladomiu A, et al. Effect of remdesivirvs standard care on clinical status at 11 days in patientswith moderate COVID-19: a randomised clinical trial. JAMA2020;324(11):1048-57. [DOI: 10.1001/jama.2020.16349] [PMID:32821939]. Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet2020;395(10236):1569-78. [CLINICALTRIALS.GOV: NCT04257656][DOI: 10.1016/s0140-6736(20)31022-9]. Mahajan L, Singh AP, GiSy. Clinical outcomes of using Remdesivir in patients with moderate to severe COVID-19: a prospective randomised study. Indian Journal of Anaesthesia2021;65:41-6. [DOI: 10.4103/ija.IJA_149_21]. WHO Solidarity Trial Consortium. Repurposed antiviral drugs for COVID-19 - interim WHO solidarity trial results. New England Journal of Medicine 2021;384(8):497-511. [CLINICALTRIALS.GOV:NCT04315948] [DOI: 10.1056/NEJMoa2023184] [EUCTR:EUCTR2020-001366-11] [ISRCTN: ISRCTN83971151]. Living Guidelines [Internet]. Caring for people with COVID-19. 2021 [cited 16 September 2021]. Available from: https://covid19evidence.net.au/#living-guidelines. The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine [Internet]. 2021 [cited 16 September 2021];384(8):693-704. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2021436. Kalil AC, Patterson TF, Mehta AK, Tomashek KM, et al. Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19. N Engl J Med 2021; 384:795-807. Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, Moya J, Falci DR, Sarkis E, Solis J, Zheng H, Scott N, Cathcart AL, Hebner CM, Sager J, Mogalian E, Tipple C, Peppercorn A, Alexander E, Pang PS, Free A, Brinson C, Aldinger M, Shapiro AE. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab [Internet]. medRxiv; May 2021 [cited 16 September 2021]. Available from: https://www.medrxiv.org/content/10.1101/2021.05.27.21257096v1. Tomazini B, Maia I, Cavalcanti A, Berwanger O, Rosa R, Veiga V et al. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19. JAMA [Internet]. 2020 [cited 16 September 2021];324(13):1307. Available from: https://jamanetwork.com/journals/jama/fullarticle/2770277. Hasan MJ, Rabbani R, Anam AM, Huq SMR, Polash MMI, Nessa SST, Bachar SC. Impact of high dose Baracitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh. BMC Infect Dis. May 2021; 21(1): 427. Available from: https://pubmed.ncbi.nlm.nih.gov/33962573/. Kit's Corner Signbank [Internet]. Auslan.org.au. 2021 [cited 01 October 2021]. Available from: https://www.auslan.org.au/dictionary/words/COVID-19-1.html. Credits:This episode was produced by the Emergency Medicine Training Network 5 with the assistance of Dr Kavita Varshney and, Deepa Dasgupta. Music/Sound Effects Angel by Ikson | https://youtube.com/ikson, Music promoted by https://www.free-stock-music.com. Blue Sweater by RYYZN | https://soundcloud.com/ryyzn, Music promoted by https://www.free-stock-music.com, Creative Commons Attribution 3.0 Unported License, https://creativecommons.org/licenses/by/3.0/deed.en_US. Nightswim by Scandinavianz | https://soundcloud.com/scandinavianz, Music promoted by https://www.free-stock-music.com, Creative Commons Attribution 3.0 Unported License, https://creativecommons.org/licenses/by/3.0/deed.en_US. Misfits (Instrumental) by RYYZN | https://soundcloud.com/ryyzn, Music promoted by https://www.free-stock-music.com, Creative Commons Attribution 3.0 Unported License, https://creativecommons.org/licenses/by/3.0/deed.en_US. Sound effects from https://www.free-stock-music.com. Thank you for listening!Please send us an email to let us know what you thought.You can contact us at westmeadedjournalclub@gmail.com.You can also follow us on Facebook, Instagram, and Twitter!See you next time,Caroline, Kit, Pramod, Samoda, and Shreyas.~
Canary Cry News Talk ep. 394 - 09.27.2021 - OCCULTECH MAGIK: Black Goo Greta, $ADA Mystery Religions, Anti-Jab Jocks, X-Men Nephilites - CCNT 394 Our LINK TREE: CanaryCry.Party SUBSCRIBE TO US ON: NewPodcastApps.com SUPPORT: CanaryCryRadio.com/Support MEET UPS: CanaryCryMeetUps.com Basil's other project: Ravel Podcast INTRO Biden gets booster on air Black Goo Greta Cover (Your Celeb Mag) Hamster has been trading crypto, out-performing S&P 500 (Biz Insider) FLIPPY 0:25:31 Can football (soccer) playing robots beat world cup winners by 2050? (BBC) GREAT RESET/CRYPTO0:37:03 Chinese News: China cuts power and production (Bloomberg) Note: Gov't must relieve supply chain turmoil (Financial Times) Huge news from Cardano $ADA during summit (Bloomberg) -Hoskinson donates $20 mil to Carnegie Mellon (Carnegie was a Mason, Mellon ties) -Partnership with Dish Network (Dishfire of NSA, $5 bil deal w/ AT&T, AWT 5G partnership) -Acala PRISM to offer DID on $ADA (PRISM of the NSA, DID traditional) -COTI to issue Djed algorithmic stablecoin on $ADA (Djed ancient Egypt) -Ouroboros PoS protocol for $ADA Australia order $14 million Ouroboros sculpture COVID 19 JINGLE/PANDEMIC SPECIAL 1:09:46 Clip: More tyranny in Australia (Brisbane military airplane drive by) Clip: Even more tyranny in Australia (photo of mask police going viral) Clip: “Get him, he's leaving his house!” Clip: UK protest with thousands Clip: NY Gov says NG to replace unvaccinated medical Ohio State HP “aware and monitoring” possible trucker protest (Fox19) R1 Variant starting to spread (SF Chronicle) Thousands dying but not from C19 (Yahoo/Telegraph) Clip: Natural Immunity potential legal challenge to federal mandates (Yahoo) I AM WACCINE 1:54:44 Clip: Scientist Dr. Ryan Cole, jab autopsies Headline: Court blocks NY city school mandates (WHBI) Unjabbed clash in NBA, Kyrie Irving satanic conspiracy (Sports Illustrated) Headline: GS Warriors, Andrew Wiggins denied religious exemption (NY Times) BREAK (producer party) 2:15:31 POLYTICKS 3:20:26 Newsom Science/Alien: CA to replace the word “Alien” for “noncitizen” and “immigrant” Harry Legs: Biden purchases drones from China (National Pulse) NEPHILIM UPDATE 3:30:55 X-Men could join MCU as Nephilites, not mutants (Screen Rant, MCL) ADDITIONAL STORIES Church at planned parenthood permanently ordered away from clinic (Spokesman Review) Joe Rogan says Trump will probably win 2024 (DailyMail) Robot Arm milking cows (ChipPewa) Not financial advice, Airport robots to rise to $2.5 bn by 2030 (Global News Wire) Mental Health: Use economic, medical, and social data for policy (WEF) India covering up snake bite massacres (Daily Beast) Proud Boys in contact with FBI on Insurrection Day (Yahoo) Inside CIA secret war against Wikileaks (Yahoo) Facebook Ray-Ban Smart Glasses solves problem, but privacy issue (Yahoo) Will robots be able to have children, celebrate mothers day? (Analytics Insights) The Army is modeling future robots on…squirrels (Pop. Mechanics) Robot designs inspired by nature (Design Boom) Scientists create genetically modified coffee (DailyMail) Waccines C19 death toll surpasses 1918 Spanish flu estimates (Smithsonian) National Guard ready to replace health care workers (Reuters) Gates Foundation, NIH, CDC funded C19 jab effectiveness study (MedRxiv) PRODUCERS ep. 394: Scott K**, Brian D, Anonymous, Aaron J, Sam W, Sir Sammons Knight of the Fishes, Sir Casey the Shield Knight, JC, Heatheruss, Sarah P, GiantsBane16, Brandt W, Veronica D, Big Tank, Juan A, Gail M, Doughty the Coyote, Runksmash, Ciara, Rob TIMESTAMPS: Christine C ART: Dame Allie of the Skillet Nation Sir Dove, Knight of Rustbeltia Ryan N Mike B Christine C
Canary Cry News Talk ep. 394 - 09.27.2021 - OCCULTECH MAGIK: Black Goo Greta, $ADA Mystery Religions, Anti-Jab Jocks, X-Men Nephilites - CCNT 394 Our LINK TREE: CanaryCry.Party SUBSCRIBE TO US ON: NewPodcastApps.com SUPPORT: CanaryCryRadio.com/Support MEET UPS: CanaryCryMeetUps.com Basil's other project: Ravel Podcast INTRO Biden gets booster on air Black Goo Greta Cover (Your Celeb Mag) Hamster has been trading crypto, out-performing S&P 500 (Biz Insider) FLIPPY 0:25:31 Can football (soccer) playing robots beat world cup winners by 2050? (BBC) GREAT RESET/CRYPTO0:37:03 Chinese News: China cuts power and production (Bloomberg) Note: Gov't must relieve supply chain turmoil (Financial Times) Huge news from Cardano $ADA during summit (Bloomberg) -Hoskinson donates $20 mil to Carnegie Mellon (Carnegie was a Mason, Mellon ties) -Partnership with Dish Network (Dishfire of NSA, $5 bil deal w/ AT&T, AWT 5G partnership) -Acala PRISM to offer DID on $ADA (PRISM of the NSA, DID traditional) -COTI to issue Djed algorithmic stablecoin on $ADA (Djed ancient Egypt) -Ouroboros PoS protocol for $ADA Australia order $14 million Ouroboros sculpture COVID 19 JINGLE/PANDEMIC SPECIAL 1:09:46 Clip: More tyranny in Australia (Brisbane military airplane drive by) Clip: Even more tyranny in Australia (photo of mask police going viral) Clip: “Get him, he's leaving his house!” Clip: UK protest with thousands Clip: NY Gov says NG to replace unvaccinated medical Ohio State HP “aware and monitoring” possible trucker protest (Fox19) R1 Variant starting to spread (SF Chronicle) Thousands dying but not from C19 (Yahoo/Telegraph) Clip: Natural Immunity potential legal challenge to federal mandates (Yahoo) I AM WACCINE 1:54:44 Clip: Scientist Dr. Ryan Cole, jab autopsies Headline: Court blocks NY city school mandates (WHBI) Unjabbed clash in NBA, Kyrie Irving satanic conspiracy (Sports Illustrated) Headline: GS Warriors, Andrew Wiggins denied religious exemption (NY Times) BREAK (producer party) 2:15:31 POLYTICKS 3:20:26 Newsom Science/Alien: CA to replace the word “Alien” for “noncitizen” and “immigrant” Harry Legs: Biden purchases drones from China (National Pulse) NEPHILIM UPDATE 3:30:55 X-Men could join MCU as Nephilites, not mutants (Screen Rant, MCL) ADDITIONAL STORIES Church at planned parenthood permanently ordered away from clinic (Spokesman Review) Joe Rogan says Trump will probably win 2024 (DailyMail) Robot Arm milking cows (ChipPewa) Not financial advice, Airport robots to rise to $2.5 bn by 2030 (Global News Wire) Mental Health: Use economic, medical, and social data for policy (WEF) India covering up snake bite massacres (Daily Beast) Proud Boys in contact with FBI on Insurrection Day (Yahoo) Inside CIA secret war against Wikileaks (Yahoo) Facebook Ray-Ban Smart Glasses solves problem, but privacy issue (Yahoo) Will robots be able to have children, celebrate mothers day? (Analytics Insights) The Army is modeling future robots on…squirrels (Pop. Mechanics) Robot designs inspired by nature (Design Boom) Scientists create genetically modified coffee (DailyMail) Waccines C19 death toll surpasses 1918 Spanish flu estimates (Smithsonian) National Guard ready to replace health care workers (Reuters) Gates Foundation, NIH, CDC funded C19 jab effectiveness study (MedRxiv) PRODUCERS ep. 394: Scott K**, Brian D, Anonymous, Aaron J, Sam W, Sir Sammons Knight of the Fishes, Sir Casey the Shield Knight, JC, Heatheruss, Sarah P, GiantsBane16, Brandt W, Veronica D, Big Tank, Juan A, Gail M, Doughty the Coyote, Runksmash, Ciara, Rob TIMESTAMPS: Christine C ART: Dame Allie of the Skillet Nation Sir Dove, Knight of Rustbeltia Ryan N Mike B Christine C
(Vaers Adverse Effects Data)https://www.openvaers.com/covid-data(1% of Adverse Effects Reported) Department of Health and Human Services, 2010https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf(Compared to Influenza)https://trialsitenews.com/covid-19-vaccinations-98-times-more-deadly-than-flu-vaccines-according-to-vaers-reports/(Anaphylaxis rate) – Jama Network, March 8, 2021https://jamanetwork.com/journals/jama/fullarticle/2777417(Blood Clotting) - The BMJ, August 27, 2021https://www.bmj.com/content/374/bmj.n1931(Questions about Graphene Ox1de possibly present) Robert Young independent Analysis https://www.drrobertyoung.com/post/transmission-electron-microscopy-reveals-graphene-oxide-in-cov-19-vaccines(More D variant related deaths associated with those with shot[s]) Public Health England, Aug 6, 2021 (page 19) https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1009243/Technical_Briefing_20.pdf(More protection from D varient if previously contracted than taking both Pf1zer doses.) medRxiv, Aug 25, 2021 https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1.full.pdf(Shot Causing Myocarditis) New England Journal of Medicine, August 25, 2021https://www.nejm.org/doi/full/10.1056/NEJMoa2110475(Ivermect1n Effectiveness) American Journal of Therapeutics: July/August 2021 - Volume 28 - Issue 4https://journals.lww.com/americantherapeutics/fulltext/2021/08000/ivermectin%20for%20prevention%20and%20treatment%20of.7.aspx(Hydr0xych10r0qu1ne and z1nc Effectiveness) MedRxiv, May 31, 2021https://www.medrxiv.org/content/10.1101/2021.05.28.21258012v1.full.pdfSupport this podcast at — https://redcircle.com/conversations-that-matter8971/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Family physician Deborah Gordon, MD is the founder and Medical Director of the Northwest Memory Center in Ashland, Oregon. Her decades-long practice has revolved around healthy and adoptable lifestyle choices that impact the development of health problems, with a more recent focus on choices that affect cognitive health and neurodegenerative disease. Deborah has been on the podcast before to talk about autoimmunity, and she's with me today to discuss her new study, currently in the peer review process, in which potential contributors to cognitive decline are identified and targeted therapeutically. On this podcast, Deborah discusses the potential for using a precision medicine approach to Alzheimer's disease and mild cognitive impairment. Inspired by the work of physician and author Dr Dale Bredesen, Deborah has been working with patients to identify and treat root causes, including environmental exposures and infections, while promoting many of the lifestyle changes we talk about all the time on this podcast. The results are astounding, and call into question the current standard of care for Alzheimer's. Here's the outline of this interview with Deborah Gordon: [00:01:10] Deborah's previous appearance on the podcast: How to Fix Autoimmunity in the over 50s. [00:01:23] Deborah's interest in cognitive decline. [00:01:38] Dale Bredesen, MD; The Buck Institute for Research on Aging. [00:02:56] Tommy Wood, MD; Video: Systems Analysis and Multiple Sclerosis – Physicians for Ancestral health Symposium, 2015. [00:03:31] Anne Hathaway, MD; Podcast: The Critical Role of Oestradiol for Women's Cognition. [00:03:45] Dr. Bredesen's study: Bredesen, Dale E. "Reversal of cognitive decline: a novel therapeutic program." Aging (Albany NY) 6.9 (2014): 707. [00:05:54] Dr. Gordon's new paper: Toups, Kat, et al. "Precision Medicine Approach to Alzheimer's Disease: Successful Proof-of-Concept Trial." medRxiv (2021). [00:06:07] Cognitive decline. [00:07:20] Alz.org. [00:10:53] Objective measures of cognition. [00:11:51] Montreal Cognitive Assessment (MoCA). [00:13:47] CNS Vital Signs; Lumosity, Brain-HQ. [00:19:09] The conventional standard of care for cognitive impairment. [00:21:10] Medications for Alzheimer's. [00:27:27] IntellxxDNA. [00:29:20] Josh Turknett, MD; Josh on the NBT podcast: 1, 2, 3, 4. [00:33:58] 4-Quadrant Model. [00:41:24] Podcast: The Postmenopausal Longevity Paradox and the Evolutionary Advantage of Our Grandmothering Life History, with Kristen Hawkes, PhD. [00:45:00] Toxic exposures and infections; mold remediation. [00:48:45] Dr. Lyn Patrick, ND. [01:01:53] Dr. Bredesen's site: Apollo Health. [01:03:49] Facebook: Dale Bredesen and The Official Bredesen Protocol Support Group. [01:04:11] Dr. Bredesen's books: 1. The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline 2. The End of Alzheimer's Program: The First Protocol to Enhance Cognition and Reverse Decline at Any Age 3. The First Survivors of Alzheimer's: How Patients Recovered Life and Hope in Their Own Words. [01:05:22] Where to find Deborah: Drdeborahmd.com; Northwest Wellness & Memory Center; Facebook.
今天來唸這一篇： Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v2 研究人員在一項針對梅約醫院醫療體系（Mayo Clinic Health System）5萬多名患者的研究中發現，莫德納疫苗的效力在2021年初有86%，到了7月，即疫情以Delta變異株為主流時，效力降至76%。同一期間，輝瑞/BNT疫苗的效力從76%降至42%。 莫德納抗Delta優於BNT？羅一鈞建議有疫苗就打 https://www.cna.com.tw/news/firstnews/202108100249.aspx 羅一鈞今天下午在指揮中心記者會中說明，上述研究是對比今年上半年流行的Alpha變種病毒成為主流株時期，及6月以後轉換成Delta變種病毒成主流株時期，兩種mRNA疫苗對不同變種病毒的保護力。 該研究發現，BNT疫苗對英國發現的Alpha變種病毒保護力仍有76％，但對源自印度的Delta變種病毒保護力僅剩42％；莫德納疫苗對Alpha變種病毒的保護力為86％，對於Delta變種病毒保護力為76％。雖莫德納疫苗對Delta變種病毒保護效果打折，但仍優於BNT疫苗。 羅一鈞提到，這是第一次有研究顯示不同疫苗對抗變異株效果，COVID-19疫苗對抗變種病毒效果雖會受影響，但仍有一定保護力，不會建議民眾都去打莫德納疫苗或BNT疫苗，呼籲民眾有疫苗就儘速施打。 延伸閱讀 以色列研究：輝瑞&BNT疫苗對Delta防護力僅39% （還沒有詳情發表） https://www.cna.com.tw/news/firstnews/202107243001.aspx BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar https://www.medrxiv.org/content/10.1101/2021.08.11.21261885v1 對抗Delta變異株 莫德納似優於輝瑞 https://www.cna.com.tw/news/firstnews/202108100080.aspx 根據刊載於醫學網站medRxiv的兩篇報告，美國輝瑞和德國BioNTech聯合研發的mRNA（傳訊核醣核酸）疫苗，在抵抗COVID-19的Delta變異株上，效力或許不及莫德納。路透社報導，這兩篇報告尚待同儕審查。medRxiv是收錄尚未發表且未經同儕審查的研究手稿的網路平台。 研究人員在一項針對梅約醫院醫療體系（Mayo Clinic Health System）5萬多名患者的研究中發現，莫德納疫苗的效力在2021年初有86%，到了7月，即疫情以Delta變異株為主流時，效力降至76%。同一期間，輝瑞/BNT疫苗的效力從76%降至42%。 隸屬麻州數據分析公司nference、主導梅約這份研究的桑達拉拉然（Venky Soundararajan）說，儘管兩支疫苗依舊可有效預防因新冠而住院，今年稍早注射輝瑞（Pfizer）/BNT或莫德納疫苗的民眾，可能很快就必須追加一劑莫德納加強劑。 而在另一份研究中，加拿大安大略省老人之家住民接種莫德納疫苗之後所產生的免疫反應，強過輝瑞/BNT疫苗，尤其在對抗讓人憂心的幾種變異株上。主導這項研究的多倫多「魯能費爾德-塔能鮑姆研究所」（Lunenfeld-Tanenbaum Research Institute）研究員金格拉斯（Anne-Claude Gingras）表示，年長者或許需要較高劑量、加強劑和其他預防措施。 路透社尋求輝瑞評論這兩份研究時，輝瑞發言人表示：「我們持續認為…完整接種之後的6到12個月內或許需要追加第3劑加強劑，以維持最高保護力。」 Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers https://www.medrxiv.org/content/10.1101/2021.08.06.21261721v1 混打疫苗可行嗎？AZ混打輝瑞/BNT AZ混打莫德納等等 https://linshibi.com/?p=39613 給長輩的AZ疫苗懶人包 https://linshibi.com/?p=39590 高端 聯亞 國產疫苗懶人包 第二期結束就緊急授權可行嗎？ https://linshibi.com/?p=39547 新冠快篩懶人包 普篩 抗體快篩 抗原快篩 https://linshibi.com/?p=36564 新冠肺炎疫情下的防疫須知 常見問題解答FAQ https://linshibi.com/?p=35408 新冠疫苗常見問題懶人包 https://linshibi.com/?p=38945 林氏璧醫師的電子名片 https://lit.link/linshibi 歡迎贊助我喝咖啡 https://pay.firstory.me/user/linshibi Powered by Firstory Hosting
ICMR ने कोविड-19 वैक्सीन की मिक्सिंग की स्टडी के नतीजे घोषित किए हैं. इस स्टडी के अनुसार वैक्सीन की मिक्सिंग इम्यूनिटी और एंटीबॉडी बढ़ाने के साथ-साथ वैरिएंट्स के ख़िलाफ़ लड़ाई में भी ज़्यादा असरदार है. यह स्टडी हेल्थ साइंसेज के प्री-प्रिंट सर्वर MedRxiv पर पब्लिश हुई है. वहीं देशभर में पिछले 24 घंटों में कोरोना के 41 हज़ार 576 नए मामले सामने आए हैं. सुनिए सुबह दस बजे का समाचार बुलेटिन - 5 मिनट
台北嘉玲！今日本土僅3例。 雖然不以清零為目標，但看到嘉玲回娘家還是很開心呀。 回頭想想，從五月中到現在能到接近清零的狀態，台灣沒有停止上班，沒有嚴峻的封城。 疫苗一劑覆蓋率衝到近4成了，醫護人員和易重症的老人家覆蓋率更高。 檢驗量能從一萬多增加到一日12萬，抓出了很多無症狀感染者，試著斷去傳染鏈。 這下半場的第一次段考，雖然一開始表現立足未穩，但我們撐過來了，而且表現還可以吧？ 直到目前，我在台北街頭看到口罩覆蓋率是100%。你們呢？ Delta一度進到屏東，但在廣泛匡列下，我們硬是把他擋下來了。 很感謝全台灣民眾的努力，Alpha/Delta都不是好惹的，但我們做到了！ 幫大家打個預防針，接下來我估計還是會有零星案例，甚至一些小小的群聚都可能發生。但只要能夠及時框列隔離，把感染控制在一定範圍，我相信台灣可以走出一條防疫和經濟兼顧的路來的。 第二次段考的考題很明顯，老師已經和你說要考Delta了。 我們對Delta的超前佈署夠了嗎？有什麼還不足之處呢？ 現在還在二級警戒，心態可以輕鬆，但行為不能放鬆。 我們要好好觀察國外學長姊應考的狀況，穩健的走下去。 8/10本土確診增3例創疫情警戒新低 個案皆來自新北 https://www.cna.com.tw/news/firstnews/202108105003.aspx 陳時中說，個案分布均在新北市；其中2例為已知感染源、1例關聯不明，將持續進行疫情調查，以釐清感染源。近期確診個案解隔離情形，5月11日至8月8日累計公布1萬4583名確診個案中，已有1萬3103人解除隔離，解隔離人數達確診人數89.9%。 陳時中表示，今天新增的3例本土個案都來自新北市，這是近期新增確診病例縣市別最少的一次，多數個案之間的關聯都能及時掌握，初步研判目前國內COVID-19疫情控制得還不錯。 今天新增5例境外移入個案，為2例男性、3例女性，年齡介於10多歲至60多歲，分別自法國（案15899）、美國（案15900、案15901）、印尼（案15904）及瑞士（案15906）入境，入境日介於6月28日至8月8日。 獨鍾莫德納疫苗不減反增 意願登記破400萬人 https://www.cna.com.tw/news/ahel/202108100335.aspx 指揮中心指揮官陳時中今天承諾保留第二劑莫德納疫苗，開放第一劑莫德納疫苗施打人數所剩不多，但截至今天下午5時，獨鍾莫德納疫苗民眾不減反增，意願登記破400萬人。 國內採購或獲贈莫德納（Moderna）的COVID-19（2019冠狀病毒疾病）疫苗總數共約855萬劑，以一人接種2劑計算，將以供427多萬人施打為目標，但據中央流行疫情指揮中心統計，截至9日莫德納疫苗已超過306萬人接種，初估國內僅剩不到100萬人可打莫德納疫苗。 此外，在全國意願登記完成總人數1339萬448人中，截至今天下午5時，僅勾選接種莫德納疫苗者已達400 萬1810人，比下午1時的399萬9260人更多，換句話說，陳時中即使在下午2時記者會承諾莫德納疫苗第一劑接種人數達目標，疫苗就不會再使用，但獨鍾莫德納疫苗者不減反增。 另截至今天下午5時的其餘疫苗登記狀況，與下午1時數據相比，僅勾選阿斯特捷利康（AZ）疫苗者為106萬3581人，占比從7.92%增至7.95%；非高端疫苗不打的民眾從18萬1974人增加為18萬2262人，但占比維持為1.36%。 若將只願意打高端疫苗人數及多重選擇COVID-19疫苗中有勾選高端疫苗者加總，意願登記高端疫苗總計105萬7577人，其中該系統7月27日重啟後才登記意願者為64萬1010人。 對抗Delta變異株 莫德納似優於輝瑞 https://www.cna.com.tw/news/firstnews/202108100080.aspx 根據刊載於醫學網站medRxiv的兩篇報告，美國輝瑞和德國BioNTech聯合研發的mRNA（傳訊核醣核酸）疫苗，在抵抗COVID-19的Delta變異株上，效力或許不及莫德納。路透社報導，這兩篇報告尚待同儕審查。medRxiv是收錄尚未發表且未經同儕審查的研究手稿的網路平台。 研究人員在一項針對梅約醫院醫療體系（Mayo Clinic Health System）5萬多名患者的研究中發現，莫德納疫苗的效力在2021年初有86%，到了7月，即疫情以Delta變異株為主流時，效力降至76%。同一期間，輝瑞/BNT疫苗的效力從76%降至42%。 隸屬麻州數據分析公司nference、主導梅約這份研究的桑達拉拉然（Venky Soundararajan）說，儘管兩支疫苗依舊可有效預防因新冠而住院，今年稍早注射輝瑞（Pfizer）/BNT或莫德納疫苗的民眾，可能很快就必須追加一劑莫德納加強劑。 而在另一份研究中，加拿大安大略省老人之家住民接種莫德納疫苗之後所產生的免疫反應，強過輝瑞/BNT疫苗，尤其在對抗讓人憂心的幾種變異株上。主導這項研究的多倫多「魯能費爾德-塔能鮑姆研究所」（Lunenfeld-Tanenbaum Research Institute）研究員金格拉斯（Anne-Claude Gingras）表示，年長者或許需要較高劑量、加強劑和其他預防措施。 路透社尋求輝瑞評論這兩份研究時，輝瑞發言人表示：「我們持續認為…完整接種之後的6到12個月內或許需要追加第3劑加強劑，以維持最高保護力。」 Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v2 Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers https://www.medrxiv.org/content/10.1101/2021.08.06.21261721v1 混打疫苗可行嗎？AZ混打輝瑞/BNT AZ混打莫德納等等 https://linshibi.com/?p=39613 給長輩的AZ疫苗懶人包 https://linshibi.com/?p=39590 高端 聯亞 國產疫苗懶人包 第二期結束就緊急授權可行嗎？ https://linshibi.com/?p=39547 新冠快篩懶人包 普篩 抗體快篩 抗原快篩 https://linshibi.com/?p=36564 新冠肺炎疫情下的防疫須知 常見問題解答FAQ https://linshibi.com/?p=35408 新冠疫苗常見問題懶人包 https://linshibi.com/?p=38945 林氏璧醫師的電子名片 https://lit.link/linshibi 歡迎贊助我喝咖啡 https://pay.firstory.me/user/linshibi Powered by Firstory Hosting
Eating a plant-based diet can help protect against COVID-19, researchers find Harvard University and Kings College London, August 2, 2021 People who eat a plant-based diet are less likely to contract COVID-19 and become severely ill with the disease, according to a recent study by researchers from Harvard Medical School, King's College London and the health science company ZOE. The researchers analyzed data from over 590,000 people from the United States and the United Kingdom who answered a survey about the foods they ate last February using the ZOE COVID Symptom Study application. The application allows users to record their symptoms in case of COVID-19 infection and to log when they've had a positive polymerase chain reaction (PCR) test. By early December 2020, 19 percent of the users who participated contracted COVID-19 based on positive PCR test results and symptoms reported via the application. “For the first time, we've been able to show that a healthier diet can cut the chances of developing [COVID-19],” said co-author Sarah Berry, a senior lecturer in nutritional sciences at King's College London. A preprint of the study was released online in medRxiv. A promising new treatment for COVID-19 infection - Nigella sativa by University of Technology, Sydney A flowering plant native to North Africa and Western Asia could be utilized in the future treatment of COVID-19 infection. The seeds of the plant, Nigella sativa, have been used for centuries as a traditional remedy for multiple medical conditions, including inflammation and infections. Now, an Australian-first research review article has found it could be used to treat COVID-19. "There is growing evidence from modeling studies that thymoquinone, an active ingredient of Nigella sativa, more commonly known as black cumin, can stick to the COVID- 19 virus spike protein and stop the virus from causing a lung infection. Research reveals promise for ginseng compound as liver cancer treatment Northwest University (China), July 28, 2021 According to news originating from Xi'an, People's Republic of China, research stated, “Hepatocellular carcinoma (HCC) is a kind of malignant tumor with high morbidity and mortality rates worldwide. Epithelial-mesenchymal transformation (EMT) is crucial for HCC progression and prognosis.” Centenarians have a distinct microbiome that may help support longevity MIT and Harvard University, August 2, 2021 Centenarians are less susceptible to age-related chronic diseases and more likely to survive infectious diseases. Now, a new study reveals that people who live to be 100 or older have a unique microbiome that may protect them from certain bacterial infections including those caused by multidrug-resistant bacteria. The findings, published in Nature, could help researchers develop new ways to treat chronic inflammation and bacterial disease.
The delta variant of COVID-19 has put the US in the precarious position of a fourth wave of the disease -- how efficacious are our vaccines against this variant? Also, are any new treatments for early COVID-19 being studied to help continue the fight? Find out more in this episode!Redeem your CPE or CME credit here!We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964References and resources: Thompson MG, Burgess JL, Naleway AL, et al. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. N Engl J Med. 2021 Jul 22;385(4):320-329. doi: 10.1056/NEJMoa2107058. Epub 2021 Jun 30. PMID: 34192428; PMCID: PMC8262622.Rossignol J, Matthew C, Oaks J, et al. Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization. medRxiv 2021.04.19.21255441; doi: https://doi.org/10.1101/2021.04.19.21255441Continuing Education Information:Learning Objectives: 1. Discuss the differences in effectiveness between the mRNA and adenovirus vaccines for the delta variant of COVID-192. Describe the use of nitazoxanide in mild to moderate COVID-19 and barriers to its use0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-21-XXX-H01-PInitial release date: 8/31/21Expiration date: 8/24/22Complete CPE & CME details can be found here.
接種疫苗後出現血栓通報率 台灣低於歐美國家 https://www.cna.com.tw/news/firstnews/202107290238.aspx 疫情指揮中心今天表示，國內目前接獲13起接種COVID-19疫苗後出現血栓（TTS）的不良事件通報，總通報率為每百萬劑有4.2件，比歐美國家通報率約每百萬劑10至20件低。 AZ疫苗接種後，可能出現罕見的血栓併血小板低下症候群（thrombosis with thrombocytopenia syndrome，TTS），一度影響國內疫苗接種狀況。 路透社報導，阿斯特捷利康領導並出資、發表在「刺胳針」（The Lancet）醫學期刊的研究顯示，施打第1劑AZ疫苗出現TTS的機率為每百萬劑8.1件；施打第2劑出現TTS的機率為每百萬劑2.3件，和未接種疫苗人口機率相當。 中央流行疫情指揮中心發言人莊人祥今天在疫情記者會說明，國內目前共接獲13件接種疫苗後發生TTS的不良事件通報，年齡介於22到80歲間，發病距離接種後4至27天發生，皆為接種AZ疫苗。比較國內外疫苗接種後發生TTS的不良事件通報率，莊人祥說，國內總通報率為每百萬劑有4.2件，50歲以下年輕族群通報率每百萬劑7.4件，50歲以上族群為每百萬劑2.5件。 莊人祥說，歐美國家TTS通報率約每百萬劑10至20件，整體通報率台灣比歐美國家低，而歐美國家同樣是50或60歲以下的年輕族群，接種疫苗後通報TTS的比率較高。 指揮中心也說明接種疫苗後死亡的解剖統計結果，截至目前已解剖117例，其中81例與慢性病相關，其餘包含嗆噎窒息、頸椎骨折、疑似肺炎、泌尿道感染等，另有5例尚待釐清。 AZ稱打第一劑疫苗後血栓額外風險小 第2劑後更低 https://www.cna.com.tw/news/aopl/202107280382.aspx 英國藥廠阿斯特捷利康（AstraZeneca，AZ）今天表示，研究顯示施打疫苗第一劑後，會有出現罕見血栓併血小板低下症候群的額外小風險，但施打第2劑後毫無這種額外風險。 路透社報導，這項由阿斯特捷利康領導並出資的研究，發表在「刺胳針」（The Lancet）醫學期刊。AZ表示，施打他們的疫苗第一劑後，出現血栓併血小板低下症候群（thrombosis with thrombocytopenia syndrome，TTS）的估計機率是每百萬人有8.1例。 阿斯特捷利康並指出，施打第2劑AZ疫苗後，出現TTS的機率是每百萬接種人口有2.3例，和未接種疫苗人口出現這類症狀的機率相當。今天公布的研究結果，是依據他們的全球安全資料庫資訊，計算截至4月30日的通報病例，且在接種第一或第2劑疫苗後14天內發病。 AZ疫苗血栓之亂 歐洲多國停打 什麼是腦靜脈竇栓塞 https://linshibi.com/?p=39066 參考網站： AZ宣布第二劑TTS機率未提高的新聞稿 https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2021/vaxzevria-showed-no-increased-incidence-of-thrombosis-with-thrombocytopenia-after-second-dose.html Thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis of rare cases. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01693-7/fulltext Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 20·6 million people in six European countries. medRxiv. 2021; (published online May 13.) (preprint). https://doi.org/10.1101/2021.05.12.21257083 英國疫苗副作用網站 https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting 血栓併血小板低下症候群(Thrombosis with Thrombocytopenia Syndrome, TTS)臨床指引 https://www.cdc.gov.tw/File/Get/qarefFfXAc-YodW2dHOQEw 給長輩的AZ疫苗懶人包 https://linshibi.com/?p=39590 高端 聯亞 國產疫苗懶人包 第二期結束就緊急授權可行嗎？ https://linshibi.com/?p=39547 新冠快篩懶人包 普篩 抗體快篩 抗原快篩 https://linshibi.com/?p=36564 新冠肺炎疫情下的防疫須知 常見問題解答FAQ https://linshibi.com/?p=35408 新冠疫苗常見問題懶人包 https://linshibi.com/?p=38945 林氏璧醫師的電子名片 https://lit.link/linshibi 歡迎贊助我喝咖啡 https://pay.firstory.me/user/linshibi Powered by Firstory Hosting
This week, CHEST issues guidelines for low-dose CT screening for lung cancer; severe COVID-19 survivors experience pulmonary impairment; the FDA approves Prograf to prevent lung transplant rejection; and more. Read the full coverage here: CHEST issues new guideline on benefits, harms, use of low-dose CT screening for lung cancer Pulmonary impairment ‘highly prevalent' in severe COVID-19 survivors following discharge FDA approves Prograf to prevent organ rejection in lung transplant recipients In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA Benefit of full-dose heparin for patients with COVID-19 warrants ‘new standard of care' References: González J, et al. Chest. 2021;doi:10.1016/j.chest.2021.02.062. Khan SU, et al. eClinical Medicine. 2021;doi:10.1016/j.eclinm.2021.100997. Mazzone PJ, et al. Chest. 2021;doi:10.1016/j.chest.2021.06.063. Press Release. Sholzberg M, et al. medRxiv. 2021;doi:10.1101/2021.07.08.21259351.
In this 89th in a series of live discussions with Bret Weinstein and Heather Heying (both PhDs in Biology), we discuss the state of the world through an evolutionary lens.In this episode, we begin by discussing a recent episode of the Making Sense podcast, in which Sam Harris and guest Eric Topol strawman both our position, and that of many people who are trying to engage honestly and carefully with scientific evidence. We discuss the evidence that having had Covid confers immunity against SARS-CoV2; the concerns of some doctors about granting EUAs for the covid vaccines to be used in children; and the selective pressure on pathogens that imperfect vaccination creates. We then discuss sleep: beginning with an excerpt from chapter 6 of A Hunter-Gatherer's Guide to the 21st Century—Sleep—we discuss dreams and hallucinations, the use of entheogens across human cultures, and the role of different qualities and intensities of light in modulating melatonin, mood, and alertness at various times of day. Finally, we speak to whether the phase of the moon affects our sleep, and conclude by noting that right now, the moon is full.Get your Goliath shirts right here: store.darkhorsepodcast.orgSupport the sponsors of this show:ReliefBand: Get relief from nausea without drugs. Go to https://www.reliefband.com, use code DARKHORSE, and you'll receive 20% off plus free shipping.Public Goods: Get $15 off your first order at Public Goods, your new everything store, at https://www.publicgoods.com/darkhorse or with code DARKHORSE at checkout.Ask questions for the Q&A here: https://darkhorsesubmissions.com/Our book, A Hunter-Gatherer's Guide to the 21st Century, is now available for pre-sale at amazon. Publication date: 9-14-21: https://www.amazon.com/dp/0593086880/ref=cm_sw_r_tw_dp_5BDTABYFKRJKZBT5GSQAhttp://huntergatherersguide.com/DarkHorse merchandise now available at: store.darkhorsepodcast.orgFind more from us on Bret's website (https://bretweinstein.net) or Heather's website (http://heatherheying.com).Become a member of the DarkHorse LiveStreams, and get access to an additional Q&A livestream every month. Join at Heather's Patreon.Like this content? Subscribe to the channel, like this video, follow us on twitter (@BretWeinstein, @HeatherEHeying), and consider helping us out by contributing to either of our Patreons or Bret's Paypal.Looking for clips from #DarkHorseLivestreams? Here are some, updated frequently: @DarkHorse Podcast ClipsTheme Music: Thank you to Martin Molin of Wintergatan for providing us the rights to use their excellent music.Q&A Link: https://youtu.be/4c2YZykOyO8Support the sponsors of this show:ReliefBand: Get relief from nausea without drugs. Go to https://www.reliefband.com, use code DARKHORSE, and you'll receive 20% off plus free shipping.Public Goods: Get $15 off your first order at Public Goods, your new everything store, at https://www.publicgoods.com/darkhorse or with code DARKHORSE at checkout.Mentioned in this episode:Sam Harris podcast with guest Eric Topol, “A Contagion of Bad Ideas:”: https://samharris.org/podcasts/256-contagion-bad-ideas/Cohen et al 2021. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Medrxiv. https://www.medrxiv.org/content/medrxiv/early/2021/04/27/2021.04.19.21255739.full.pdfIvanova et al 2021. Discrete immune response signature to SARS-CoV-2 mRNA vaccination versus infection. https://www.medrxiv.org/content/medrxiv/early/2021/04/21/2021.04.20.21255677.full.pdfWastila et al 2021. Why we petitioned the FDA to refrain from fully approving Support the show (https://www.patreon.com/bretweinstein)
這集來談談高端疫苗近來的三個風波。 1.陳建仁參加國產疫苗二期試驗 被告知打的是安慰劑 https://www.cna.com.tw/news/firstnews/202107160020.aspx 前副總統陳建仁日前參加國產疫苗二期試驗，他15日深夜透露，已獲通知打到安慰劑，他也決定參加補施打疫苗的延伸計畫，繼續支持國產疫苗研發。 陳建仁打到安慰劑 高端：銜接計畫可先個別解盲 https://www.cna.com.tw/news/firstnews/202107160110.aspx 高端今天發布新聞稿說明，約4000人規模的二期臨床主試驗，依照試驗設計及法規單位要求，採雙盲試驗設計，高端公司、醫院、受試者皆全程被要求維持盲性，直至所有受試者到達第二劑後6個月安全監視期滿後，才可進行全體受試者解盲。但因應台灣疫情升溫及公費疫苗施打擴大，高端疫苗已取得法規單位核准同意，在不影響主試驗執行下，新增延伸性試驗，以維護受試者權益。 逾300人比陳建仁早知道！這個「神秘單位」決定你何時獲知解盲 https://www.gvm.com.tw/article/80974 2.國產疫苗受試者確診？ 高端：資料已送衛福部 https://www.cna.com.tw/news/ahel/202107150261.aspx 「不演了新聞台」今天貼文指出，有受試者在接種兩劑高端疫苗後仍確診。高端指出，的確有收到一個確診個案，但到底是疫苗組或安慰劑組目前還不清楚，10月底、11月初才會真正解盲，但送交CDE審查EUA的資料中有相關資料，可以進行比對。 3.遭疑疫苗保護力不佳 高端：粉專誤導視聽將提告 https://www.cna.com.tw/news/afe/202107130361.aspx Facebook粉絲專頁「不演了新聞台」聲稱自己為吹哨者並指出高端一二期臨床試驗報告，針對傳染力最強的Delta變種株，與重症率最高的Beta變種株，不管低中高劑量，中和抗體數據不佳，例如，Delta變種株的中和抗體平均值，僅有對COVID-19原始株的1/16，許多樣本甚至呈現中和抗體為「陰性」，就是抗體少到連儀器都驗不出來等。 高端晚間發出新聞稿表示，今天Facebook粉絲專頁「不演了新聞台」，聲稱自己為吹哨者取得資訊，內容為斷章取義解讀，惡意誤導視聽的不實陳述。高端表示，關於變異株評估，已在今年3月23日於MedRxiv發表資料，Beta株中和抗體效價下降約7倍（申請EUA使用之中劑量15ug），數據與其他已上市的mRNA疫苗 （6-10倍下降）趨勢相近。 由於Delta偽病毒中和抗體實驗進行時 （2021年6月），國內尚無Delta野生活病毒株可供實驗，因此該項Delta偽病毒中和數據，尚未與野生活病毒 （WT）完成確效比對，數據顯示偽病毒在Delta中和抗體數值為5 至7倍降低，也不是粉專所稱16倍降低，此數據同樣與國際其他已上市疫苗趨勢一致。 另外，粉專也提到，中研院執行的高端疫苗「小鼠AAV攻毒報告」顯示，小鼠感染5天後的肺部病毒數據表現也不佳，低中高劑量與對照組差異不大。高端回應，粉專陳述結果是將報告說明內容移花接木，刻意擷取片段文字，並顛倒是非。在中研院所執行的AAV小鼠攻毒試驗中，事實上已證明疫苗具有優異保護力。 高端表示，Facebook粉絲專頁「不演了新聞台」貼文已涉及非法不當侵害取得政府機密文件，且斷章取義，刻意誤導視聽，嚴重傷害高端聲譽。高端已委請律師提出刑事告訴與民事求償，並同時函請調查局、地檢署、金管會、衛福部及相關主管機關調查，以正視聽。高端也呼籲，期待科學數據應回歸科學專業審查，切勿以訛傳訛、散播不實傳言，以免觸法。 高端完成EUA審查補件 正式對社群粉專提刑事告訴 https://www.cna.com.tw/news/firstnews/202107140313.aspx 高端COVID-19疫苗正申請緊急使用授權EUA審查，食藥署日前通知還要再補件，高端證實，已於今日完成資料補件提交；同時，針對社群粉專內容，高端下午向台北地方檢察署正式提出刑事告訴。 給長輩的AZ疫苗懶人包 https://linshibi.com/?p=39590 高端 聯亞 國產疫苗懶人包 第二期結束就緊急授權可行嗎？ https://linshibi.com/?p=39547 新冠快篩懶人包 普篩 抗體快篩 抗原快篩 https://linshibi.com/?p=36564 新冠肺炎疫情下的防疫須知 常見問題解答FAQ https://linshibi.com/?p=35408 新冠疫苗常見問題懶人包 https://linshibi.com/?p=38945 林氏璧醫師的電子名片 https://lit.link/linshibi 歡迎贊助我喝咖啡 https://pay.firstory.me/user/linshibi Powered by Firstory Hosting
Dass Gesundheitsrisiken gesellschaftlich ungleich verteilt sind, ist lange bekannt. Trotzdem trägt die Pandemiepolitik dem nicht Rechnung. Das Coronavirus trifft arme und bildungsferne Menschen besonders hart, und das nicht nur beim Infektionsrisiko, sondern auch, was den Krankheitsverlauf angeht. In einer Sonderfolge spricht Wissenschaftsredakteurin Korinna Hennig mit dem Medizinsoziologen Nico Dragano über die sozioökonomische Seite der Corona-Krise. Er erklärt, was man aus früheren Pandemien hätte lernen können, welche Rolle Nahverkehr und Arbeitsplätze spielen - und was man anders machen müsste. Die Hintergrundinformationen • Sozioökonomische Ungleichheit und COVID-19 | Robert Koch-Insititut: Eine Übersicht über den internationalen Forschungsstand https://edoc.rki.de/handle/176904/6965 • Risikofaktoren und Covid-19-Tests in Großbritannien | Marc Chadeau-Hyam, Barbara Bodinier, Joshua Elliott, Matthew D Whitaker, Ioanna Tzoulaki, Roel Vermeulen, Michelle Kelly-Irving, Cyrille Delpierre und Paul Elliott: "Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data", erschienen August 2020 bei Oxford Academic https://academic.oup.com/ije/article/49/5/1454/5894660?login=true • Covid-19 Inzidenz und Sterberate in Abhängigkeit von schlechten Wohnverhältnissen in den USA | Khansa Ahmad, Sebhat Erqou, Nishant Shah, Umair Nazir, Alan R. Morrison, Gaurav Choudhary und Wen-Chih Wu: "Association of poor housing conditions with COVID-19 incidence and mortality across US counties", erschienen November 2020 bei PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241327 • Mobilität und Nahverkehr in der Corona-Pandemie in New York | Karla Therese L. Sy, Micaela E. Martinez, Benjamin Rader und Laura F. White: "Socioeconomic disparities in subway use and COVID-19 outcomes in New York City", erschienen Mai 2020 auf medRxiv https://www.medrxiv.org/content/10.1101/2020.05.28.20115949v1.full.pdf • Mobilität und Ungleichheit | Serina Chang, Emma Pierson, Pang Wei Koh, Jaline Gerardin, Beth Redbird, David Grusky und Jure Leskovec: "Mobility network models of COVID-19 explain inequities and inform reopening", erschienen November 2020 bei Nature https://www.nature.com/articles/s41586-020-2923-3.pdf • Studie aus Israel zum Zugang zu Tests und Infektionsrisiken in der Corona-Pandemie | Khitam Muhsen, Wasef Na'aminh, Yelena Lapidot, Sophy Goren, Yonatan Amir, Saritte Perlman, Manfred S. Green, Gabriel Chodick und Dani Cohen: "A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021", erschienen August 2020 in The Lancet Regional Health - Europe auf ScienceDirect https://www.sciencedirect.com/science/article/pii/S2666776221001071 • Risikofaktoren und Krankheitsverläufe in Schweden | Jonathan Bergman, Marcel Ballin, Anna Nordström und Peter Nordström: "Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study", erschienen März 2021 in European Journal of Epidemiology volume bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00732-w • Risikofaktoren und Krankheitsverläufe in Großbritannien | Joshua Elliott, Barbara Bodinier, Matthew Whitaker, Cyrille Delpierre, Roel Vermeulen, Ioanna Tzoulaki, Paul Elliott und Marc Chadeau-Hyam: "COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors", erschienen Februar 2021 im European Journal of Epidemiology bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00722-y • Erhöhtes Risiko eines COVID-19-bedingten Krankenhausaufenthaltes für Arbeitslose | Morten Wahrendorf, Christoph J. Rupprecht, Olga Dortmann, Maria Scheider und Nico Dragano: Eine Analyse von Krankenkassendaten von 1,28 Mio. Versicherten in Deutschland, erschienen Januar 2021 im Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz auf Springer Nature https://link.springer.com/article/10.1007%2Fs00103-021-03280-6 • Inzidenz und Sterblichkeit in Abhängigkeit vom sozialen Status in Chile | Gonzalo E. Mena, Pamela P. Martinez, Ayesha S. Mahmud, Pablo A. Marquet, Caroline O. Buckee und Mauricio Santillana: "Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile", erschienen Mai 2021 bei Science https://science.sciencemag.org/content/372/6545/eabg5298.abstract • Impfungen und Bevölkerungsgruppen - Studie aus Italien | Alexander Domnich, Maura Cambiaggi, Alessandro Vasco, Luca Maraniello, Filippo Ansaldi, Vincenzo Baldo, Paolo Bonanni, Giovanna Elisa Calabrò, Claudio Costantino, Chiara de Waure, Giovanni Gabutti, Vincenzo Restivo, Caterina Rizzo, Francesco Vitale und Riccardo Grassi: "Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey", erschienen November 2020 bei MDPI https://www.mdpi.com/2076-393X/8/4/711 • Grippe und Impfung bei 65+ | Jason M Nagata, Isabel Hernández-Ramos, Anand Sivasankara Kurup, Daniel Albrecht, Claudia Vivas-Torrealba und Carlos Franco-Paredes, "Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data", erschienen April 2013 bei BMC (Springer Nature) https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-388 • Daten aus früheren Pandemien - Hohe Sterberaten bei niedrigem sozialen Status | "Social inequality - a forgotten factor in pandemic influenza preparedness", erschienen Juni 2017 bei Tidsskrift for Den norske legeforening Oslo https://tidsskriftet.no/2017/05/global-helse/social-inequality-forgotten-factor-pandemic-influenza-preparedness • Frühere Pandemien - SARS | Grace Wong Bucchianeri: "Is SARS a Poor Man's Disease? Socioeconomic Status and Risk Factors for SARS Transmission", erschienen 2010 in Forum for Health Economics & Policy https://www.degruyter.com/document/doi/10.2202/1558-9544.1209/html • Frühere Pandemien - Blick auf Chicago 1918 | Kyra H. Grantz, Madhura S. Rane, Henrik Salje, Gregory E. Glass, Stephen E. Schachterle, and Derek A. T. Cummings: "Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918", erschienen November 2016 bei PNAS https://www.pnas.org/content/113/48/13839.short • Ungleichheit und Epidemien als Herausforderung für die globale Sicherheit | Sandra Crouse Quinn und Supriya Kumar: "Health Inequalities and Infectious Disease Epidemics: A Challenge for Global Health Security", erschienen September 2014 im Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science bei Mary Ann Liebert, Inc., publishers https://www.liebertpub.com/doi/abs/10.1089/bsp.2014.0032
Dass Gesundheitsrisiken gesellschaftlich ungleich verteilt sind, ist lange bekannt. Trotzdem trägt die Pandemiepolitik dem nicht Rechnung. Das Coronavirus trifft arme und bildungsferne Menschen besonders hart, und das nicht nur beim Infektionsrisiko, sondern auch, was den Krankheitsverlauf angeht. In einer Sonderfolge spricht Wissenschaftsredakteurin Korinna Hennig mit dem Medizinsoziologen Nico Dragano über die sozioökonomische Seite der Corona-Krise. Er erklärt, was man aus früheren Pandemien hätte lernen können, welche Rolle Nahverkehr und Arbeitsplätze spielen - und was man anders machen müsste. Die Hintergrundinformationen • Sozioökonomische Ungleichheit und COVID-19 | Robert Koch-Insititut: Eine Übersicht über den internationalen Forschungsstand https://edoc.rki.de/handle/176904/6965 • Risikofaktoren und Covid-19-Tests in Großbritannien | Marc Chadeau-Hyam, Barbara Bodinier, Joshua Elliott, Matthew D Whitaker, Ioanna Tzoulaki, Roel Vermeulen, Michelle Kelly-Irving, Cyrille Delpierre und Paul Elliott: "Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data", erschienen August 2020 bei Oxford Academic https://academic.oup.com/ije/article/49/5/1454/5894660?login=true • Covid-19 Inzidenz und Sterberate in Abhängigkeit von schlechten Wohnverhältnissen in den USA | Khansa Ahmad, Sebhat Erqou, Nishant Shah, Umair Nazir, Alan R. Morrison, Gaurav Choudhary und Wen-Chih Wu: "Association of poor housing conditions with COVID-19 incidence and mortality across US counties", erschienen November 2020 bei PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241327 • Mobilität und Nahverkehr in der Corona-Pandemie in New York | Karla Therese L. Sy, Micaela E. Martinez, Benjamin Rader und Laura F. White: "Socioeconomic disparities in subway use and COVID-19 outcomes in New York City", erschienen Mai 2020 auf medRxiv https://www.medrxiv.org/content/10.1101/2020.05.28.20115949v1.full.pdf • Mobilität und Ungleichheit | Serina Chang, Emma Pierson, Pang Wei Koh, Jaline Gerardin, Beth Redbird, David Grusky und Jure Leskovec: "Mobility network models of COVID-19 explain inequities and inform reopening", erschienen November 2020 bei Nature https://www.nature.com/articles/s41586-020-2923-3.pdf • Studie aus Israel zum Zugang zu Tests und Infektionsrisiken in der Corona-Pandemie | Khitam Muhsen, Wasef Na'aminh, Yelena Lapidot, Sophy Goren, Yonatan Amir, Saritte Perlman, Manfred S. Green, Gabriel Chodick und Dani Cohen: "A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021", erschienen August 2020 in The Lancet Regional Health - Europe auf ScienceDirect https://www.sciencedirect.com/science/article/pii/S2666776221001071 • Risikofaktoren und Krankheitsverläufe in Schweden | Jonathan Bergman, Marcel Ballin, Anna Nordström und Peter Nordström: "Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study", erschienen März 2021 in European Journal of Epidemiology volume bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00732-w • Risikofaktoren und Krankheitsverläufe in Großbritannien | Joshua Elliott, Barbara Bodinier, Matthew Whitaker, Cyrille Delpierre, Roel Vermeulen, Ioanna Tzoulaki, Paul Elliott und Marc Chadeau-Hyam: "COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors", erschienen Februar 2021 im European Journal of Epidemiology bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00722-y • Erhöhtes Risiko eines COVID-19-bedingten Krankenhausaufenthaltes für Arbeitslose | Morten Wahrendorf, Christoph J. Rupprecht, Olga Dortmann, Maria Scheider und Nico Dragano: Eine Analyse von Krankenkassendaten von 1,28 Mio. Versicherten in Deutschland, erschienen Januar 2021 im Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz auf Springer Nature https://link.springer.com/article/10.1007%2Fs00103-021-03280-6 • Inzidenz und Sterblichkeit in Abhängigkeit vom sozialen Status in Chile | Gonzalo E. Mena, Pamela P. Martinez, Ayesha S. Mahmud, Pablo A. Marquet, Caroline O. Buckee und Mauricio Santillana: "Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile", erschienen Mai 2021 bei Science https://science.sciencemag.org/content/372/6545/eabg5298.abstract • Impfungen und Bevölkerungsgruppen - Studie aus Italien | Alexander Domnich, Maura Cambiaggi, Alessandro Vasco, Luca Maraniello, Filippo Ansaldi, Vincenzo Baldo, Paolo Bonanni, Giovanna Elisa Calabrò, Claudio Costantino, Chiara de Waure, Giovanni Gabutti, Vincenzo Restivo, Caterina Rizzo, Francesco Vitale und Riccardo Grassi: "Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey", erschienen November 2020 bei MDPI https://www.mdpi.com/2076-393X/8/4/711 • Grippe und Impfung bei 65+ | Jason M Nagata, Isabel Hernández-Ramos, Anand Sivasankara Kurup, Daniel Albrecht, Claudia Vivas-Torrealba und Carlos Franco-Paredes, "Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data", erschienen April 2013 bei BMC (Springer Nature) https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-388 • Daten aus früheren Pandemien - Hohe Sterberaten bei niedrigem sozialen Status | "Social inequality - a forgotten factor in pandemic influenza preparedness", erschienen Juni 2017 bei Tidsskrift for Den norske legeforening Oslo https://tidsskriftet.no/2017/05/global-helse/social-inequality-forgotten-factor-pandemic-influenza-preparedness • Frühere Pandemien - SARS | Grace Wong Bucchianeri: "Is SARS a Poor Man's Disease? Socioeconomic Status and Risk Factors for SARS Transmission", erschienen 2010 in Forum for Health Economics & Policy https://www.degruyter.com/document/doi/10.2202/1558-9544.1209/html • Frühere Pandemien - Blick auf Chicago 1918 | Kyra H. Grantz, Madhura S. Rane, Henrik Salje, Gregory E. Glass, Stephen E. Schachterle, and Derek A. T. Cummings: "Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918", erschienen November 2016 bei PNAS https://www.pnas.org/content/113/48/13839.short • Ungleichheit und Epidemien als Herausforderung für die globale Sicherheit | Sandra Crouse Quinn und Supriya Kumar: "Health Inequalities and Infectious Disease Epidemics: A Challenge for Global Health Security", erschienen September 2014 im Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science bei Mary Ann Liebert, Inc., publishers https://www.liebertpub.com/doi/abs/10.1089/bsp.2014.0032
Vaccines are the mainstay of care in the COVID-19 pandemic. However, patients may still become infected and need treatment options. Two studies have evaluated the role of inhaled budesonide for the early treatment of outpatient COVID-19 infections. Can budesonide hasten the resolution of symptoms or prevent hospitalizations?Redeem your CPE or CME credit here!References and resources:Ramakrishnan S, Nicolau DV, Langford B, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. The Lancet Respiratory Medicine. April 2021. doi:10.1016/s2213-2600(21)00160-0Yu L-M, Bafadhel M, Dorward J, et al. Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial. medRxiv. Published online January 1, 2021:2021.04.10.21254672. doi:10.1101/2021.04.10.21254672Continuing Education Information:Learning Objective: Identify the appropriate patient population for inhaled budesonide in the treatment of COVID-190.05 CEU | 0.5 HrsACPE UAN: 0107-0000-21-228-H01-P0.50 AMA PRA Category 1 CreditsTM.(the TM needs to be super scripted)Initial release date: 6/29/21Expiration date: 6/29/22Complete CPE & CME details can be found here.
Covid Vaccine Spike Protein is Very Dangerous- it's Cytotoxic and Why Effective Treatments Are Being Suppressed. Spike protein is very dangerous, it's cytotoxic (Robert Malone, Steve Kirsch, Bret Weinstein) Why is this treatment being suppressed? (Pierre Kory & Bret Weinstein) Spike protein is very dangerous, it's cytotoxic (Robert Malone, Steve Kirsch, Bret Weinstein) https://youtu.be/Du2wm5nhTXY DarkHorse Podcast Clips 162K subscribers Spike protein is very dangerous, it's cytotoxic. Dr. Robert Malone is the inventor of mRNA Vaccine technology. Mr. Steve Kirsch is a serial entrepreneur who has been researching adverse reactions to COVID vaccines. Bret talks to Robert and Steve about the pandemic, treatment and the COVID vaccines. Steve's paper on COVID vaccine reactions: https://trialsitenews.com/should-you-... Steve's Twitter: https://twitter.com/stkirsch COVID-19 Early Treatment Fund: https://www.treatearly.org/team/steve... Dr. Malone's website: https://www.rwmalonemd.com/mrna-vacci... Robert's LinkedIn profile: https://www.linkedin.com/in/rwmalonemd Robert's Twitter: https://twitter.com/RWMaloneMD Find Bret Weinstein on Twitter: @BretWeinstein, and on Patreon. https://www.patreon.com/bretweinstein https://twitter.com/BretWeinstein Please subscribe to this channel for more long form content like this, and subscribe to the clips channel @DarkHorse Podcast Clips for short clips of all our podcasts. DarkHorse merchandise now available at: store.darkhorsepodcast.org Clip from DarkHorse podcast. Full livestream here: https://youtu.be/-_NNTVJzqtY Bitchute for backup: https://www.bitchute.com/video/TH2HAm... Why is this treatment being suppressed? (Pierre Kory & Bret Weinstein) https://youtu.be/q01LUg97eto 65,187 views DarkHorse Podcast Clips 162K subscribers Why is this COVID treatment being suppressed? Clip from Bret Weinstein and Pierre Kory on DarkHorse - CENSORED on YouTube - available on Spotify or here: https://www.bitchute.com/video/qHjNQI... 00:00 Disclaimer 01:33 Clip starts On this very special live broadcast of the DarkHorse podcast, Dr. Bret Weinstein (Ph.D) and Dr. Pierre Kory (M.D.) will discuss the ongoing pandemic, the care of COVID-19 patients, and the incredible story of Ivermectin. Mentioned in the full episode: British Ivermectin Recommendation Development group: https://bird-group.org The BIRD Recommendation on the Use of Ivermectin for Covid-19: Executive Summary: https://bird-group.org/wp-content/upl... Carvallo et al 2020. Study of the efficacy and safety of topical ivermectin+ iota-carrageenan in the prophylaxis against COVID-19 in health personnel. J. Biomed. Res. Clin. Investig., 2. https://medicalpressopenaccess.com/up... Cobos-Campos et al 2021.Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection: Efficacy of ivermectin for SARS-CoV-2. Clin Res Trials, 7: 1-5. https://www.readkong.com/page/potenti... Database of all ivermectin COVID-19 studies. 93 studies, 55 peer reviewed, 56 with results comparing treatment and control groups: https://c19ivermectin.com Karale et al 2021. A Meta-analysis of Mortality, Need for ICU admission, Use of Mechanical Ventilation and Adverse Effects with Ivermectin Use in COVID-19 Patients. medRxiv. https://www.medrxiv.org/content/medrx... Kory et al 2021. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. American Journal of Therapeutics, 28(3): e299: https://www.ncbi.nlm.nih.gov/pmc/arti... Nardelli et al 2021. Crying wolf in time of Corona: the strange case of ivermectin and hydroxychloroquine. Is the fear of failure withholding potential life-saving treatment from clinical use?. Signa Vitae, 1: 2. https://oss.signavitae.com/mre-signav... Yagisawa et al 2021. Global trends in clinical studies of ivermectin in COVID-19. The Japanese Journal of Antibiotics, 74: 1. https://www.psychoactif.org/forum/upl... --- The FLCCC: https://covid19criticalcare.com/ Dr. Kory on Twitter: @PierreKory --- Find Bret Weinstein on Twitter: @BretWeinstein, and on Patreon. Please subscribe to this channel for more long form content like this, and subscribe to the clips channel @DarkHorse Podcast Clips for short clips of all our podcasts. DarkHorse merchandise now available at: store.darkhorsepodcast.org From Trial Site News- Should you get vaccinated? Steve KirschMay 25, 2021 I always get vaccinated. I have been fully vaccinated with the Moderna COVID vaccine. My three daughters have all been vaccinated. I recently learned that these vaccines have killed over 25,800 Americans and disabled at least 1,000,000 more. And we're only halfway to the finish line. We need to PAUSE these vaccines NOW before more people are killed. Based on what I now know about the miniscule vaccine benefits (approximately a .3% reduction in absolute risk), side effects (including death), current COVID rates, and the success rate of early treatment protocols, the answer I would give today to anyone asking me for advice as to whether to take any of the current vaccines would be, “Just say NO.” The current vaccines are particularly contraindicated if you have already been infected with COVID or are under age 20. For these people, I would say “NO! NO! NO!” In this article, I will explain what I have learned since I was vaccinated that totally changed my mind. You will learn how these vaccines work and the shortcuts that led to the mistakes that were made. You will understand why there are so many side effects and why these are so varied and why they usually happen within 30 days of vaccination. You will understand why kids are having heart issues (for which there is no treatment), and temporarily losing their sight, and ability to talk. You will understand why as many as 3% may be severely disabled by the vaccine. What I find deeply disturbing is the lack of transparency on how dangerous the current COVID vaccines are. Healthy people could end up dead or permanently disabled at a rate that is “off the charts” compared with any other vaccine in our history. Look at the death report in our government's official Vaccine Adverse Event Reporting System (VAERS) summarized in the tweet below. This is the most deadly vaccine we've ever made by a long shot. That's why they have to give you incentives to get vaccinated. They need to vaccinate everyone BEFORE people read this article or watch this video of Dr. Peter McCullough explaining clearly why the current COVID vaccines are unsafe and completely unnecessary for our children. The death rate from this vaccine is off the charts, more than all 70 vaccines over the past 30 years combined But this is just the beginning of our story. We have a lot of ground to cover. I'll talk about Fauci, NIAID, CDC, Congress, academia, Cliff Lane, and more . Before we jump into the details, here are some key points: At least 6,000 deaths from the vaccine. The OpenVAERS team think it is over 20,000 due to under reporting. Biodistribution data shows massive accumulation in ovaries of the LNP (which instructs cells in ovaries to sprout toxic spike protein). Whoops. That was never supposed to be leaked out. We obtained it via FOIA request. The CDC never told you about that one, did they? Of course not! 82% miscarriage rate in first 20 weeks (10% is the normal rate). It is baffling that the CDC says the vaccine is safe for pregnant women when it is so clear that this is not the case. For example, one our family friends is a victim of this. She miscarried at 25 weeks and is having an abortion on 6/9/21. She had her first shot 7 weeks ago, and her second shot 4 weeks ago. The baby had severe bleeding of the brain and other disfigurements. Her gynecologist had never seen anything like that before in her life. They called in a specialist who said it was probably a genetic defect (because everyone buys into the narrative that the vaccine is safe it is always ruled out as a possible cause). No VAERS report. No CDC report. Yet the doctors I've talked to say that it is over 99% certain it was the vaccine. The family doesn't want an autopsy for fear that their daughter will find out it was the vaccine. This is a perfect example of how these horrible side effects just never get reported anywhere. 25X the possibility of myocarditis for teen boys (can lead to heart failure and death) Kids already have natural immunity (Science Magazine article), so there is no benefit to vaccination, only risk. Have you ever seen the risk / benefit analysis by the CDC?? Ask for it before you consent. No point vaccinating those who've had COVID-19: Findings of Cleveland Clinic study. No benefit, only risk. Doctors who attribute adverse events to the vaccine are punished (such as Dr. Hoffe). So under reporting is incentivized. The CDC refuses to say how many people have died and is “still investigating” heart damage in kids even though it is obvious why (free spike protein causing clotting and inflammation). A 25X increase when the only “new” thing is the vaccine isn't hard to figure out. Ask the CDC for their current top 5 hypotheses for the cause. It will be more than amusing to see what they say. If it isn't the vaccine, heads should roll. The CDC is deliberately misleading the American people. Check out the side effects page. Death, disability, excessive miscarriage rates, heart attacks, stroke, inability to walk, talk, or see, Bell's Palsy, persistent pain, Parkinson's like symptoms, re-activation of shingles, blood clots, etc. are all missing. >500X more deadly than the flu vaccine COVID vaccines have generated more adverse reports in the last 6 months than all 70 vaccines over the past 30 years combined. They missed that one. Defective virus design (s1 was never supposed to be free, inclusion of PEG was unnecessary and allows LNP to be widely distributed) Strong opposition to vaccination by extremely credible voices like Malone, Geert Vanden Bossche, others NIAID (Cliff Lane) is improperly manipulating the COVID Treatment Guidelines to make it appear these drugs do not work, thus giving the world the false impression that the vaccine, even if imperfect, is the only way out. Ivermectin and fluvoxamine have been confirmed in Phase 3 trials. Ivermectin has a very high quality systematic review, the highest possible level in Evidence Based Medicine. Repurposed drugs are safer and more effective than the current vaccines. In general, early treatment with an effective protocols reduce your risk of dying by more than 100X so instead of 600,000 deaths, we'd have fewer than 6,000 deaths. NOTE: The vaccine has already killed over 6,000 people and that's from the vaccine alone (and doesn't count any breakthrough deaths). Vaccines skipped proper toxicology studies in order to bring to market faster. We don't know what we don't know. The unpredictable and horrifying side effects of this vaccine on heathy kids, such as the 16 year old girl who was unable to speak and see just 48 hours after being vaccinated Debilitating side effects can happen at any time because vaccine victims are very similar to COVID long haulers (Dr. Bruce Patterson has discovered this) and we all know that long haul can start at anytime (even when the disease is asymptomatic) and could be incurable. Because the vaccine is not perfectly safe, the government is required by law to warn people of the death and disability risks caused by the vaccine and to obtain informed consent. Always be sure to ask for the 50 most serious side effects and how often they happen. And find out whether they will compensate you if you are disabled for life from the vaccine. This is important because the blood clots can form anywhere with this very unsafe virus. Note: this is a large document and different sections were written at different times so you may find that the numbers may be inconsistent. If you spot an error, please use the comments to point it out. If you enjoyed reading this article, please follow me on Twitter at @stkirsch so I can keep you apprised of how this story progresses. The more followers I have, the less likely they will ignore my requests for informed consent and data transparency. Also, please share with your friends on social media. Thanks! New research shows why we should not vaccinate kids Will we listen to the SCIENCE? Or will will follow the Biden, CDC, NIH narrative blindly? Time to decide.
Covid Vaccine Spike Protein is Very Dangerous- it's Cytotoxic and Why Effective Treatments Are Being Suppressed. Spike protein is very dangerous, it's cytotoxic (Robert Malone, Steve Kirsch, Bret Weinstein) Why is this treatment being suppressed? (Pierre Kory & Bret Weinstein) Spike protein is very dangerous, it's cytotoxic (Robert Malone, Steve Kirsch, Bret Weinstein) https://youtu.be/Du2wm5nhTXY DarkHorse Podcast Clips 162K subscribers Spike protein is very dangerous, it's cytotoxic. Dr. Robert Malone is the inventor of mRNA Vaccine technology. Mr. Steve Kirsch is a serial entrepreneur who has been researching adverse reactions to COVID vaccines. Bret talks to Robert and Steve about the pandemic, treatment and the COVID vaccines. Steve's paper on COVID vaccine reactions: https://trialsitenews.com/should-you-... Steve's Twitter: https://twitter.com/stkirsch COVID-19 Early Treatment Fund: https://www.treatearly.org/team/steve... Dr. Malone's website: https://www.rwmalonemd.com/mrna-vacci... Robert's LinkedIn profile: https://www.linkedin.com/in/rwmalonemd Robert's Twitter: https://twitter.com/RWMaloneMD Find Bret Weinstein on Twitter: @BretWeinstein, and on Patreon. https://www.patreon.com/bretweinstein https://twitter.com/BretWeinstein Please subscribe to this channel for more long form content like this, and subscribe to the clips channel @DarkHorse Podcast Clips for short clips of all our podcasts. DarkHorse merchandise now available at: store.darkhorsepodcast.org Clip from DarkHorse podcast. Full livestream here: https://youtu.be/-_NNTVJzqtY Bitchute for backup: https://www.bitchute.com/video/TH2HAm... Why is this treatment being suppressed? (Pierre Kory & Bret Weinstein) https://youtu.be/q01LUg97eto 65,187 views DarkHorse Podcast Clips 162K subscribers Why is this COVID treatment being suppressed? Clip from Bret Weinstein and Pierre Kory on DarkHorse - CENSORED on YouTube - available on Spotify or here: https://www.bitchute.com/video/qHjNQI... 00:00 Disclaimer 01:33 Clip starts On this very special live broadcast of the DarkHorse podcast, Dr. Bret Weinstein (Ph.D) and Dr. Pierre Kory (M.D.) will discuss the ongoing pandemic, the care of COVID-19 patients, and the incredible story of Ivermectin. Mentioned in the full episode: British Ivermectin Recommendation Development group: https://bird-group.org The BIRD Recommendation on the Use of Ivermectin for Covid-19: Executive Summary: https://bird-group.org/wp-content/upl... Carvallo et al 2020. Study of the efficacy and safety of topical ivermectin+ iota-carrageenan in the prophylaxis against COVID-19 in health personnel. J. Biomed. Res. Clin. Investig., 2. https://medicalpressopenaccess.com/up... Cobos-Campos et al 2021.Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection: Efficacy of ivermectin for SARS-CoV-2. Clin Res Trials, 7: 1-5. https://www.readkong.com/page/potenti... Database of all ivermectin COVID-19 studies. 93 studies, 55 peer reviewed, 56 with results comparing treatment and control groups: https://c19ivermectin.com Karale et al 2021. A Meta-analysis of Mortality, Need for ICU admission, Use of Mechanical Ventilation and Adverse Effects with Ivermectin Use in COVID-19 Patients. medRxiv. https://www.medrxiv.org/content/medrx... Kory et al 2021. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. American Journal of Therapeutics, 28(3): e299: https://www.ncbi.nlm.nih.gov/pmc/arti... Nardelli et al 2021. Crying wolf in time of Corona: the strange case of ivermectin and hydroxychloroquine. Is the fear of failure withholding potential life-saving treatment from clinical use?. Signa Vitae, 1: 2. https://oss.signavitae.com/mre-signav... Yagisawa et al 2021. Global trends in clinical studies of ivermectin in COVID-19. The Japanese Journal of Antibiotics, 74: 1. https://www.psychoactif.org/forum/upl... --- The FLCCC: https://covid19criticalcare.com/ Dr. Kory on Twitter: @PierreKory --- Find Bret Weinstein on Twitter: @BretWeinstein, and on Patreon. Please subscribe to this channel for more long form content like this, and subscribe to the clips channel @DarkHorse Podcast Clips for short clips of all our podcasts. DarkHorse merchandise now available at: store.darkhorsepodcast.org From Trial Site News- Should you get vaccinated? Steve KirschMay 25, 2021 I always get vaccinated. I have been fully vaccinated with the Moderna COVID vaccine. My three daughters have all been vaccinated. I recently learned that these vaccines have killed over 25,800 Americans and disabled at least 1,000,000 more. And we're only halfway to the finish line. We need to PAUSE these vaccines NOW before more people are killed. Based on what I now know about the miniscule vaccine benefits (approximately a .3% reduction in absolute risk), side effects (including death), current COVID rates, and the success rate of early treatment protocols, the answer I would give today to anyone asking me for advice as to whether to take any of the current vaccines would be, “Just say NO.” The current vaccines are particularly contraindicated if you have already been infected with COVID or are under age 20. For these people, I would say “NO! NO! NO!” In this article, I will explain what I have learned since I was vaccinated that totally changed my mind. You will learn how these vaccines work and the shortcuts that led to the mistakes that were made. You will understand why there are so many side effects and why these are so varied and why they usually happen within 30 days of vaccination. You will understand why kids are having heart issues (for which there is no treatment), and temporarily losing their sight, and ability to talk. You will understand why as many as 3% may be severely disabled by the vaccine. What I find deeply disturbing is the lack of transparency on how dangerous the current COVID vaccines are. Healthy people could end up dead or permanently disabled at a rate that is “off the charts” compared with any other vaccine in our history. Look at the death report in our government's official Vaccine Adverse Event Reporting System (VAERS) summarized in the tweet below. This is the most deadly vaccine we've ever made by a long shot. That's why they have to give you incentives to get vaccinated. They need to vaccinate everyone BEFORE people read this article or watch this video of Dr. Peter McCullough explaining clearly why the current COVID vaccines are unsafe and completely unnecessary for our children. The death rate from this vaccine is off the charts, more than all 70 vaccines over the past 30 years combined But this is just the beginning of our story. We have a lot of ground to cover. I'll talk about Fauci, NIAID, CDC, Congress, academia, Cliff Lane, and more . Before we jump into the details, here are some key points: At least 6,000 deaths from the vaccine. The OpenVAERS team think it is over 20,000 due to under reporting. Biodistribution data shows massive accumulation in ovaries of the LNP (which instructs cells in ovaries to sprout toxic spike protein). Whoops. That was never supposed to be leaked out. We obtained it via FOIA request. The CDC never told you about that one, did they? Of course not! 82% miscarriage rate in first 20 weeks (10% is the normal rate). It is baffling that the CDC says the vaccine is safe for pregnant women when it is so clear that this is not the case. For example, one our family friends is a victim of this. She miscarried at 25 weeks and is having an abortion on 6/9/21. She had her first shot 7 weeks ago, and her second shot 4 weeks ago. The baby had severe bleeding of the brain and other disfigurements. Her gynecologist had never seen anything like that before in her life. They called in a specialist who said it was probably a genetic defect (because everyone buys into the narrative that the vaccine is safe it is always ruled out as a possible cause). No VAERS report. No CDC report. Yet the doctors I've talked to say that it is over 99% certain it was the vaccine. The family doesn't want an autopsy for fear that their daughter will find out it was the vaccine. This is a perfect example of how these horrible side effects just never get reported anywhere. 25X the possibility of myocarditis for teen boys (can lead to heart failure and death) Kids already have natural immunity (Science Magazine article), so there is no benefit to vaccination, only risk. Have you ever seen the risk / benefit analysis by the CDC?? Ask for it before you consent. No point vaccinating those who've had COVID-19: Findings of Cleveland Clinic study. No benefit, only risk. Doctors who attribute adverse events to the vaccine are punished (such as Dr. Hoffe). So under reporting is incentivized. The CDC refuses to say how many people have died and is “still investigating” heart damage in kids even though it is obvious why (free spike protein causing clotting and inflammation). A 25X increase when the only “new” thing is the vaccine isn't hard to figure out. Ask the CDC for their current top 5 hypotheses for the cause. It will be more than amusing to see what they say. If it isn't the vaccine, heads should roll. The CDC is deliberately misleading the American people. Check out the side effects page. Death, disability, excessive miscarriage rates, heart attacks, stroke, inability to walk, talk, or see, Bell's Palsy, persistent pain, Parkinson's like symptoms, re-activation of shingles, blood clots, etc. are all missing. >500X more deadly than the flu vaccine COVID vaccines have generated more adverse reports in the last 6 months than all 70 vaccines over the past 30 years combined. They missed that one. Defective virus design (s1 was never supposed to be free, inclusion of PEG was unnecessary and allows LNP to be widely distributed) Strong opposition to vaccination by extremely credible voices like Malone, Geert Vanden Bossche, others NIAID (Cliff Lane) is improperly manipulating the COVID Treatment Guidelines to make it appear these drugs do not work, thus giving the world the false impression that the vaccine, even if imperfect, is the only way out. Ivermectin and fluvoxamine have been confirmed in Phase 3 trials. Ivermectin has a very high quality systematic review, the highest possible level in Evidence Based Medicine. Repurposed drugs are safer and more effective than the current vaccines. In general, early treatment with an effective protocols reduce your risk of dying by more than 100X so instead of 600,000 deaths, we'd have fewer than 6,000 deaths. NOTE: The vaccine has already killed over 6,000 people and that's from the vaccine alone (and doesn't count any breakthrough deaths). Vaccines skipped proper toxicology studies in order to bring to market faster. We don't know what we don't know. The unpredictable and horrifying side effects of this vaccine on heathy kids, such as the 16 year old girl who was unable to speak and see just 48 hours after being vaccinated Debilitating side effects can happen at any time because vaccine victims are very similar to COVID long haulers (Dr. Bruce Patterson has discovered this) and we all know that long haul can start at anytime (even when the disease is asymptomatic) and could be incurable. Because the vaccine is not perfectly safe, the government is required by law to warn people of the death and disability risks caused by the vaccine and to obtain informed consent. Always be sure to ask for the 50 most serious side effects and how often they happen. And find out whether they will compensate you if you are disabled for life from the vaccine. This is important because the blood clots can form anywhere with this very unsafe virus. Note: this is a large document and different sections were written at different times so you may find that the numbers may be inconsistent. If you spot an error, please use the comments to point it out. If you enjoyed reading this article, please follow me on Twitter at @stkirsch so I can keep you apprised of how this story progresses. The more followers I have, the less likely they will ignore my requests for informed consent and data transparency. Also, please share with your friends on social media. Thanks! New research shows why we should not vaccinate kids Will we listen to the SCIENCE? Or will will follow the Biden, CDC, NIH narrative blindly? Time to decide.
Pesquisadores brasileiros conseguiram comprovar o papel essencial da resposta imune adaptativa, ou seja, específica para cada patógeno, do nosso próprio organismo para evitar a recorrência da Covid-19. Tudo isso graças à imunidade celular, isto é, a ação dos chamados linfócitos T, células com funções imunológicas de efetuação de respostas antivirais. Quem nos ajuda a entender melhor é o professor Daniel de Oliveira Gomes, do Centro de Ciências da Saúde da Universidade Federal do Espírito Santo (Ufes), doutor em Imunologia pela UFRJ e Universidade de Harvard. Acompanhe! Quando um vírus infecta uma pessoa e passa a se multiplicar dentro de suas células, ele desencadeia primeiro a resposta imune inata (inespecífica). Células chamadas de macrófagos identificam o vírus e o fagocitam. Há também a ação de proteínas chamadas interferons, uma espécie de “cadeado” que impede as células infectadas de replicarem o vírus. Se a resposta imune inata não resolver o problema, entra em cena o sistema imune adaptativo, formado por anticorpos neutralizantes (resposta humoral) e pelos linfócitos T (imunidade celular), que reconhecem o patógeno e podem destruir as células infectadas. O estudo é da Universidade de São Paulo e um preprint já foi publicado na plataforma medRxiv, mas ainda precisa ser revisado por pares.
I will be discussing two children ill with both Lyme disease and Mono. In this episode, I will be reviewing a topic that was recently featured in Vox Magazine by author Julia Belluz.1 The article, “Long COVID isn’t as unique as we thought” reviews some commonalities between patients with post-COVID-19 symptoms and those with other chronic illnesses. In her article, she describes the case of Dr. Craig Spencer, who experienced long-term symptoms after contracting Ebola in late 2014 while working with Doctors without Borders.Dr. Spencer explains, “Though the physical effects eventually faded, cognitive complications persist to this day.” These symptoms are “a subtle but noticeable difference in concentration and ability to form new memories.” He also has muscle and joint pain, along with fatigue.Ebola, COVID-19 and Lyme disease share the same chronic symptoms including fatigue, pain and cognitive issues. Dr. Spencer’s experience has “led him to join the growing chorus of health professionals, patient advocates, and researchers who argue we need to reframe how we think about coronavirus long-haulers.” wrote the author.Trust me. It is a good read.1. Long Covid isn’t as unique as we thought by Julia Belluz in Vox. https://www.vox.com/22298751/long-term-side-effects-covid-19-hauler-symptoms Last accessed 4/10/21. . 2. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. Jan 30 2021;doi:10.1101/2021.01.27.21250617You can hear more about these cases through his blogs, social media, and YouTube. Sign up for our newsletter to keep up with these cases.How to Connect with Dr. Daniel Cameron:Check out his website: https://www.DanielCameronMD.com/Call his office: 914-666-4665Email him: DCameron@DanielCameronMD.com Send him a request: https://danielcameronmd.com/contact-daniel-cameron-md/Like him on Instagram: https://www.instagram.com/drdanielcameron/Join his Facebook group: https://www.facebook.com/danielcameronmd/Follow him on Twitter: https://twitter.com/DrDanielCameronSign up for his newsletter: https://www.DanielCameronMD.com/Subscribe and ring the bell: https://www.youtube.com/user/danielcameronmd/ Leave a review on iTunes or wherever else you get your podcasts.We, of course, hope you’ll join the conversation, connect with us and other readers, ask questions, and share your insights. Dr. Cameron is a Lyme disease expert and the author "Inside Lyme: An expert's guide to the science of Lyme disease." He has been treating adolescents and adults for more than 30 years.Please remember that the advice given is general and not intended as specific advice as to any particular patient. If you require specific advice, then please seek that advice from an experienced professional.
雑談回。エヴァ(観てない)、シン・ゴジラ、ボストンの海鮮、ワクチン、ヘイトクライム等について。 Show Notes: Evangelion 3.0+1.0 Thrice Upon A Time...本当に見たい 鷺巣詩郎...エヴァの音楽作ってる人。さぎすしろう。 巨神兵東京に現わる...庵野監督による特撮作品 Union Oyster House...ボストンのシーフードの老舗 Legal Sea Foods...村上春樹もよく行っている(た)というシーフード店。(「ラオスにいったい何があるんですか？」に収録) アストラゼネカ製ワクチンと血栓症には因果関係は認められず、リスクがメリットを上回るため基本的には継続使用を推奨するというWHOのレポート。(*3/20時点での情報なので最新の情報にアクセスするようにしてください) Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities...medRxivのイスラエルにおけるPfizar-BioNTechのBNT162b2のCOVID疫学プレプリント。ここまで効果的とは...mRNAすごい。 White supremacy and hate are haunting Asian Americans...在米アジア人は気をつけましょう Editorial Notes: 巨神兵東京に現る、はシン・ゴジラじゃなくてQとの同時公開でしたね…記憶力を強くしたい…（宮脇） >Qとの同時公開 うーん、すると観てるはずなんですが記憶にない... シン・ゴジラのキャスティングはほぼほぼ全員よかったのですが、特にノーメイク+前髪脂ぎってベタベタになった市川実日子が、人の肌の陰影のコントラストをやたらに高めた画作りも相まって最高に味が出ていてよかったですね。あと高橋一生は2枚目でない変人をやらせた方がハマる、というのを再確認。 (萩原)
The past year has seen an increase in antibiotic prescriptions, especially for broad-spectrum antibiotics. This might be due to the rise in teleconsultations, which limit the ability to examine patients, causing GPs to experience higher levels of uncertainty in making diagnoses. This week, we discuss the impact that COVID-19, and COVID tests, have had on access to healthcare, the risk of antimicrobial resistance, and how the pandemic has altered the presentation and case mix seen in GP surgeries. With teleconsulting likely here to stay, how do we adjust to the changes in primary care provision, in order to prescribe with confidence? And how do we become good antibiotic stewards? Our guests: Geva Greenfield is a research fellow in the Department of Primary Care & Public Health at Imperial College London's School of Public Health. His research focuses on primary care and health policy, and big healthcare data analytics. Benedict Hayhoe is a London-based GP, and a clinical lecturer in the Department of Primary Care & Public Health at Imperial College London's School of Public Health. His research interests include digital health and antimicrobial resistance. Further reading: https://www.expmedndm.ox.ac.uk/step-up Armitage A, Nellums L. Antibiotic prescribing in general practice during COVID-19. The Lancet Infectious Diseases 2020. https://doi.org/10.1016/S1473-3099(20)30917-8 de Lusignan S, Joy M, Sherlock J, Tripathy M, van Hecke O, Gbinigie O et al. PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship. medRxiv. 2021. https://doi.org/10.1101/2021.02.02.21250902 Han SM, Greenfield G, Majeed A, Hayhoe B. Impact of Remote Consultations on Antibiotic Prescribing in Primary Health Care: Systematic Review. Journal of Medical Internet Research 2020; 22(11):e23482. https://doi.org/10.2196/23482 Hayhoe B, Butler C, Majeed A, Saxena S. Telling the truth about antibiotics: benefits, harms and moral duty in prescribing for children in primary care. Journal of Antimicrobial Chemotherapy 2018; 73(9):2298-2304. https://doi.org/10.1093/jac/dky223 Hayhoe B, Greenfield G, Majeed A. Is it getting easier to obtain antibiotics in the UK? British Journal of General Practice 2019; 69(679):54-55. https://doi.org/10.3399/bjgp19X700829 Morrell L, Buchanan J, Roope L, Pouwels K, Butler C, Hayhoe B et al.. Delayed Antibiotic Prescription by General Practitioners in the UK: A Stated-Choice Study. Antibiotics 2020; 9(608). https://doi.org/10.3390/antibiotics9090608 Shah S, Wordley, Thompson W.. How did COVID-19 impact on antibiotic prescribing across England? British Dental Journal 2020; 229(9):601-604. https://doi.org/10.1038/s41415-020-2336-6 van de Pol A, Boeijen J, Venekamp R, Platteel T, Damoiseaux R, Kortekaas M et al.. Impact of the COVID-19 Pandemic on Antibiotic Prescribing for Common Infections in The Netherlands: A Primary Care-Based Observational Cohort Study. Antibiotics 2021; 10(196). https://doi.org/10.3390/antibiotics10020196 Zhu N, Aylin P, Rawson T, Gilchrist M, Majeed A, Holmes A.. Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves. Clinical Microbiology and Infection 2021. https://doi.org/10.1016/j.cmi.2021.02.007
The evidence geekery continues, and this week Helen Macdonald and Duncan Jarvies are joined by Joe Ross, The BMJ's US research editor, and professor of medicine and public health at Yale. This week we pick up on a preprint in medRxiv, which has been attracting attention on social media - it tries to look at the longer term effects of covid hospitalisation. Joe explains why he thinks propensity matching can be summarised as "doing your best". Finally, as more and more care moves remotely, we discuss a trial on a digital intervention to help manage poorly controlled hypertension remotely. Reading list: Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study https://www.medrxiv.org/content/10.1101/2021.01.15.21249885v1.full.pdf Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial https://www.bmj.com/content/372/bmj.m4858
The evidence geekery continues, and this week Helen Macdonald and Duncan Jarvies are joined by Joe Ross, The BMJ's US research editor, and professor of medicine and public health at Yale. This week we pick up on a preprint in medRxiv, which has been attracting attention on social media - it tries to look at the longer term effects of covid hospitalisation. Joe explains why he thinks propensity matching can be summarised as "doing your best". Finally, as more and more care moves remotely, we discuss a trial on a digital intervention to help manage poorly controlled hypertension remotely. Reading list: Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study https://www.medrxiv.org/content/10.1101/2021.01.15.21249885v1.full.pdf Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial https://www.bmj.com/content/372/bmj.m4858
In der 45. Folge des Infektiopods geht es um eine Studie zu Colchicin als Mittel gegen schwere Verläufe von Covid-19 und um einen vektorbasierten Impfstoff der Firma J&J mit dem Namen Ad26.CoV2.S, für den Phase 1/2-Daten veröffentlicht wurden und die Phase-3 Daten kurz bevor stehen. Links: Colchicin-preprint auf MedRxiv.org Nachtrag zu Mutationen von Moderna: mRNA-1273 … „Infektiopod#45 Covid-19: Colchicin & Ad26.CoV2.S (Impfstoff von J&J)“ weiterlesen
Reuters owns the content. Check out reports posted in medRxiv on Saturday ahead of peer review, (bit.ly/3qUFUZM), (bit.ly/348Jkhx), (bit.ly/386b4EX), (bit.ly/2LBZ7zd). Open tmsnrt.rs/3a5EyDh in an external browser for a Reuters graphic on vaccines and treatments in development.
In the never ending battle with COVID-19, new studies have demonstrated a role for IVIG in the treatment of acute COVID-19 pneumonia, the potential benefit of honey and black seed in mild to moderate COVID-19, and the efficacy of an mRNA vaccine. What does this all mean for current practice? Additional References: IVIG: Gharebaghi, N., Nejadrahim, R., Mousavi, S.J. et al. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial. BMC Infect Dis 20, 786 (2020). https://doi.org/10.1186/s12879-020-05507-4 Honey: Ashraf S, Ashraf S, Imran M, et al. Efficacy of honey and Nigella sativa against COVID-19: HNS-COVID-PK Trial. medRxiv 2020.10.30.20217364; doi: https://doi.org/10.1101/2020.10.30.20217364 Cleveland Clinic Hospitalization Risk for COVID-19 Positive Calculator: https://riskcalc.org/COVID19Hospitalization/ Cleveland Clinic Predict COVID-19 test result Calculator: https://riskcalc.org/COVID19/ This episode is accredited for CPE. Subscribe at CEimpact https://www.ceimpact.com/pharmacist and claim your CE today! The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
In the never ending battle with COVID-19, new studies have demonstrated a role for IVIG in the treatment of acute COVID-19 pneumonia, the potential benefit of honey and black seed in mild to moderate COVID-19, and the efficacy of an mRNA vaccine. What does this all mean for current practice?Additional References:IVIG: Gharebaghi, N., Nejadrahim, R., Mousavi, S.J. et al. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial. BMC Infect Dis 20, 786 (2020). https://doi.org/10.1186/s12879-020-05507-4 Honey: Ashraf S, Ashraf S, Imran M, et al. Efficacy of honey and Nigella sativa against COVID-19: HNS-COVID-PK Trial. medRxiv 2020.10.30.20217364; doi: https://doi.org/10.1101/2020.10.30.20217364 Cleveland Clinic Hospitalization Risk for COVID-19 Positive Calculator: https://riskcalc.org/COVID19Hospitalization/ Cleveland Clinic Predict COVID-19 test result Calculator: https://riskcalc.org/COVID19/ This episode is accredited for CPE. Subscribe at CEimpact https://www.ceimpact.com/pharmacist and claim your CE today!The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information.
In the never ending battle with COVID-19, new studies have demonstrated a role for IVIG in the treatment of acute COVID-19 pneumonia, the potential benefit of honey and black seed in mild to moderate COVID-19, and the efficacy of an mRNA vaccine. What does this all mean for current practice? Additional References: IVIG: Gharebaghi, N., Nejadrahim, R., Mousavi, S.J. et al. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial. BMC Infect Dis 20, 786 (2020). https://doi.org/10.1186/s12879-020-05507-4 Honey: Ashraf S, Ashraf S, Imran M, et al. Efficacy of honey and Nigella sativa against COVID-19: HNS-COVID-PK Trial. medRxiv 2020.10.30.20217364; doi: https://doi.org/10.1101/2020.10.30.20217364 Cleveland Clinic Hospitalization Risk for COVID-19 Positive Calculator: https://riskcalc.org/COVID19Hospitalization/ Cleveland Clinic Predict COVID-19 test result Calculator: https://riskcalc.org/COVID19/ This episode is accredited for CPE. Subscribe at CEimpact https://www.ceimpact.com/pharmacist and claim your CE today! The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information.
Interview with Rebecca Pinals (recorded 2020-11-09) Rebecca Pinals is scientist and grad student with the Landry Lab at UC Berkeley. We discuss how the optical properties of Carbon nanotube nanosensors make them a great tool for sensing of biochemicals and how she and her group recently applied nanotubes to detect coronavirus SARS-CoV-2. Landry Lab at UC Berkeley: https://landrylab.com/ Rebecca Pinals on Twitter: https://twitter.com/rlplikesscience Landry Lab on Twitter: https://twitter.com/Landry_Lab Related articles to optical sensing of Coronavirus with Carbon Nanotube nanosensors: Pinals, R. L. et al. Rapid SARS-CoV-2 Detection by Carbon Nanotube-Based Near-Infrared Nanosensors. medRxiv preprint (2020). Pinals, R. L. et al. Quantitative Protein Corona Composition and Dynamics on Carbon Nanotubes in Biological Environments. Angewandte Chemie International Edition (2020). Pinals, R. L. et al. Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function. Analyst (2020). SCIENCE OFF CAMERA PODCAST Anchor: https://anchor.fm/science-off-camera/ Apple Podcast: https://apple.co/2XCqCfz Spotify: https://spoti.fi/3dx1nRn Google: https://bit.ly/2BC5mOw TELEDYNE PRINCETON INSTRUMENTS ONLINE Web: https://www.princetoninstruments.com Twitter: https://www.twitter.com/Princeton_Inst LinkedIn: https://www.linkedin.com/company/princeton-instruments Youtube: https://www.youtube.com/user/princetoninstruments Welcome to Science Off Camera, brought to you by Teledyne Princeton Instruments and Teledyne Photometrics, hosted by Dr. Matthew Kose-Dunn and Sebastian Remi. On this podcast you will find conversations with scientists and industry leaders in scientific imaging and spectroscopy.
O resumo semanal do news.med.br traz as seguintes publicações: - Neurofilamento de cadeia leve no humor vítreo do olho pode sinalizar risco de neurodegenaração (Alzheimer's Research & Therapy); - SARS-CoV-2 infecta astrócitos cerebrais de pacientes com COVID-19 e prejudica a viabilidade neuronal (medRxiv); - Glândulas salivares tubárias: um novo órgão potencial em risco para radioterapia (Radiotherapy and Oncology); - Relação entre ansiedade e depressão maternas e asma em crianças: estudo associa asma com sofrimento psicológico materno (Thorax); - Gotículas de lipídios de mamíferos são centros imunes inatos que integram o metabolismo celular e a defesa do hospedeiro (Science); - Tratamento intensivo para reduzir a pressão arterial versus tratamento padrão não resultou em diferença clinicamente relevante na função cognitiva de domínios específicos (The Lancet). Veja mais notícias em news.med.br.
Today on The Leaders' Brief - Russian ambassador to Mali, Igor Gromyko, was one of the first officials to be received by the Mali Junta after a coup overthrew President Ibrahim Boubacar Keita. Local media houses have reported that the military leaders of the coup had spent a year training in Russia. The report was suggestive that Moscow was planning to increase its security presence in Africa. China's coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe, according to researchers who published their findings in a paper posted on the medRxiv preprint server. On Tuesday, the Indian government said it had approved incentives for 16 companies, including Apple suppliers Foxconn, Wistron, and Pegatron, to manufacture smartphones in the country. India's Production Link Incentive aims at producing mobile phones and phone components worth over $140 billion in the next five years. About egomonk: Website | Facebook | Twitter | LinkedInegomonk is a global intelligence platform delivering asymmetric outcomes by bringing organizations closer to the communities they want to serve and the leaders they wish to influence. If you wish to collaborate with us then email us at contact@egomonk.com.
Preprint serveri: - arXiv (https://arxiv.org/), preteča svih - buiRxiv (https://www.biorxiv.org/), za biologiju - medRxiv (https://www.medrxiv.org/), za medicinu Povučeni radovi: - Surgisphere članak u Lancet-u (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31324-6/fulltext) - Surgisphere članak u NEJM-u (https://www.nejm.org/doi/full/10.1056/NEJMc2021225) Radovi koje bi možda trebalo povući: - (šalimo se, takvih je previše!) Dorbi preprinti: - Deksametazon u RECOVERY studiji (https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1) - Pregled NHS kartona (https://www.medrxiv.org/content/10.1101/2020.05.06.20092999v1) Loši preprinti: - Previše za nabrojati Zli preprinti: - SARS-CoV-2 je nastao u laboratoriji (https://zenodo.org/record/4028830#.X2aUa9YpCAb)
Recorded July 27, 2020https://walkinverse.buzzsprout.com/For those who still take any kind of test for COV I would advise you to stop. Since I wrote this initial report we have learned more about the test and procedures used. The PCR test doesn't work, it generates false positives. The nasal swabs are now known to cause severe adverse reactions due to the chemicals contained within. The e-book will be updated with new inforomation and expanded. Once complete, it'll be available to all paid members or on Amazon for $5.99.Episode #15, "PCR Test, the Gold Standard." In this report, we will dig into the PCR test that they claim is the gold standard and used to drive policy in the US and world.According to Dr. Pascal Sacré, the test is not reliable as it produces simplistic answers, allowing governments to manipulate results to manage what people think and believe. It's to instill fear for political gain, to deceive the people into giving up their rights.The way the PCR test works, it collects cell samples from the back of the nose, hence the long swabs. They then search the samples (your DNA) for the SARS-COV-2 virus by amplifying the gathered cells to identify the person as positive or negative for COVID-19.An important note is this test is highly complicated and subject to a collection of missteps. Yet, we are told this is the gold standard? [1]PCR Test Results (False Positives & Negatives)And as we dig further into PCR, the issue with this test is emerging to the forefront. Even the CDC has come out with guidelines on how to interrupt the results. A Gold Standard test now needs interpretations of its results. On the Whitehouse website, their guidance states for all COVID test that “if you test positive you Most likely* have an active COVID-19 infection. [2]”And what does the asterisk mean with the word likely?“No test is ever perfect. All tests occasionally result in false-positive results…”And if we look at the CDC website on antibody testing, what do they say a positive test means?“A positive test result shows you may have antibodies from an infection with the virus that causes COVID-19. However, there is a chance a positive result means that you have antibodies from an infection with a virus from the same family of viruses (called coronaviruses), such as the one that causes the common cold. [3]”It means you can have a common cold. With that said, in an article dated May 2020 [4], it states how growing concerns are over the accuracy of the test.Quote:“First, you should know that a true positive result means that the test did find what it was looking for. For example, if you get tested for flu, a true positive result means that the test detected the presence of genetic material from the flu virus. On the other hand, a true false result means that no genetic material from the flu was detected.”“But the trouble with tests (PCR) is that you can't be sure what you are getting is a true positive or true negative. You have to rely on probabilities.”And secondly:“A false positive means that the test shows a positive result, but in reality it should be a negative result. This means that a patient may be told that they have COVID-19, but they actually do not.”“A false negative means that the test shows a negative result, but it should have been a positive result. This means that the patient may be told they don't have COVID-19, but they actually are infected.”And as sated earlier, they contribute some reason for these fraudulent results to samples contaminated with the virus and, or, human error [5]. “Coronavirus Cases Up The report showed that Orlando Health had a 98 percent positivity rate. However, when FOX 35 News contacted the hospital, they confirmed errors in the report. Orlando Health's positivity rate is only 9.4 percent, not 98 percent as in the report.”With all that stated, what does Dr. Kary Mullins say about the PCR test he created [6],“Kary Mullis… With regard to the viral-load tests, which attempt to use PCR for counting viruses, Mullis has stated: ‘Quantitative PCR is an oxymoron.' PCR is intended to identify substances qualitatively, but by its very nature is unsuited for estimating numbers. Although there is a common misimpression that the viral-load tests actually count the number of viruses in the blood, these tests cannot detect free, infectious viruses at all; they can only detect proteins that are believed, in some cases wrongly, to be unique to HIV. The tests can detect genetic sequences of viruses, but not viruses themselves.”In other words, when he stated, “Quantitative PCR is an oxymoron.” He's saying the PCR test can't be used to define how much of the virus is in the body. The test is pretty much meaningless for COVID results; its primary purpose is its ability to lock you down and strip away your liberties and freedoms. Let that sink in.Don't use PCR for COVAs we continue, what else Dr. Mullis have to say on the topic [7],“PCR detects a very small segment of the nucleic acid which is part of a virus itself. The specific fragment detected is determined by the somewhat arbitrary choice of DNA primers used which become the ends of the amplified fragment.”And when Dr. David Rasnick, a biochemist, was asked about the test and process he expressed the following,“You have to have a whopping amount of any organism to cause symptoms. Huge amounts of it…”“You don't start with testing; you start with listening to the lungs. I'm skeptical that a PCR test is ever true. It's a great scientific research tool. It's a horrible tool for clinical medicine. 30% of your infected cells have been killed before you show symptoms. By the time you show symptoms … the dead cells are generating the symptoms.” [7]They then asked about his advice on whether one should take the test. He replied,“Don't do it… No healthy person should be tested. It means nothing but it can destroy your life, make you absolutely miserable.”Now, why would this doctor state this test would devastate your life?Quote,“Every time somebody takes a swab, a tissue sample of their DNA, it goes into a government database. It's to track us, they're not just looking for the virus.”And one last take away from Dr. Rasnick is, “PCR for diagnosis is a big problem,” he continues. “When you have to amplify it these huge numbers of time, it's going to generate massive amounts of false positives. Again, I'm skeptical that a PCR test is ever true.”And in another article, it reaffirms what Dr. Rasnick said without realizing it. They concluded, “PCR tests specific for COVID-19 are possible because the viral sequence was shared globally via a public database.” [8]So, as stated by the inventor and many other experts, once the DNA is collected and replicated millions of times, lab technicians check the results against a shared global public database such as the REDCap [9] database.REDCap: Global SurveillanceREDCap is a globally distributed database used today by over 4,300 active partners in 137 countries, including the CDC and WHO. It's used for the tracking and support of COVID-19 test results and individuals.In April, ApiJet Systems Corp. was awarded a $138M DoD contract to provide 100 [10] million pre-filled syringes for distribution across the United States by the end of 2020 via project Jumpstart.These syringes have an optional RFID tag and GPS-based location tracking option, a.k.a. Contact Tracing. The data is submitted to a global data store for real-time injection mapping and monitoring, thanks to big-tech companies such as Apple and Google [11].And to make everyone feel more confident, they claim this is for their citizens' safety as it allows their governments to defend them against pandemics and improve global access to essential medicines (vaccines).WIV Reports — Uncensored is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.References1. Wyllie, A. L. et al. Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs. medRxiv 2020.04.16.20067835 (2020) doi:10.1101/2020.04.16.20067835.2. Interpreting COVID-19 Test Results. Whitehouse 1.3. CDC. Coronavirus Disease 2019 (COVID-19): Testing. Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/testing/serology-overview.html (2020).4. Chia-Yi Hou. False positive and false negative coronavirus test results explained. TheHill https://thehill.com/changing-america/well-being/prevention-cures/496651-false-positive-and-false-negative-coronavirus (2020).5. Tyler Durden. Florida Labs Acknowledge ‘Major Errors' After Reporting Positivity Rates Of 100%. Zero Hedge https://www.zerohedge.com/geopolitical/several-florida-labs-report-positivity-rates-100 (2020).6. The Ebola Test's Inventor Says The Test Is Unreliable. Transmissions http://transmissionsmedia.com/the-ebola-tests-inventor-says-the-test-is-unreliable/ (2014).7. Farber, C. Was the COVID-19 Test Meant to Detect a Virus? UncoverDC https://uncoverdc.com/2020/04/07/was-the-covid-19-test-meant-to-detect-a-virus/ (2020).8. PCR testing inventor speaks to WGN amid COVID-19 pandemic. WGN-TV https://wgntv.com/news/coronavirus/pcr-testing-inventor-speaks-to-wgn-amid-covid-19-pandemic/ (2020).9. REDCap. REDCap https://projectredcap.org/10. $138M DOD Contract: ApiJect Will Supply Prefilled Coronavirus Syringes with RFID GPS Tracking and Confirmation. USAHITMAN Conspiracy News https://usahitman.com/apiject-rfid-covid/ (2020).11. Gurman, M. Apple, Google Bring Covid-19 Contact-Tracing to 3 Billion People. Bloomberg.com (2020). This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit walkinverse.substack.com/subscribe
Zwei große Studien zu COVID-19 sind jüngst von den Autoren zurückgezogen worden. Beide Arbeiten waren zuvor nach Peer Reviews in hochrangigen Journals veröffentlicht worden – im "New England Journal of Medicine" und in "The Lancet". Die Arbeiten hatten sich mit wichtigen klinischen Fragen zum Coronavirus SARS-CoV-2 beschäftigt: eine Studie mit dem Risiko von Blutdrucksenkern (ACE-Hemmern und Sartanen), die andere mit dem Nutzen und möglichen Nebenwirkungen des Malariamittels Hydroxychloroquin. Problem der Arbeiten, hinter denen teils dieselben Autoren standen, sind erhebliche Zweifel an der Qualität der zugrundeliegenden Registerdaten. Doch dies lässt sich nicht prüfen, da ein Autor die Daten nicht zur Prüfung bereitstellen will. Was bedeuten solche Retractions im Allgemeinen und ganz speziell mit Blick auf die Situation bei COVID-19? Welche Auswirkungen kann das auf die klinische Praxis haben? Und wie lassen sich solche Widerrufe vermeiden? Darüber reden wir in dieser "CoronaUpdate"-Episode. Und wir besprechen eine Fallserie mit 1000 Patienten aus New York. Darin entwickelten die meisten Patienten auf der Intensivstation ein akutes Nierenversagen. Wir überlegen, ob die Niere womöglich ein "COVID-19-Organ" ist. Quellen: 1. Argenziano MG, Bruce SL, Slater CL, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020;369:m1996. Published 2020 May 29. doi: https://doi.org/10.1136/bmj.m1996 2. Michael G Argenziano, Samuel L Bruce, Cody L Slater, et al. Characterization and clinical course of 1000 Patients with COVID-19 in New York: retrospective case series. medRxiv 2020.04.20.20072116; doi: https://doi.org/10.1101/2020.04.20.20072116 3. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 [published online ahead of print, 2020 May 1] [retracted in: N Engl J Med. 2020 Jun 4;:]. N Engl J Med. 2020;NEJMoa2007621. doi: https://doi.org/10.1056/NEJMoa2007621 4. Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis [published online ahead of print, 2020 May 22] [published correction appears in Lancet. 2020 May 30;:]. Lancet. 2020;S0140-6736(20)31180-6. doi: https://doi.org/10.1016/S0140-6736(20)31180-6 5. Corona-Warn-App. The official COVID-19 exposure notification app for Germany. GitHub. https://github.com/corona-warn-app
Jetzt beginnt das große Testen, das Testen auf Corona-Infektionen. Denn wenn Schulen und Kitas wieder öffnen, könnten sich rasch wieder neue SARS-2-Coronavirus-Cluster bilden. Und im Hintergrund steht die Furcht vor einer „zweiten Welle“. Jetzt gilt es, neue Infektionsherde früh zu erkennen, um rasch eingreifen zu können. Und das mit dem Wissen, dass rund die Hälfte aller Übertragungen in den Tagen vor den ersten Symptomen einer infizierten Person stattfindet. Doch wie könnte eine kluge Teststrategie aussehen? Welche Gruppen sollten wie getestet werden, damit Laborressourcen nicht unnötig verbraucht werden? Und damit es noch eine gute Aussagekraft angesichts der geringen Prävalenz gibt. Könnte eine Pooltestung helfen? Quellen: 1. He, X., et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 26, 672–675 (2020). https://doi.org/10.1038/s41591-020-0869-5 2. Ganyani Tapiwa, et al. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveill. 2020;25(17):pii=2000257. https://doi.org/10.2807/1560-7917.ES.2020.25.17.2000257 3. Tomas Pueyo. Coronavirus: The Hammer and the Dance. 13.03.2020. https://medium.com/@tomaspueyo/coronavirus-the-hammer-and-the-dance-be9337092b56 4. Bayerische Staatskanzlei. Bericht aus der Kabinettssitzung. Nr. 103. 26.05.2020. https://www.bayern.de/wp-content/uploads/2020/05/200526-ministerrat.pdf 5. Deutschlandfunk. Bundesfamilienministerin kündigt bundesweites Kita-Register zum Corona-Geschehen an. 27.05.2020. https://www.deutschlandfunk.de/covid-19-bundesfamilienministerin-kuendigt-bundesweites.1939.de.html?drn:news_id=1134918 6. Zi und DEGAM. Anforderungen an die Organisation der ambulanten hausärztlichen Versorgung während der COVID-19-Pandemie. 6.05.2020. https://www.zi.de/fileadmin/images/content/PMs/Zi_DEGAM_Versorgungsplanung_2020-05-06_final.pdf 7. Anno Fricke. Jens Spahn lockert Vorschriften für Corona-Tests. 27.05.2020. https://www.aerztezeitung.de/Politik/Jens-Spahn-lockert-Vorschriften-fuer-Corona-Tests-409830.html 8. ICD-10-GM 2020: Neuer U-Kode U99.0! und neue Kodierfrage zu Testung auf SARS-CoV-2. 25.05.2020. https://www.dimdi.de/dynamic/de/das-dimdi/aktuelles/meldung/icd-10-gm-2020-neuer-u-kode-u99.0-und-neue-kodierfrage-zu-testung-auf-sars-cov-2/ 9. Hendrik Streeck, et al. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. medRxiv 2020.05.04.20090076; doi: https://doi.org/10.1101/2020.05.04.20090076 10. Verena Kraehling, et al. Epidemiological study to detect active SARS-CoV-2 infections and seropositive persons in a selected cohort of employees in the Frankfurt am Main metropolitan area. medRxiv 2020.05.20.20107730; doi: https://doi.org/10.1101/2020.05.20.20107730 11. Ing AJ, et al. COVID-19: in the footsteps of Ernest Shackleton. Thorax. Published Online First: 27 May 2020. https://doi.org/10.1136/thoraxjnl-2020-215091 12. Smriti Mallapaty. Will antibody tests for the coronavirus really change everything? Nature 580, 571-572 (2020). https://doi.org/10.1038/d41586-020-01115-z 13. Lauren M. Kucirka, et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure. Ann Int Med 2020. https://doi.org/10.7326/M20-1495 14. Watson Jessica, et al. Interpreting a covid-19 test result BMJ 2020; 369: m1808. https://doi.org/10.1136/bmj.m1808 15. Diagnostic tests for covid-19—improving accuracy and global harmonization. https://blogs.bmj.com/bmj/2020/05/06/diagnostic-tests-for-covid-19-improving-accuracy-and-global-harmonisation/
Nebojša je odsutan. Miloš pokušava da prevede svoje predavanje o Covid-19 i pacijentima sa rakom na srpski. Izvori: 1. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. 2. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. 2020:eabb2762. 3. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–3. 4. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020. 5. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science. 2020:eabb3221. 6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020 7. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. J Clin Invest. 2020. 8. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. Jama. 2020. 9. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. medRxiv. 2020:2020.04.23.20076042. 10. Collaborative TO, Williamson E, Walker AJ, Bhaskaran KJ, Bacon S, Bates C, et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. medRxiv. 2020:2020.05.06.20092999. 11. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020. 12. Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov. 2020. Linkovi: 1. The Covid-19 and cancer consortium (https://ccc19us.org) 2. ASCO Covid-19 resources (https://www.asco.org/asco-coronavirus-information) 3. ASH Covid-19 resources (https://www.hematology.org/covid-19)
Die Schulen haben wieder geöffnet – zumindest teilweise und in verkleinerten Klassen dürfen die Schüler zurück. Auch Geschäfte sollen in Kürze wieder öffnen dürfen, haben Bund und Länder am Mittwoch (6. Mai) beschlossen. Doch zeitgleich zur Öffnung der Schulen tobt eine Diskussion über mutmaßlich wissenschaftliche Beweise, die mal für und mal gegen diesen Schritt sprechen sollen. Kinder könnten genauso "infektiös" wie Erwachsene sein, heißt es in jüngst veröffentlichten Untersuchungen. Jedenfalls konnten Virologen bei Abstrichen von Kindern eine fast ähnlich hohe Viruslast feststellen. Doch taugt das als Argument gegen eine Schulschließung? Ist eine hohe Viruslast gleichzusetzen mit hoher Infektiosität? Und was hat das Schließen von Schulen in China eigentlich gebracht? In diesem "CoronaUpdate" machen wir wieder den Evidenzcheck. Und es ist der erste Akt zu der Frage, wie die neue "Normalität" nach und mit Corona aussehen wird. Quellen: 1. Tweet von Karl Lauterbach: https://twitter.com/Karl_Lauterbach/status/1257292931385483264 2. Terry C. Jones et al. An analysis of SARS-CoV-2 viral load by patient age. 29. April 2020. Preprint: https://zoonosen.charite.de/fileadmin/user_upload/microsites/m_cc05/virologie-ccm/dateien_upload/Weitere_Dateien/analysis-of-SARS-CoV-2-viral-load-by-patient-age.pdf 3. Arnaud G L'Huillier et al. Shedding of infectious SARS-CoV-2 in symptomatic neonates, children and adolescents. medRxiv 2020.04.27.20076778; doi: https://doi.org/10.1101/2020.04.27.20076778 4. Juanjuan Zhang et al. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Science 29 APR 2020. doi: https://doi.org/10.1126/science.abb8001 5. Goldstein Edward, Lipsitch Marc. Temporal rise in the proportion of younger adults and older adolescents among coronavirus disease (COVID-19) cases following the introduction of physical distancing measures, Germany, March to April 2020. Euro Surveill. 2020;25(17):pii=2000596. doi: https://doi.org/10.2807/1560-7917.ES.2020.25.17.2000596 6. Hendrik Streeck et al. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. 4. Mai 2020. Preprint: https://www.ukbonn.de/C12582D3002FD21D/vwLookupDownloads/Streeck_et_al_Infection_fatality_rate_of_SARS_CoV_2_infection2.pdf/$FILE/Streeck_et_al_Infection_fatality_rate_of_SARS_CoV_2_infection2.pdf
Es sind besondere Zeiten in dieser Coronavirus-Pandemie. Die Bundeskanzlerin kritisiert "Öffnungsdiskussionsorgien". Aus Schweden hören wir von Sonderwegen, und auch in der Forschung ist immer mehr von sonderlichen Wegen zu hören. Medizin und Wissenschaft befinden sich im Moment im Hochbetrieb. Bei Pubmed sind allein über 6000 Veröffentlichungen zu den Stichworten COVID-19, SARS-CoV-2 und 2019-nCoV gelistet. Im US-Studienregister clinicaltrials.gov rund 800 Vorhaben registriert. Nicht zu sprechen von den Hunderten ungeprüften Veröffentlichungen auf den Preprintservern. Das Problem: Solche – notwendige – Hyperaktivitätswissenschaft kann schnell auch eine Menge Non-sense produzieren. Die Frage ist dann für Forscher, Mediziner oder Journalisten: Wie die Spreu vom Weizen trennen? Selbst Wissenschaftler räumen im Moment ein, dass sie es nicht immer so ganz genau nehmen: "Angesichts der Dringlichkeit der Situation können einige Einschränkungen ... akzeptabel sein, einschließlich der kleinen Stichprobengröße, der Verwendung eines nicht validierten Surrogatendpunktes und des Fehlens von Randomisierung oder Verblindung", heißt es etwa in einer Veröffentlichung. In diesem "CoronaUpdate" befassen wir uns mit fünf Kriterien für gute Wissenschaft in der Krise und drei Regeln, die jeder Forscher und Arzt beherzigen sollte. Und wir schauen, wie Mediziner konkret damit in der Praxis oder am Krankenbett umgehen können. Quellen: 1. Alex J. London, Jonathan Kimmelman. Against pandemic research exceptionalism. Science 23 Apr 2020: eabc1731. doi: https://doi.org/10.1126/science.abc1731 2. Kim AH, Sparks JA, Liew JW, et al, for the COVID-19 Global Rheumatology Alliance. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020; [Epub ahead of print 30 March 2020]. doi: https://doi.org/10.7326/M20-1223 3. Joseph Magagnoli, Siddharth Narendran, Felipe Pereira, Tammy Cummings, James W Hardin, S Scott Sutton, Jayakrishna Ambati. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv 2020.04.16.20065920; doi: https://doi.org/10.1101/2020.04.16.20065920
Angesichts der COVID-19-Pandemie läuft die Suche nach Impfstoffen und Therapien auf Hochtouren. Allein auf der Website des Verbands forschender Arzneimittelhersteller, dem vfa, ist die Rede von „mindestens 80 Impfstoffprojekten“. Und zig Wirkstoffe und Kombinationen werden genannt, an denen geforscht wird. Im US-Studienregister clinicaltrials.gov findet man über 440 registrierte interventionelle Studien zu COVID-19. In der vergleichbaren EU-Datenbank EudraCT sind immerhin gut über 100 gemeldete klinische Forschungsprojekte registriert. In dieser Episode vom "CoronaUpdate" beschäftigen wir uns mit zwei Wirkstoffen, die momentan erforscht werden: Chloroquin und Remdesivir. Letzteres, ein RNA-Polymerasehemmer, hat jetzt in Studienpublikationen erste Wirksamkeitsnachweise angetreten. Doch wie aussagekräftig können diese Studiendaten sein? Und beim Malariamedikament Chloroquin war jüngst eine Studie teilweise abgebrochen worden, weil es unter der Hochdosistherapie zu Todesfällen kam. Dämpft das die Hoffnung für eine Arznei, die US-Präsident Donald Trump "ein starkes Medikament" nannte? Quellen: 1. Jonathan Grein, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med April 10, 2020. DOI: https://doi.org/10.1056/NEJMoa2007016 2. Brandi N. Williamson, et al. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. bioRxiv 2020.04.15.043166; doi: https://doi.org/10.1101/2020.04.15.043166 3. Mayla Gabriela Silva Borba, et al., CloroCovid-19 Team. Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study). medRxiv 2020.04.07.20056424; doi: https://doi.org/10.1101/2020.04.07.20056424 4. David N. Juurlink. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. CMAJ Apr 2020, cmaj.200528; DOI: https://doi.org/10.1503/cmaj.200528
Für den schrittweisen Ausstieg aus dem Lockdown fordern Wissenschaftler und Politiker unter anderem das Tragen von Masken in der Öffentlichkeit, zumindest in speziellen Situationen, etwa in Bussen und Bahnen. Wie wirksam aber wäre der Schutz vor SARS-CoV-2, würden alle Bürger Masken tragen? Ließe sich die Pandemie damit bezwingen? Oder wiegen wir uns mit ihnen vielleicht nur in trügerischer Sicherheit? Die Forschung hat sich des Themas schon vor Jahren angenommen und ist auch jetzt angesichts der Coronavirus-Pandemie aktiv. Gesucht wird nach dem Beweis, welche Masken was nützen. In dieser Episode vom "CoronaUpdate" sichten wir die jüngste Literatur. Quellen: 1. Lydia Bourouiba. A Sneeze. N Engl J Med 2016; 375:e15. doi: https://doi.org/10.1056/NEJMicm1501197. 2. Greenhalgh Trisha, Schmid Manuel B, Czypionka Thomas, Bassler Dirk, Gruer Laurence. Face masks for the public during the covid-19 crisis BMJ 2020; 369 :m1435. doi: https://doi.org/10.1136/bmj.m1435 3. Marasinghe KM. A systematic review investigating the effectiveness of face mask use in limiting the spread of COVID-19 among medically not diagnosed individuals: shedding light on current recommendations provided to individuals not medically diagnosed with covid-19. Version 2. Research Square 2020.[Preprint.] doi: https://doi.org/10.21203/rs.3.rs-16701/v2 4. Long Y, Hu T, Liu L, et al. Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis. J Evid Based Med2020. doi: https://doi.org/10.1111/jebm.12381 pmid:32167245 5. MacIntyre CR, Cauchemez S, Dwyer DE, et al. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis2009;15:233-41. doi: https://doi.org/10.3201/eid1502.081166 pmid:19193267 6. Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev2011;7:CD006207. doi: https://doi.org/10.1002/14651858.CD006207.pub4 pmid:21735402 7. Cowling BJ, Zhou Y, Ip DK, Leung GM, Aiello AE. Face masks to prevent transmission of influenza virus: a systematic review. Epidemiol Infect2010;138:449-56. doi: https://doi.org/10.1017/S0950268809991658 pmid:20092668 8. Aledort JE, Lurie N, Wasserman J, Bozzette SA. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health2007;7:208. doi: https://doi.org/10.1186/1471-2458-7-208 pmid:17697389 9. Xiao J, Shiu EYC, Gao H, et al. Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings-personal protective and environmental measures. Emerg Infect Dis2020;26. doi: https://doi.org/10.3201/eid2605.190994 pmid:32027586 10. Brainard JS, Jones N, Lake I, et al. Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review. MedRxiv 2020.04.01.20049528 [Preprint.] 2020 doi: https://doi.org/10.1101/2020.04.01.20049528 11. Cowling BJ, Ali ST, Ng TW, et al. Impact assessment of non-pharmaceutical interventions against COVID-19 and influenza in Hong Kong: an observational study. medRxiv 2020.03.12.20034660. [Preprint.] doi: https://doi.org/10.1101/2020.03.12.20034660 12. Bae S, Kim M, Kim JY, et al. Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled Comparison in 4 Patients. Ann Intern Med. 2020; [Epub ahead of print 6 April 2020]. doi: https://doi.org/10.7326/M20-1342
Die offiziellen Zahlen zur Corona-Pandemie zeigen uns nur ein Zerrbild: nämlich nur die Daten der laborbestätigten Fälle. Um aber das wahre Ausmaß der Epidemie hierzulande abschätzen zu können, braucht es andere Daten. Reihenweise sind jetzt Studien angelaufen, die das untersuchen sollen. Die Forscher wollen die Durchseuchung der Bevölkerung ermitteln – über repräsentative Stichproben. Damit könnten sie auch feststellen, wie viele Menschen womöglich immun gegen das Coronavirus SARS-CoV-2 sind, etwa weil sie eine Infektion längst unbemerkt durchgemacht haben. Erste vorläufige Ergebnisse einer solchen Studie gibt es in Deutschland bereits für das Örtchen Gangelt im schwer betroffenen Landkreis Heinsberg in Nordrhein-Westfalen. Doch kaum waren die ersten Daten am Gründonnerstag veröffentlicht, kam Kritik an der Untersuchung auf. In dieser Episode vom "CoronaUpdate" beschäftigen wir uns näher mit der Gangelt-Studie und der Kritik daran. Ist sie womöglich berechtigt? Welche Schlüsse können wir aus einer Erhebung in einem kleinen Ort für die ganze Republik ziehen? Und wie verlässlich sind die Testverfahren, die die Forscher für diese Untersuchungen einsetzen? Eine neue Validitätsstudie aus Kopenhagen lässt nämlich einige Zweifel an Antikörpertests aufkommen. Quellen: 1. Hendrik Streeck, Gunther Hartmann, Martin Exner, Matthias Schmid. Vorläufiges Ergebnis und Schlussfolgerungen der COVID-19 Case-ClusterStudy (Gemeinde Gangelt). www.land.nrw. 9. April 2. Akkreditierten Labore in der Medizin (ALM) e.V. 7. April 3. Ria Lassaunière, Anders Frische, Zitta B Harboe, Alex CY Nielsen, Anders Fomsgaard, Karen A Krogfelt, Charlotte S Jørgensen. Evaluation of nine commercial SARS-CoV-2 immunoassays. medRxiv 2020.04.09.20056325; doi: 10.1101/2020.04.09.20056325
3月17日，一篇尚未经过同行评议的论文刊发在预印本平台medRxiv上面，标题叫做《Relationship between the ABO Blood Group and the COVID-19 Susceptibility》，汉译为《ABO等血型与新冠病毒易感性的关系》，论文内容指出A、B、O、AB血型与新冠肺炎易感性存在关联，具体来说，O型血对新冠肺炎相对不易感，风险较低；而A型血对新冠肺炎相对易感，风险也较高。
For the next few months Talk Evidence is going to focus on the new corona virus pandemic. There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing. We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues. This week 5.00 - Carl gives us an update about pneumonia in primary care, should you give antibiotics when you're not sure if it's bacterial or viral 10.00 - The importance and difficulty of making guidelines now 15.00 - We hear from guideline maker Per Vandvik, about making guidance. 21.40 - Preprint servers for medicine are showing their use in this fast changing situation. Joseph Ross from Yale School of Medicine, and one of The BMJ's research editors, talks to us about the kind of information we're seeing on medRxiv. 31.10 - Testing. What are the tests, and when do we want specificity, and when do we want sensitivity. Nick Beeching from the Liverpool School of Tropical Medicine joins us to explain. Reading list: www.bmj.com/coronavirus Rapidly managing pneumonia in older people during a pandemic https://www.cebm.net/covid-19/rapidly-managing-pneumonia-in-older-people-during-a-pandemic/ https://www.medrxiv.org/ Covid-19: testing times https://www.bmj.com/content/369/bmj.m1403
For the next few months Talk Evidence is going to focus on the new corona virus pandemic. There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing. We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues. This week 5.00 - Carl gives us an update about pneumonia in primary care, should you give antibiotics when you're not sure if it's bacterial or viral 10.00 - The importance and difficulty of making guidelines now 15.00 - We hear from guideline maker Per Vandvik, about making guidance. 21.40 - Preprint servers for medicine are showing their use in this fast changing situation. Joseph Ross from Yale School of Medicine, and one of The BMJ's research editors, talks to us about the kind of information we're seeing on medRxiv. 31.10 - Testing. What are the tests, and when do we want specificity, and when do we want sensitivity. Nick Beeching from the Liverpool School of Tropical Medicine joins us to explain. Reading list: www.bmj.com/coronavirus Rapidly managing pneumonia in older people during a pandemic https://www.cebm.net/covid-19/rapidly-managing-pneumonia-in-older-people-during-a-pandemic/ https://www.medrxiv.org/ Covid-19: testing times https://www.bmj.com/content/369/bmj.m1403
For the next few months Talk Evidence is going to focus on the new corona virus pandemic. There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing. We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues. This week 5.00 - Carl gives us an update about pneumonia in primary care, should you give antibiotics when you're not sure if it's bacterial or viral 10.00 - The importance and difficulty of making guidelines now 15.00 - We hear from guideline maker Per Vandvik, about making guidance. 21.40 - Preprint servers for medicine are showing their use in this fast changing situation. Joseph Ross from Yale School of Medicine, and one of The BMJ's research editors, talks to us about the kind of information we're seeing on medRxiv. 31.10 - Testing. What are the tests, and when do we want specificity, and when do we want sensitivity. Nick Beeching from the Liverpool School of Tropical Medicine joins us to explain. Reading list: www.bmj.com/coronavirus Rapidly managing pneumonia in older people during a pandemic https://www.cebm.net/covid-19/rapidly-managing-pneumonia-in-older-people-during-a-pandemic/ https://www.medrxiv.org/ Covid-19: testing times https://www.bmj.com/content/369/bmj.m1403
© 2020-2025 Ivy Podcast Discovery LLC
